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ABSTRACT 
 A series of experiments were conducted to examine the effect of chemical 
composition of the diet on intestinal Clostridium perfringens populations and necrotic 
enteritis (NE) in broiler chickens. In the first experiment, birds were fed high 
concentrations of dietary protein (fish meal or soy protein concentrate) and soluble fiber 
(guar gum). Clinical NE was not observed, however, there was a high level of C. 
perfringens colonization especially in guar gum fed birds. The next set of experiments 
examined the effect of various levels of DL-Met or MHA-FA on C. perfringens and other 
intestinal microbes. These experiments demonstrated a significant reduction (P < 0.05) in 
C. perfringens growth with methionine supplementation in ileum and cecum. The results 
suggest that both DL-Met and MHA-FA may reduce intestinal populations of C. 
perfringens in broiler chickens when used in high concentrations. The next three 
experiments were conducted to examine the effect of dietary glycine levels on gut C. 
perfringens populations, α-toxin production and NE lesion scores. Majority of birds 
showed clinical signs of disease with 4.16-8.33% mortality. There was a direct 
correlation between intestinal C. perfringens populations, NE lesions scores and mortality 
with dietary glycine level. However, due to the use of gelatin as the dietary source of 
glycine in these experiments, the diets also contained high proline levels which 
confounded our results. The last study was conducted to establish a direct causative 
relationship between dietary glycine concentration and C. perfringens growth and/or NE 
in broiler chickens using encapsulated amino acids. Birds fed diets containing high levels 
of encapsulated glycine had higher NE lesion scores than those fed encapsulated proline 
or no encapsulated amino acids, thus demonstrating a direct effect of glycine on intestinal 
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C. perfringens growth. It is concluded that amino acid composition of dietary protein is 
an important determinant of intestinal microbial growth, particularly C. perfringens, and 
could affect incidence of NE in broiler chickens.  
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1.0. INTRODUCTION 
Enteric diseases are an important concern to the poultry industry because of lost 
productivity, increased mortality, reduced welfare of birds and the associated 
contamination of poultry products for human consumption. For the past four decades, 
antibiotics have been supplemented to animal and poultry feed to improve growth 
performance and efficiency and protect animals from adverse effects of pathogenic and 
non-pathogenic enteric microorganisms (Ferket et al., 2002). Currently, most antibiotics 
are used for therapeutic purposes in humans while medicated animal feeds are the second 
largest consumer of antibiotics. The Union of Concerned Scientists (2003) estimates that 
11.4 million kg of antibiotics are used in medicated feeds in the US each year. In the EU, 
the European Federation of Animal Health reported that in 1999, farm animals consumed 
4.7 million kg or 35% of all antibiotics administered in the EU (European Commission 
Directorate General XXIV Directorate B, 1999). The net effect of using antibiotic growth 
promoters in the poultry industry is estimated to be a 3-5 per cent increase in growth and 
feed conversion efficiency (Thomke and Elwinger, 1998). It has been argued that 
continued, excessive use of antibiotic growth promoters (AGPs) in animal feeds imposes 
a selection pressure for bacteria that are resistant to antibiotics (JETACAR, 1999). 
Hence, antibiotics have come under increasing scrutiny by some scientists, consumers 
and government regulators because of the potential development of antibiotic-resistant 
human pathogenic bacteria after prolonged use (Ratcliff, 2000). Various trade disputes 
among the European Union member countries, coupled with rising consumer concern 
about antibiotic resistance, have caused Scandinavian countries to severely curtail or 
prohibit the use of non-therapeutic antibiotics in poultry feed (Norton, 2000). With a ban 
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on sub-therapeutic antibiotic usage in Europe and the potential for a ban in North 
America, there is increasing interest in finding alternatives to antibiotics for poultry 
production. The Animal Health Institute of America (AHI, 1998) has estimated that, 
without the use of AGPs, the USA would require an additional 452 million chickens, 23 
million more cattle and 12 million more pigs to reach the levels of production attained by 
the current practices. A total ban of prophylactic and therapeutic antibiotics would cost 
the US consumers some US$ 1.2-2.5 billion per year (Gill and Best, 1998).  
The ban of AGPs in broiler feed is an important factor that will inevitably change 
the microbial ecology in the intestinal tract of broiler chickens ( Dumonceaux et al., 
2006; Knarreborg et al., 2002). In the poultry industry, the most significant threat is the 
sporadic outbreak of necrotic enteritis (NE) which, in sub clinical cases, affects growth 
and feed efficiency and in severe cases causes high mortality (Hofshagen & Kaldhusdal, 
1992; Kaldhusdal et al., 2001; Hofacre et al., 2003). The EU ban on sub-therapeutic 
antibiotic usage has had a profound effect on the incidence of NE in broiler chickens 
throughout Europe. For example, the incidence of NE in France increased from 4.0% in 
1995 to 12.4% of reported diseases in 1999 (Drouin, 1999) and similar increases have 
been reported in other countries in Europe (Kaldhusdal and Lovland, 2000). Broiler 
producers in USA who have stopped using in-feed AGPs have seen increases in NE, 
cholangiohepatitis, gangrenous dermatitis and botulism (Shane, 2004). Currently, the use 
of coccidiostats of ionophore type is probably one of the main tool to control NE in the 
absence of AGPs because ionophores not only exert an effect against coccidia, but also 
against several intestinal bacteria including Clostridium perfringens (Elwinger et al., 
1994; Elwinger et al., 1998; Engberg et al., 2000). However, the use of ionophore 
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anticoccidials is currently discussed in EU and will probably also be forbidden by the 
year 2012. The big question for poultry researchers, broiler producers and feed 
manufactures is how to control this disease in the absence of antibiotic growth promoters.  
2.0. LITERATURE REVIEW 
2.1. Etiology and Pathogenesis of Necrotic Enteritis 
 Necrotic enteritis of domestic broiler chickens was first described by Parish in 
1961 and now it is a common disease found in all poultry-growing areas of the world 
(Ficken and Wages, 1997). It is a potentially fatal disease and flock mortality rates may 
reach up to 1% per day with total mortalities attaining 30% (Helmboldt and Bryant, 
1971). The causative agent of NE, Clostridium perfringens, types A (Al-Sheikhly and 
Truscott, 1977b; Long et al., 1974; Long and Truscott, 1976; Niilo, 1978; Songer and 
Meer, 1996; Truscott and Al-Sheikhly, 1977) or C (Engstrom et al., 2003; Nairn and 
Bamford, 1967; Shane et al., 1984), is a nearly ubiquitous gram positive, spore forming, 
extremely prolific, toxigenic anaerobic bacteria found in soil, dust, feces, feed, poultry 
litter, and intestinal contents. The disease usually occurs in broiler chickens 2 to 6 weeks 
after hatching and is characterized by sudden onset of diarrhea and mucosal necrosis 
caused by the overgrowth of C. perfringens in the small intestine (Fukata et al., 1991). 
Normally the number of C. perfringens in the intestine is low (about 104 CFU/g of 
digesta) but disturbances in normal intestinal microflora may cause rapid proliferation of 
C. perfringens, increasing bacterial numbers to 107-109  CFU/g of digesta resulting in the 
development of clinical NE (Kondo, 1988). Also, the presence of C. perfringens in 
poultry meat posses an important threat to public health (Immerseel et al., 2004). Over 
800 serotypes of C. perfringens are known and 17 different toxic fractions have been 
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isolated (Hatheway, 1990; McDonel, 1980). However, one toxic fraction, the 
chromosomal-encoded α toxin is considered the main virulence factor for this disease 
because birds are about 200 times more susceptible to α toxin than to beta or epsilon 
toxin. Alpha toxin is a zinc-metalloenzyme phospholipase C spingomyelinase that 
hydrolyzes phospholipids and promotes membrane disorganization (Naylor et al., 1998; 
Rood, 1998; Titball et al., 2000). Alpha toxin has direct effects on host metabolism 
including inhibition of neutrophil chemotaxis, vasoconstriction and platelet aggregation, 
hemolysis of erythrocytes and necrosis of other body cells;  and modulation of cell 
metabolism by activating the arachidonic acid cascade and protein kinase C (Titball et 
al., 1999). More α toxin  may be produced by isolates from birds with NE than by 
isolates from normal birds (Hofshagen and Stenwig, 1992). Alpha toxin destruction of 
mucosal tissue manifests as macroscopic lesions that are usually seen in jejunum and 
ileum but can also appear in duodenum (Al-Sheikhly and Truscott, 1977a; Fukata et al., 
1988). A mixture of sloughed-off epithelial tissue trapped in fibrin will form a 
diphtheritic membrane that is characteristic of NE. Outbreaks of NE are sporadic and 
may result in high mortality and severe economic losses. It has been estimated that the 
cost of sub-clinical NE can be as much as US $ 0.05 per bird with total global loss of 
almost US$ 2 billion (Van der Sluis, 2000a, 2000b). According to a rough estimate the 
NE (either clinical or sub clinical) is causing a US$ 2 billion loss to the world poultry 
industry per annum. The sub-clinical form of NE may be most economically important 
because of impaired feed conversion, reduced live weight at slaughter and increased 
condemnation percentage associated with C. perfringens infection (Lovland and 
Kaldhusdal, 2001; Stutz and Lawton, 1984). 
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2.2. Experimental Models of Necrotic Enteritis 
 Although C. perfringens is recognized as the etiological agent of NE, other 
contributing factors are usually required which predispose the flocks to disease.  The 
presence of C. perfringens in the intestinal tract of broiler chickens or inoculation of 
animals with high doses of C. perfringens, however, does not always lead to the 
development of NE (Craven et al., 2001; Drew et al., 2004; Kaldhusdal et al., 1999; 
Shane et al., 1984). Due to lack of knowledge of predisposing factors that precipitate the 
disease, a reliable and reproducible C. perfringens infection model has not been 
published. However, some researchers have been able to induce disease and mortality in 
chickens using cultures of unwashed vegetative cells (Al-Sheikhly and Truscott, 1977a; 
Bernier et al., 1977; Branton et al., 1997; Cowen et al., 1987; Long and Truscott, 1976; 
Prescott, 1979). Long and Truscott (1976) used a pure culture challenge model to 
reproduce NE in broiler chickens. Total NE mortality ranged from 1 to 28%. This model 
was later modified to include elevated dietary concentration of fish meal prior to 
initiation of inoculum administration and intra-duodenal administration of inoculum (Al-
Sheikhly and Truscott, 1977a). Infection of broilers with Eimeria acervulina prior to 
administration of a C. perfringens challenge, markedly increased (from 28 to 53%) 
mortality due to NE. E. acervulina or E. necatrix infection alone or feeding C. 
perfringens-contaminated feed without Eimeria infection, did not result in mortality (Al-
Sheikhly and Al-Saieg, 1980).   
 Successful induction of disease usually requires previous intestinal damage, 
particularly sloughing of intestinal epithelial cells and leakage of plasma protein into the 
intestinal lumen. Since the minimum requirements for growth of C. perfringens include 
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more than 11 amino acids, besides various growth factors and vitamins (Fuchs and 
Bonde, 1957; Muhammed et al., 1975; Petit et al., 1999), the leaking of plasma proteins 
to the intestinal lumen may provide a necessary growth substrate for over proliferation of 
C. perfringens and/or for up regulation of α toxin  gene. Shane et al. (1985) reported that 
infection of broiler chickens with Eimeria acervulina prior to inoculation with C. 
perfringens increased mortality from 8% in Eimeria-free control to 35% in Eimeria-
infected birds. This was associated with destruction and sloughing of intestinal 
epithelium, a 39% increase in intestinal passage time, reduced intestinal pH and 
depressed serum protein concentration.  
 Hamdy et al. (1983) used litter from a source that had experienced an outbreak of 
NE and were able to induce the disease. Cowen et al. (1987) tried three different 
methods: a broth culture and feed mixtures, infected litter, and a combination of these. 
The combination was the most effective.  Kaldhusdal et al. (1999) experimented with a 
spontaneous disease model in some of their studies. Williams et al. (2003) demonstrated 
that a combination of diet (high inclusion of wheat and fish meal), infection with Eimeria 
maxima followed by per cloacal C. perfringens inoculation 6 days later resulted in NE 
lesions but no mortality. Jansman et al. (2003) presented a sub-clinical model of NE 
based on a combined challenge with E. acervulina on day 10 of age and a C. perfringens 
challenge on day 14-16 of age. The combined challenge was shown to reduce feed intake 
and body weight gain by 15 and 23%, respectively, and increase feed conversion ratio by 
10% compared to control birds. Necrotic enteritis lesions were observed in almost 50% of 
the challenged birds. Recently, McReynolds et al. (2004) described the disease 
production in broiler chickens using immunosuppressive agents, commercial coccidial 
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and bursal disease vaccines. Despite numerous attempts, there is no generally accepted 
disease model for the experimental production of NE in broiler chickens because 
consistent reproduction of the disease is difficult to achieve and so more work on disease 
models is necessary. This lack of reliable experimental models hampers efforts to 
evaluate the predisposing effects of putative risk factors and efficacy of preventive 
measures (Pedersen et al., 2003).  
2.3. Predisposing Factors for Necrotic Enteritis in Poultry 
 Despite our present understanding of this disease, and the identification of C. 
perfringens as the etiological agent, the predisposing factors that lead to over 
proliferation of C. perfringens and the subsequent progression to disease are poorly 
understood. It is well accepted that NE is a multi-factorial disease process in which a 
number of co-factors are usually required to precipitate an outbreak of the disease. These 
predisposing factors are numerous, but many are ill-defined and experimental results 
have been contradictory. We have grouped the various risk factors for NE into 5 broad 
categories (Table 2.1). This short list of well-documented predisposing factors is 
probably far from complete. Even when taking into account the known precipitating 
factors; it is still difficult to reproduce the symptoms and lesions of NE experimentally. 
Despite the identification of various risk factors, no study has been conducted that 
correctly calculates the relative risk of the different dietary factors and no study on the 
relative importance of different environmental management strategies has been 
performed. 
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2.4. Potential Strategies to Control Necrotic Enteritis   
 There are three basic strategies that can be employed to cope with the loss of 
AGPs and control NE in broiler chickens. These are: 1) pathogen reduction; 2) 
augentation of immune response; and 3) nutritional strategies and/or feed additives 
(Revington, 2002). Pathogen reduction strategies typically involve establishing effective 
farm-site biosecurity and poultry house sanitation protocols and will not be addressed 
here.  Vaccination strategies have been investigated to augent specific immunity against 
C. perfringens and there are a number of diet-related strategies designed to control NE 
which rely on several proposed mechanisms of action, including direct antimicrobial 
activity, competitive exclusion as well as augentation of immunity.  We will review a 
number of strategies for control of C. perfringens including: 1) Direct-fed microbials 
including competitive exclusion products and probiotics, 2) Prebiotics, 3) Organic acids, 
4) Plant extracts or essential oils, 5) Feed enzymes, 6) Hen egg antibodies, 7) Vaccination 
against C. perfringens, 8) Anticoccidial vaccination, 9) Bacteriophages, and 10) Diet 
formulation and ingredient selection. 
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Table 2.1. List of various predisposing factors of NE in broiler chickens. 
Risk factors References 
Eimeria infection (Al-Sheikhly and Al-Saieg, 1980; Baba et al., 1992; Baba et al., 
1997; Balauca, 1976; Broussard et al., 1986; Droual et al., 1995; 
Elwinger et al., 1992; Frame and Bickford, 1986; Helmboldt and 
Bryant, 1971; Hofacre et al., 2003; Hofacre et al., 1998; Jackson 
et al., 2003; Jansman et al., 2003; Kwatra and Chaudhury, 1976; 
Nairn and Bamford, 1967; Shane et al., 1985) 
Removal of coccidiostats or  AGPs 
from poultry feed 
(Arakawa and Oe, 1975; Brennan et al., 2001; Brennan et al., 
2001; Brennan et al., 2003; Broussard et al., 1986; Collier et al., 
2003; Elwinger et al., 1998; Elwinger et al., 1994; Elwinger et al., 
1992; Emborg et al., 2001; Engberg et al., 2000; George et al., 
1982; Prescott et al., 1978; Stutz and Lawton, 1984; Vissiennon et 
al., 2000; Watkins et al., 1997; Williams et al., 2003) 
Environmental and managemental 
conditions 
(Cowen et al., 1987; Craven et al., 2003; Craven et al., 2001; 
Craven et al., 2001; Kaldhusdal et al., 1999) 
Physiological stress and 
immunosuppression 
(Craven, 2000; Dykstra and Reid, 1978a; Estrada and Wilkie, 
2000; Fukata et al., 1991; McReynolds et al., 2004) 
Nature and form of diet (Annett et al., 2002; Branton et al., 1997; Branton et al., 1987; 
Dahiya et al., 2004; Drew et al., 2004; Engberg et al., 2002; 
Kaldhusdal and Hofshagen, 1992; Kaldhusdal et al., 1999; 
Kaldhusdal and Skjerve, 1996; Kaldhusdal, 2000; Knarreborg et 
al., 2002; Nairn and Bamford, 1967; Riddell and Kong, 1992; 
Truscott and Al-Sheikhly, 1977; Wilkie et al., 2005) 
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2.4.1. Direct-fed Microbials 
The term direct-fed microbial (DFM) or probiotic has been defined as a “live 
microbial feed supplement which beneficially affects the host animal by improving its 
intestinal balance” (Fuller, 1999). DFMs are intended to modify the gastrointestinal 
microflora in such a way that bacterial activities advantageous to the host are stimulated 
and those adverse to the host health are suppressed (Netherwood et al., 1999; Simmering 
and Blaut, 2001). The modes of action of DFM include: 1) maintaining “normal” 
intestinal microflora by competitive exclusion and antagonism of pathogens 2) altering 
metabolism by increasing digestive enzyme activity and decreasing bacterial enzyme 
activity and ammonia production, 3) improving feed intake and digestion and 4) 
neutralizing enterotoxins and 5) stimulating the immune system (Collins and Gibson, 
1999; Simmering and Blaut, 2001; Walker and Duffy, 1998). Competitive exclusion of 
pathogens may be accomplished by a number of possible mechanisms including 
competition for mucosal binding sites, competition for luminal nutrients or production of 
inhibitory substances such volatile fatty acids, low pH and bacteroicins which are 
bacteriostatic or bacteriocidal for pathogenic bacteria (Tannock, 1997). 
 DFM can broadly be categorized as undefined preparations of “normal gut flora” 
or defined products composed of a single or small number of characterized bacterial 
strains.  In relation to the avian intestinal tract, “normal gut flora” is a preparation of live 
obligate and facultative anaerobic bacteria, originating from normal, healthy adult 
individuals of an avian species, which is free from specific pathogenic microorganisms 
and is quality controlled (WHO, 1994). Such preparations can be provided orally in 
newly hatched chicks to promote the rapid establishment of an adult-type intestinal 
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microflora and produce almost immediate resistance to colonization by pathogens that 
gain access to the rearing environment (Mead, 2000; Nisbet, 1998; Nurmi et al., 1992).  
The chick exits the egg with a sterile intestinal tract which is rapidly colonized by 
bacteria present in the local environment (Hume et al., 2003). In commercial broiler 
hatcheries this environment is far removed from the hen and thus delays the normal 
succession of intestinal colonization characterized by increasing complexity and 
dominance by anaerobic bacteria over aerobes (Barnes et al., 1980; van der Wielen et al., 
2002).   Normal gut flora preparations have shown efficacy against food borne pathogens 
such as Salmonella spp., Campylobacter jejuni, C. botulinum, C. perfringens, pathogenic 
strains of Escherichia coli and Yersinia enterocolitica (Mead, 2000). Morishita et al. 
(1997) observed a 70% reduction in frequency of Campylobacter jejuni shedding and 
27% reduction in jejunal colonization when day old chicks were given a Lactobacillus 
acidphilus and Streptococcus faecium probiotic. In a comprehensive study of 296 strains 
of lactic acid bacteria from 50 chicks, 77 of the strains were found to inhibit the growth 
of enteropathogenic S. enteritidis and E. coli (Garriga et al., 1998).   
A number of studies have reported a potential benefit  of “normal gut flora” on 
NE in broiler chickens including reduced NE mortality and caecal colonization of C. 
perfringens (Barnes et al., 1980; Elwinger et al., 1992; Snoeyenbos et al., 1983). Hofacre 
et al. (1998) challenged broiler chickens experimentally with C. perfringens, and 
observed that normal gut flora products reduced gross intestinal lesions and improved 
feed efficiency in their disease model. Craven et al. (1999) reported a reduction in C. 
perfringens colonization and decreased incidence of NE in chickens treated with normal 
gut flora, together with increased slaughter yield. In a field study, Kaldhusdal et al. 
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(2001) found that post-hatch use of flora prepared from adult birds was associated with 
delayed intestinal proliferation of C. perfringens, delayed appearance of NE gross lesions 
and better production performance at slaughter.  Taken together, these studies suggest 
that the use of DFMs designed to promote an adult-type intestinal flora have promise for 
control of NE. For widespread commercial use in this application, however, it is essential 
that these preparations be free of all known human and avian pathogens, can be 
reproducibly produced and efficacy against C. perfringens clearly established.   
 Much work has been done to establish defined bacterial cultures that are equally 
effective as undefined cultures, but so far with limited success (Mead, 2000). Many 
strains of organisms have been used commercially, including Lactobacillus spp., Bacillus 
spp., Enterococcus spp., and Saccharomyces spp. (Gusils et al., 1999; Jin et al., 2000, 
1998; Lan et al., 2003; Patterson and Burkholder, 2003). Most of the studies concerning 
effects of probiotics on C. perfringens were conducted in humans and other mammals. 
Rinkinen et al. (2003) documented that lactobacilli reduced the adhesion of C. 
perfringens to immobilized canine mucus in vitro. Although some studies are 
inconclusive, oral uptake of lactobacilli and bifidobacteria have been shown to decrease 
the number of intestinal C. perfringens bacteria and spores in humans and mice (Gallaher 
et al., 1996; O'Mahony et al., 2001; Romond et al., 1998). Studies are limited regarding 
the protective effects of probiotic strains against C. perfringens in chickens. Fukata et al 
(1991) and Fukata et al (1988) reported a very low mortality in chicks inoculated with 
Lactobacillus acidophilus or Streptococcus faecalis and then challenged with C. 
perfringens compared with a 50% mortality rate in germ free chicks and there was no 
mortality in conventional birds. They also observed a suppression of α toxin production 
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when chick intestinal contents were cocultured with C. perfringens. Hofacre et al. (1998) 
observed that a commercial probiotic product reduced gross lesions of NE in chickens, 
but the protection was far less than that conferred by a normal gut flora preparation. 
Mortality due to NE was significantly reduced from 60 to 30% in an experimentally 
challenged broilers when they were treated with a defined lactic acid bacterial culture at 
day 1 of age (Hofacre et al., 2003). In this experiment, feed to gain ratio was decreased in 
the group that was given lactobacilli, but weight gain was not affected. La Ragione and 
Woodward (2003) documented that when 1-day-old and 20-day-old chickens were 
challenged with 109 spores of Bacillus subtilis strain and infected 24 h later with 105 CFU 
of C. perfringens, colonization and persistence of C. perfringens was suppressed. Thus, 
some promising results have been reported for control of C. perfringens with probiotics. 
However, most of the proposed mechanisms of action remain hypothetical and much 
work remains to be done to confirm the efficacy of this approach. 
2.4.2. Prebiotics   
Another approach which may be employed to manipulate the broiler gut 
ecosystem is the supplementation of diet with prebiotics. A prebiotic is an indigestible 
feed ingredient that beneficially affects the host by selectively stimulating the growth or 
activity of beneficial bacterial species already resident in the intestinal tract (Gibson and 
Roberfroid, 1995). For a feed ingredient to be classified as a prebiotic, it must not be 
hydrolyzed or absorbed in the small intestine, must be a selective substrate for one or a 
limited number of potentially beneficial commensal bacteria in the large intestine, thus 
stimulating the bacteria to grow, become metabolically activated and thus alter the 
intestinal microflora toward a healthier composition (Collins and Gibson, 1999). 
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Prebiotics are predominantly polysaccharides including fructooligosaccharides (FOS) 
inulin, trans-galactooligosaccharides, glucooligosaccharides, glycooligosacchriades, 
lactulose, lactitol, maltooligosaccharides, xylo-oligosaccharides, stachyose, raffinose, and 
sucrose thermal oligosaccharides (Collins and Gibson, 1999; Orban et al., 1997; 
Patterson et al., 1997).  Some oligosaccharides, such as mannan oligosaccharides (MOS) 
have been described as prebiotics; however, their mode of action may be different. MOS 
are thought to block pathogen binding to mannan receptors on the mucosal surface and 
stimulate the immune system (Spring et al., 2000).  
 Various studies have been conducted on the effects of prebiotics on C. 
perfringens but most were performed in mammals and in vitro systems. McBain and 
MacFarlane (2001) and Bello et al. (2001) documented that when FOS were added to 
batch cultures inoculated with human faeces in vitro or a continous culture model of 
human intestine, growth of C. perfringens was enhanced. However, a significant 
reduction in the C. perfringens populations was reported in the intestinal tract of rats, cats 
and dogs due to addition of FOS to their diets compared to those fed unsupplemented 
diets (Gallaher et al., 1996; Sparkes et al., 1998; Swanson et al., 2002).  
The prebiotic effect of oligofructose has been studied in a quail model of the 
human disease neonatal necrotizing enterocolitis. C. perfringens is one of the several 
bacterial species assumed to be associated with the disease. In this case, the passage of an 
indigestible nutrient into the caeca apparently does not exert any prebiotic effect (Butel et 
al., 2002). There is a strong possibility that the prebiotic products may also be effective in 
reducing NE lesions in broiler chickens. Takeda et al. (1995) reported that the number of 
C. perfringens organisms were significantly lower in the cecal contents of chickens on 
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2% and 10% lactose-supplemented feed than in chickens on unsupplemented feed. 
However, there has been no work to determine if including competitive exclusion and 
complex carbohydrates will more effectively prevent clinical NE, sub-clinical NE, or 
both. The lactic acid producing bacterial culture alone or combined with the mannan-
oligosaccharide, was effective in reducing C. perfringens-associated mortality and sub-
clinical effects on feed efficiency in experimentally challenged broiler chickens but 
neither addition of FOS or MOS to the diet had a significant effect on mortality caused by 
NE (Hofacre et al., 2003).  
2.4.3. Organic Acids  
  Organic acids are widely used both in raw materials and finished feed in Europe 
to inhibit enteric pathogens like Salmonella. For microorganisms, organic acids can act 
either as a source of carbon and energy, or as inhibitory agents depending upon the 
concentration of the acid, its ability to enter the cell and capacity of the organisms to 
metabolize the acid (Cherrington et al., 1991). Despite their long history of use as 
antimicrobial agents in both food and feeds, the mode of action of organic acids against 
microorganisms still has not been satisfactorily explained (Adams, 2004). The key basic 
principle on the mode of action of organic acids on bacteria is that non-dissociated (non-
ionised, more lipophilic) organic acids can penetrate the bacterial cell wall and disrupt the 
normal physiology of certain types of bacteria. As described by Lambert and Stratford 
(1999), after penetrating the bacterial cell wall, the un-dissociated organic acids will be 
exposed to the internal pH of bacteria and dissociate, releasing H+ and anions. The 
internal pH will decrease and because pH sensitive bacteria do not tolerate a large spread 
between the internal and external pH, a specific mechanism (H+-ATPase pump) will act 
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to bring the pH inside the bacteria to a normal level. This process consumes energy and 
eventually can stop the growth of the bacteria or even kill it (Gauthier, 2002). The 
anionic part of the acid is trapped inside the bacteria and becomes toxic to the bacteria by 
complex mechanisms leading to internal osmotic problems for the bacteria (Roe et al., 
1998). Organic acid-based products can be designed to inhibit the growth of undesirable 
microorganisms in different feed and poultry health situations.  
 The effect of organic acids on broiler performance is dependent upon dose, type 
of acid product, and whether the acids are included in the feed or drinking water (Patten 
and Waldroup, 1988). The performance enhancing effect of organic acids in poultry does 
not appear to be as pronounced as in pigs (Patten and Waldroup, 1988; Thompson and 
Hinton, 1997).  Izat et al. (1990) noticed a significant reduction in the total number of 
coliforms and E. coli in the intestinal tract of broiler chickens fed buffered propionic acid 
in their diets at different concentrations. A propionic acid-based product was quite 
effective in alleviating turkey poult enteritis and mortality syndrome (Roy et al., 2002). 
These workers also found that addition of organic acids at 1.25% to the feed decreased 
the bacterial load in the intestine and caeca. Chaveerach et al. (2004) demonstrated that 
organic acids in drinking water were able the keep the water free from Campylobacter, 
and acidified drinking water could have a potential effect on Campylobacter infection in 
young chicks. The promising results obtained from past research have resulted in the 
development of a large number of commercial products, however more comprehensive 
and thorough research is needed to improve their effectiveness. Of particular interest is 
the phenomenon of acid tolerance which may be considered as a problem and represents 
a challenge for future work.  
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2.4.4. Herbs, Spices and Various Plant Extracts/Essential Oils 
For many years, herbs and spices and their essential oils have been used as 
pharmaceuticals in alternative medicine and as a natural therapy. Herbs have been found 
to enhance anti-microbial activity, known to have anti-viral and anti-oxidative properties 
and are said to stimulate the endocrine and immune system. They promote a higher 
metabolic and immune status within the animal, as well as enhancing welfare. Various 
botanical ingredients have been shown to facilitate beneficial effects on gut environment 
and microflora (Besra et al., 2002; Rao and Nigam, 1970). Essential oils are known to 
stimulate digestive enzymes and to have an in vitro antimicrobial activity against many 
bacteria. Briozza et al. (1989) documented that various strains of Staphylococcus aureus, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, C. perfringens, and E. coli inoculated 
at a level of 107 CFU/mL were killed (greater than 99.99%) after 2-7 min in a laboratory 
broth supplemented with 63% (v/w) of sugar, and containing 0.4% (v/w) of essential oil 
of clove, with its active principle eugenol. There are various reports in literature 
regarding the antibacterial effects of Origanum vulgare, Piper nigrum, Syzygium 
aromaticum, and Thymus vulgaris, and the essential oil components thymol, carvacrol, 
curcumin, piperin and eugenol against various strains of clostridia including C. 
perfringnes (Briozzo et al., 1989; Dorman and Deans, 2000) and other bacteria such as E. 
coli, Staphylococcus aureus, Salmonella typhimurium, Listeria monocytogenes and 
Yersinia enterocolotica.  (Cosentino et al., 1999; Fabio et al., 2003). Lutomski et al. 
(1974) reported growth inhibition in Clostridium septicum, Clostridium novyi, and 
Clostridium sporogenes with alcohol extract and the essential oil from Curcuma longa. 
However, majority of these tests were performed in vitro with only a few tests performed 
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in animal models. To be effective on a practical scale, it is likely that these compounds 
will need to be provided in more concentrated form than they are found in their natural 
source. Wilkinson et al. (2003) demonstrated in vitro activity against C. perfringens of 
several plant products.  
Giving a supplementation of a commercial preparation of essential oil 
components in the feed  (Crina® poultry; Crina SA, Gland, Switzerland), Losa and Kohler 
(2001) found a reduced concentration of C. perfringens per g of intestinal contents and a 
lower rate of detection of C. perfringnes in the ileum, rectum and colon on day 5, 18 and 
32. The use of Crina® poultry (Crina SA, Gland, Switzerland) was found to decrease the 
intestinal C. perfringens counts of broilers in a field study on days 14, 21 and 30 (Mitsch 
et al., 2002). Lee et al. (2003) did not find any significant effect of thymol, 
cinnmaldehyde and Crina® poultry on growth performance in female broiler chickens, but 
they did not rule out the possibility that positive effects would have been observed under 
less hygienic environmental conditions or when using a less digestible diet.  Mitsch et al. 
(2004) reported that specific blends of essential oil components containing thymol or 
carvacrol and eugenol, curcumin and piperin can control the proliferation of C. 
perfringens in the broiler intestine and therefore, may reduce the risk of NE. They 
suggested that essential oil antibacterial effect in vitro and effect of stimulation of 
digestive enzymes, stabilization of intestinal microflora, and inactivation of C. 
perfringens toxins may reduce C. perfringerns colonization in the broiler gut.  
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2.4.5. Feed Enzymes 
The effect of antibiotics and disease outcomes is gut-microflora related and 
therefore investigation of any diet-induced changes in the gut ecosystem is the starting 
point for the quest of finding suitable alternatives to antibiotics. Feed is a complex 
mixture containing many chemical species. In addition to the major nutrients like starch, 
protein and fats, there are many other components such as β-glucans, pentosans, 
mannans, cellulose, lignin, and phytic acid, which cannot be digested by poultry. These 
non-digestible feed ingredients generate digestive stress in poultry causing reduction in 
nutrient utilization which in turn allows pathogenic bacteria to grow in the 
gastrointestinal tract (Adams, 2004). Excessive growth of bacteria in the gastrointestinal 
tract requires energy and protein which reduces the nutrients available to support the 
growth of the bird. Recently, in the absence of AGPs, these problems have been 
overcome by using various feed enzymes. The utilization of diets containing high levels 
of xylans and β-glucans from wheat and barley, respectively, can be significantly 
improved through supplementation of xylanase and β-glucanase enzymes (Bedford and 
Classen, 1992; Jackson et al., 1999; Mathlouthi et al., 2002; Mathlouthi et al., 2003; Wu 
and Ravindran, 2004). The mechanism responsible for this effect is still unclear. It has 
been suggested that these complex carbohydrates might influence gastrointestinal 
bacteria. Choct et al. (1999) reported that important effects of supplementary enzymes 
included improved nutrient digestibility, reduced small intestinal fermentation and 
increased cecal fermentation in chickens. The increased microbial activity in the caeca is 
a likely result of poorly absorbed products of enzymatic degradation entering the caeca, 
where they stimulate bacterial fermentation (Bedford, 2000). Increase in VFA production 
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and changes in VFA profile may serve to favor the beneficial organisms (for example 
Bifidobacteria) and suppress populations of deleterious bacteria (Salmonella, 
Campylobacter and Clostridium).  
Published studies have produced contradictory results regarding the effects of 
enzyme supplementation on various bacterial populations including C. perfringens  in the 
intestinal tract of broiler chickens (Hubener et al., 2002; Riddell and Kong, 1992; Sinlae 
and Choct, 2000). Riddel and Kong (1992) could not find any beneficial effect of dietary 
pentosanase supplementation on the susceptibility of NE in broilers fed wheat-based 
diets. Sinlae and Choct (2000) demonstrated that the number of C .perfringens may be 
manipulated by diet or use of dietary enzymes. However, Jackson et al. (2003) reported 
that the feed enzyme β-mannanase significantly reduced the severity of challenge by 
Eimeria sp. and C. perfringens in broiler chickens. They reported a significant 
improvement in body weight gain and a reduction in intestine lesion score with β-
mannanase supplementation in corn-based diets. A number of experiments have 
demonstrated that β-mannans crossing the intestinal mucosa are potent stimulators of 
innate immune system, resulting in increased proliferation of macrophages and 
monocytes and resultant cytokine production (Duncan et al., 2002; Zhang and Tizard, 
1996). However, further research in this area is required to elucidate the effect of feed 
enzymes on the incidence of NE. 
2.4.6. Hen Egg Antibodies 
 One promising alternative to antibiotics in controlling NE in poultry involves the 
feeding of anti-clostridial antibodies to neutralize pathogenic organisms in the 
gastrointestinal tract. The advantage of feeding antibodies with the diet is that they 
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provide a continuous control of potential pathogens and do not result in the development 
of antibiotic resistant strains of microorganisms. In simple terms, hens are exposed to 
inactivated clostridia antigens and their immune system is stimulated to produce 
immunoglobulins. The immunoglobulins are harvested from eggs and mixed in feed. 
Immunized hens transport approximately 100-150 mg of immunoglobulin to each egg 
(Rose et al., 1974). Thus, an immunized hen can produce in excess of 40 g of 
immunoglobulin each year making this a cost-effective measure for the 
immunotherapeutic control of enteric pathogens. The use of pathogen-specific antibodies 
obtained from the egg yolks of hyperimmunized hens has been examined as a means for 
the control of gastrointestinal disease in various animal and avian species. Various 
reports have documented that hen egg antibodies can be used effectively to reduce 
morbidity and mortality in piglets (Imberechts et al., 1997; Marquardt et al., 1999; 
Yokoyama et al., 1997), calves (Kuroki et al., 1997; Yokoyama et al., 1998), mice 
(Peralta et al., 1994; Yokoyama et al., 1998), fish (Lee et al., 2000) and humans (Sugita-
Konishi et al., 2000). Although the literature is scant regarding the immunoprophylactic 
effect of hen egg antibody (HEA) in the avian model, they have been shown to be 
efficacious in the reduction of Salmonella enteritidis in Pekin ducklings  when 
administered with probiotics (Fulton et al., 2002). More recently, Kassaify and Mine 
(2004) demonstrated that HEA from normal or salmonella hyper-immunized hens may 
act to reduce intestinal colonization by Salmonella enteritidis in laying hens. 
  To the best of my knowledge their use for the control of C. perfringens has not 
been previously investigated. Earlier, Wilkie et al. (2005) observed that HEA antigen 
binding activity was present throughout gastrointestinal tract of birds when they were fed 
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HEA-supplemented feed, however, HEA from hens immunized against a C. perfringens 
bacterin did not provide a protective affect against C. perfringens colonization. As in all 
vaccination strategies, the selection of target antigen has a major influence on efficacy.  
For example, it is possible that feeding HEA harvested from hens immunized against the 
C. perfringens α toxin, which is the most accepted cause of NE, may significantly reduce 
the incidence of NE by blocking the ability of α toxin to interact with the intestinal 
mucosa.  
2.4.7. Vaccination against Clostridium perfringens  
 Vaccination is a widely used preventive measure against many infectious diseases 
in mammals and poultry. C. perfringens may cause necrotizing enteritis in several 
mammalian species including humans, and some of these conditions have been 
successfully prevented by vaccination (Lawrence et al., 1990; Springer and Selbitz, 1999; 
Uzal and Kelly, 1998). There are several studies in the literature to show that vaccination 
can induce antibody titers against clostridia and clostridial toxins in calves, lambs, goats, 
piglets and mice (Clarkson et al., 1985; Schoepe et al., 2001; Springer and Selbitz, 1999; 
Troxel et al., 1997; Uzal et al., 1998). Antibodies to α toxin inhibited the development of 
gas gangrene in an experimental mouse model (Williamson and Titball, 1993). Recently, 
Belyi and Varfolomeeva (2003) constructed a chimeric peptide carrying antigenic 
determinants of enteric clostridial toxins viz. α toxin, β toxin and enterotoxin and 
demonstrated that this fusion molecule was effective in eliciting antibody responses 
against each component when injected in mice. At present no vaccine against C. 
perfringens-associated diseases in poultry is available in the market.   
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It is well known that necrotizing α toxin released by C. perfringens type A or C is 
the main pathogenic factor responsible for intestinal mucosal necrosis (Al-Sheikhly and 
Truscott, 1977b, 1977c), so it is reasonable to assume that specific antibodies against α 
toxin might protect the birds from the disease. Fukata et al. (1988) demonstrated that 
specific antibodies against C. perfringens α toxin neutralized the effect of a C. 
perfringens culture supernatant in a challenge study using germ free chickens. Based on 
this observation, there is a possibility that antibodies against C. perfringens toxins may 
protect the birds against NE. Heier et al. (2001) conducted a field study to determine the 
level of naturally occurring specific humoral immunity against phospholipase-C in 
Norwegian flocks and observed that flocks with high titres of maternal antibodies against 
α toxin had lower mortality during the production period than flocks with low titres. They 
also noticed that progeny from older parent flocks had significantly higher levels of 
specific maternal antibodies against α toxin than did chicks from younger flocks. In 
support of this, vaccination of broiler breeder hens with C. perfringens type A and type C 
toxoids adjuvanted with aluminium hydroxide resulted in a strong serum IgG response to 
C. perfringens α toxin in parent hens, and specific antibodies were transferred to their 
progeny (Lovland et al., 2004). The authors suggested that maternal vaccination may 
protect against the toxins without any clear effect on numbers of intestinal C. perfringens.  
2.4.8. Anticoccidial Vaccination 
 We have already discussed the controversial relationship between coccidia and 
clostridioses. Various laboratory experiments and natural field cases suggest that 
coccidiasis or coccidiosis especially Eimeria species may predispose birds to clostridial 
enteritis (Al-Sheikhly and Al-Saieg, 1980; Baba et al., 1997; Hofacre et al., 1998; 
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Jackson et al., 2003; Shane et al., 1985) but other observations have not necessarily 
corroborated such evidence (Helmboldt and Bryant, 1971; Kaldhusdal and Hofshagen, 
1992; Long et al., 1974). Recently this relationship was nicely reviewed by Williams 
(2005). It has been proven in some studies that coccidial vaccines were able to prevent C. 
perfringens-associated NE (Engberg et al., 2000; Jackson et al., 2003; Williams et al., 
2003).  Use of live anticoccidial vaccines is on the rise in the poultry industry around the 
world. Keeping this in mind it is very important to know the effects, whether beneficial 
or harmful, of vaccination against coccidiosis on clostridial enteritis. Williams et al. 
(1999) reported that birds receiving a live attenuated anticoccidial vaccine in drinking 
water consisting of seven species of Eimeria were protected against NE, whereas birds 
fed ionophores with AGPs suffered from clostridiosis. Again Williams et al. (2003) 
examined the relationships between coccidiosis, anticoccidial vaccines and NE in broiler 
chickens and observed that immunization against virulent coccidial challenge reduced the 
severity of the later clostridial challenge. It might be due to the fact that any coccidial 
lesions that might have predisposed birds to NE were prevented because of vaccination.   
 In contrast, Williams (1994) and Williams and Andrews (2001) documented that 
vaccination itself may cause mild coccidial lesions in some birds, but those lesions were 
not severe enough to predispose immunized birds to NE, as suggested by Williams et al. 
(2003). Further research experiments involving simultaneous vaccination and C. 
perfringens challenge is needed to reach a definite conclusion.    
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2.4.9. Use of Bacteriophages 
 Bacteriophages are viruses which infect bacterial cells, utilize the bacterial 
metabolic machinery to replicate and then destroy the bacterial host by lysis in order to 
release new phage into the environment. Bacteriophages have received significant 
attention as potential alternative to antibiotic control of bacterial replication. Indeed, 
Immerseel et al. (2004) suggested the use of bacteriophages, which are active against C. 
perfringens strains, for controlling NE in poultry. Bacteriophages were successfully used 
to combat experimentally induced vancomycin-resistant Enterococcus faecium infection 
in mice (Biswas et al., 2002). Zimmer et al. (2002) investigated the murein hydrolase 
from bacteriophage Ф3626, which lysed all 48 strains of C. perfringens tested, whereas 
other clostridia and bacteria belonging to other genera were generally unaffected. This 
highly specific activity towards C. perfringens might be useful for novel biocontrol 
measures in food, feed, and complex microbial communities.  
2.4.10. Appropriate Diet Formulation and Ingredient Selection  
Physical and chemical attributes of the diet can modify the populations of 
microorganisms in the gastrointestinal tract and the integrity of delicate intestinal 
epithelium in various mammals and birds (Apajalahti et al., 2001; Hill et al., 2005; 
Jansman et al., 2003; Jensen and Jorgensen, 1994; Langhout et al., 1999; Smith and 
Macfarlane, 1998; Wagner and Thomas, 1978). Apajalahti (2004) documented that 
feeding corn and sorghum-based diets increased numbers of Enterococcus, barley 
increased Lactobacillus populations, oat promoted growth of Escherichia and 
Lactococcus, and rye increased Streptococcus population in broiler chickens. 
Supplementation of flaxseed or certain fractions of flaxseed may have benefits beyond its 
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nutritional value through modification of intestinal microbial colonization. Linolenic 
acid, which represents 59% of the fatty acids present in flaxseed, may inhibit bacterial 
growth by preventing the adhesion of bacteria to intestinal mucus and epithelial cells 
(Kankaanpaa et al., 2001). An increase in lactobacilli was observed in poultry fed 
flaxseed (Alzueta et al., 2003). Dibner et al. (1996) reported an increase in numbers of E. 
coli and decrease in lactobacilli with unstabilized rancid fat in the diet. Dietary 
ingredients have a great influence on the incidence of NE in broiler chickens (Annett et 
al., 2002; Baba et al., 1992; Drew et al., 2004; Elwinger et al., 1992; Kaldhusdal et al., 
1999; Kaldhusdal and Skjerve, 1996; Knarreborg et al., 2002; Riddell and Kong, 1992). 
There appear to be two important dietary factors which predispose broiler chickens to 
NE. The first factor is cereal grain type, such as wheat, rye and barley that increases the 
viscosity of digesta, prolong intestinal transit time and increase incidence of NE. The 
second dietary factor is protein level and source, where high levels of protein from 
animal sources predispose to NE. Oxidized fats and mycotoxins have also been shown 
associated with NE (Ferket, 1996). More recently, the dietary fat source was also found 
to be an important factor affecting C. perfringens populations in broiler chickens 
(Knarreborg et al., 2002). These workers reported that there was a significant elevation in 
the C. perfringens population in ileum of broiler chickens which were fed animal fat 
(mixture of lard and tallow) compared to those fed soy oil. 
2.4.10.1. Types of Cereal Grains 
 There are various studies in literature that have reported that corn-based diets 
reduce the incidence and severity of NE compared to diets based on wheat, barley, rye or 
oats.  Diets based on rye caused a decline in chick growth and increase in the number of 
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bacteria adhering to the lower part of intestine, an effect that might be associated with the 
relatively high content of complex carbohydrates in rye (Untawale et al., 1978). Branton 
et al. (1987) reported 2.9% mortality in broilers fed a corn-based diet, while mortalities 
were 28.9 and 18.1% when hammer mill or roller mill-ground wheat were used, 
respectively. When broiler chickens were challenged by feeding C. perfringens-
inoculated feed for 3 consecutive days, mortality ranged from 0 to 12.5% in broilers fed a 
corn-based diet, however, it ranged from 26 to 35% in broilers fed a diet with high 
amounts of wheat, barley or rye (Riddell and Kong, 1992). They also reported that 
addition of pectin and guar gum to different rations reduced growth rate and eliminated 
NE from test birds. In a separate study, Kaldhusdal and Hofshagen (1992) indicated that a 
barley-based diet was associated with a lower number of lactobacilli and streptococci and 
higher frequencies of sub-clinical NE than a corn-based diet. Kaldhusdal and Skjerve 
(1996) studied the association of the cereal content of diets fed to broiler chickens in 
Norway from 1969-1989 and observed that two major outbreaks of NE were associated 
with increased use of barley and wheat in broiler diets. The inclusion levels of corn, 
barley, oats and wheat in broiler starter feed varied between 0 and 38%, 0 and 20%, 0 and 
26% and, 6 and 38.6%, respectively.  They demonstrated that the ratio of wheat plus 
barley to corn was positively correlated with the incidence of NE. Branton et al. (1996) 
conducted two experiments to determine the in vitro effect of water soluble wheat 
extracts on the growth of C. perfringens in thioglycolate broth medium and found that the 
growth was suppressed by inclusion of both autoclaved and non autoclaved wheat 
extracts. Branton et al. (1997) reported that NE lesion scores were lowest in chickens 
given the corn-based diets with no C. perfringens challenge and highest in chickens fed 
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the wheat diets with C. perfringens challenge. Chickens consuming a wheat diet with no 
added complex carbohydrates or added fiber exhibited the highest lesion score. Langhout 
et al. (1999) found increased deconjugation of bile salts and higher numbers of 
Enterococci, Bacteriodaceae, Clostridia and E. coli in the ileum of pectin-fed chickens 
and also reported that fat digestibility decreased when microbial activity increased.  
Craven (2000) documented that intestinal numbers of C. perfringens in 
contaminated broiler chicks on the corn-based diet were ≤ log10 6.2 and did not increase 
in any portion of the intestinal tract from day 2 to 21, however, numbers of C. 
perfringens during this time period increased 3.3 to 4.9 log units in the ileum, ceca, and 
feces of birds on the 50% rye diet to as high as log10 7.1 to 7.9 at 21 day. Annett et al. 
(2002) reported that C. perfringens growth was significantly lower in in vitro digested 
broiler diets based on corn than in corresponding diets based on wheat and barley. This 
difference was not found when undigested diets were compared.  They suggested that 
digestive enzymes may generate or activate one or more components in the corn diet, 
thereby suppressing clostridial proliferation.  
While many hypotheses have been postulated to explain the effect of cereal type 
on intestinal C. perfringens populations, the actual mechanism(s) behind this effect is still 
unknown. It has been suggested that complex carbohydrates (viscous polysaccharides) 
may influence intestinal bacterial populations and broiler growth performance (Choct et 
al., 1996; Hubener et al., 2002; Langhout et al., 1999). Wheat, rye, barley, and oat groats 
contain different levels of complex carbohydrates, including arabinoxylans and β-
glucans, which may elevate the digesta viscosity, increase intestinal transit time and thus 
interfere with digestion. Enzymes such as xylanase can be used to break down non-starch 
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polysaccharides and thus addition of enzymes to diets based on wheat/barley grains can 
reduce digesta viscosity, increase passage rate while reducing the bacterial population in 
small intestine. Riddle and Kong (1992) also suggested that carbohydrates in corn may be 
less available to microbial digestion than those in wheat, a hypothesis they supported by 
showing that there was an increase in mortality due to NE in a corn-based ration to which 
glucose had been added. Williams (1992) documented that pathogenicity of E. tenella 
was lower in corn-fed chickens than in wheat-fed chickens and it might be due to the 
protective effect of higher concentrations of vitamin A and E derived from corn diets or 
that the higher concentration of niacin and riboflavin in wheat than in corn might enhance 
coccidial pathogenicity. Since coccidial lesions are a predisposing factor for NE, this can 
also play a significant role in the protective effect of corn. Annett et al. (2002) postulated 
that proliferation of C. perfringens and production of α toxin may be elevated by various 
components present in wheat and barley, or wheat and barley diets may inactivate 
intestinal digestive enzymes, thereby decreasing the α toxin degradation. The release of 
soluble non-starch polysaccharides from certain cereals represents another possible 
explanation of the phenomenon. Corn alone among the commonly used cereals usually 
does not appear to release soluble non-starch polysaccharides in amounts sufficient to 
produce a detectable depression in performance (Chesson, 2001).  
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2.4.10.2. Feed Processing Methods 
Feed processing methods also appear to be important precursors for NE. It has 
been observed that highly processed feeds can lead to atrophy and malfunction of 
gizzard, which then acts more like a transient organ rather than a grinding organ. Normal 
gastric reflux does not occur when birds consume finely ground feed and, as a 
consequence, more protein ends up in the hind gut where it is subjected to microbial 
fermentation. One of the consequences is the potential for finely ground material to 
trigger proliferation of clostridia and, as a result, NE. Branton et al. (1987) found that the 
mortality due to NE was increased in birds fed ground feed (hammer-mill) compared 
with coarsely ground feed (roller-mill). The influence of feed grinding (coarsely or finely 
ground feed) and feed form (mash or pellet) on the intestinal microenvironment was also 
investigated in a growth experiment by Engberg et al. (2002) with broiler chickens taking 
into consideration the intestinal microflora and intestinal viscosity. They found no effects 
of the feed grinding on C. perfringens counts in the intestine, however, counts of C. 
perfringens and lactobacilli were significantly higher in the distal end of the intestinal 
tract (caecum and rectum) of mash-fed birds. Microbial fermentation as assessed by VFA 
concentration was found to be significantly higher in the ceca of pellet-fed birds than in 
mash-fed birds. Grinding raw materials over 4 mm screen size has been found beneficial 
(Engberg et al.  2002). Many broiler companies in Europe have been diluting broiler feed 
by adding up to 30% whole wheat on top of the manufactured feed. Inclusion of whole 
wheat stimulates the function of the gizzard with a resulting benefit on gut motility. This, 
in turn, is felt to be beneficial in helping to inhibit the C. perfringens multiplication in the 
intestinal tract. Engberg et al. (2002) and Bjerrum et al. (2005) observed that whole 
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wheat feeding reduced the pH in gizzard contents and decreased intestinal counts of C. 
perfringens in broiler chickens. 
2.4.10.3. Dietary Protein Source/Level  
Numerous studies have reported that feeding high animal protein based-diets to 
pigs (Mansson & Smith, 1962; Mansson & Olhagen, 1967) and dogs (Zentek et al., 1998; 
Zentek, 2000; Zentek et al., 2003; Zentek et al., 2004) resulted in significant increase in 
the number of C. perfringens in the small intestine and/or feces. In broiler chickens high 
protein diets and especially diets consisting of high level of animal source proteins have 
been reported to predispose birds to NE (Drew et al., 2004; Kaldhusdal, 2000; Kocher, 
2003; Wilkie et al., 2005). In a longitudinal study of NE and feeding practices over a 20 
year period, Kaldhusdal and Skjerve (1996) found that the use of animal source protein in 
broiler diets in Norway was associated with an increased incidence of NE. This 
observation is based on feeding diets at or near NRC requirements. Although NE is 
associated with feeding high levels of dietary crude protein, the literature is limited 
regarding the direct effect of high levels of dietary crude protein on the composition of 
intestinal microflora in broiler chickens, particularly on the C. perfringens populations. 
There are some in vitro studies showing the association between certain amino acids and 
C. perfringens growth and/or α toxin production. A local increase in protein 
concentration or a particular amino acid in the small intestine may initiate the overgrowth 
of C. perfringens since the growth of this bacteria and production of α toxin are 
influenced by the presence of various amino acids (Titball et al., 1999). Muhammed et al. 
(1975) documented that methionine, while not a required nutrient for C. perfringens, was 
highly stimulatory for growth and was required for sporulation. Another study reported 
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that glycine also accelerated the growth of C. perfringens and production of α toxin in 
vitro (Ispolatovskaya, 1971).  In defined media, α toxin requires the presence of glycine-
containing peptides (Nakamura et al., 1968; Stevens and Rood, 2000). Hence, one factor 
in animal protein based diets that could predispose birds to NE is glycine content. 
Animal-source proteins contain from 2 to 4 times as much glycine as a percentage of 
crude protein compared to plant based proteins (AminoDat™, 2001). Animal-source 
protein diets may therefore oversupply glycine and contribute to the overgrowth of C. 
perfringens in the intestinal tract. The source of a particular amino acid is also important 
in influencing the microbial community in the gastrointestinal tract. A study was 
conducted to determine the apparent absorption of hydroxy analogue of methionine and 
DL-Methionine in germ free and conventionally reared broiler chickens and concluded 
that 2-hydroxy-4-methylthiobutoanic acid (MHA-FA) might be comparatively more 
available to gastrointestinal microbes than DL-Methionine (Drew et al., 2003). 
 Preliminary work in our laboratory examined the effects of protein source (fish 
meal vs. soy protein concentrate, SPC) and protein concentration (230, 315 or 400 g/kg 
crude protein) on intestinal populations of C. perfringens in broiler chickens (Drew et al., 
2004). We observed a significant increase in C. perfringens counts in birds fed 400 g/kg 
crude protein fish meal diet, however,  C. perfringens counts were low in ileum of birds 
fed SPC-based diets at all levels of crude protein. C. perfringens counts in ileum and 
cecum increased as crude protein level increased from 23 to 40% in birds fed fish meal-
based diets but not in birds fed SPC diets.  The feeds were analyzed for their amino acid 
content and a ratio was calculated by dividing amino acid present in 40% fish meal diet 
by amino acid present in 40% SPC diet. The ratio was higher for glycine (1.65) and 
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methionine (1.35) compared to other amino acids suggesting that these amino acids are in 
relative excess in the 40% fish meal diet compared to the 40% SPC diet. Wilkie et al. 
(2005) performed an experiment to assess C. perfringens colonization for a wide range of 
protein sources and to determine whether increased C. perfringens colonization could be 
correlated with the supply of specific amino acids. Seven different diets were formulated 
to contain 400 g/kg crude protein using fish meal, meat and bone meal, feather meal, 
potato protein concentrate, pea protein concentrate, soy protein concentrate or corn gluten 
meal as the primary source of protein. The number of C. perfringens in ileal and cecal 
digesta of chickens fed animal protein-based diets were significantly higher compared to 
those fed the control diet or the plant protein-based diets with the exception of potato 
protein concentrate diet. Correlation analysis of the amino acids content of eight 
experimental diets and intestinal C. perfringens populations revealed a significant 
positive correlation between the level of glycine present in the diet and the number of C. 
perfringens in both ileum and cecum. None of the other dietary amino acids were 
significantly correlated with the C. perfringens number neither in ileum nor in cecum. 
Further studies are required to confirm a cause and effect relationship between dietary 
glycine concentration and intestinal C. perfringens populations in broilers.   
2.5. Conclusions 
Whether or not the livestock industry is to blame for the emergence of antibiotic-
resistant bacteria, the reality is that the consuming public does not like the idea of 
routinely feeding antibiotics to animals, for whatever reason, and so North America may 
follow the European lead, either by government regulation or voluntarily, to reduce or 
discontinue the use of AGPs in animal feed. Experiences of many European countries 
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yield important information about how we might best cope with a restricted use of 
anibiotics and what changes we might expect in North America. Experiments from 
Sweden and Denmark have confirmed that one of the key problems for countries reliant 
on wheat-based formulations is the control of NE once AGPs have been removed. 
Currently, many parts of the world are experimenting alternative feed additives that may 
be used to alleviate the problems associated with the withdrawal of antibiotics from feed. 
To date no single preventive therapy that can substitute for in-feed antibiotics in poultry 
feeds has been found. Effective non-antibiotic prevention of C. perfringens-associated 
health and performance problems will only be attained by means of extensive 
multidisciplinary research efforts. There are number of alternatives that may be used 
strategically to decrease the incidences of NE in poultry. However, limited data has been 
presented to support the efficacy of AGPs alternatives.  
Increased feed particle size, the feeding of whole wheat, feeding corn-based diets, 
reducing non-starch polysaccharides and reducing the level of animal-based proteins in 
the diet all seem to help reduce the incidence of NE. Furthermore, the effect of feed 
composition, particularly the effect of grain source and amino acid profile on NE requires 
significantly more study. The bacteria in the gastrointestinal tract of birds derive most of 
their energy for reproduction and growth from various dietary compounds, and several 
bacterial species have different substrate preferences and growth requirements. The 
chemical composition of the digesta largely determines the microbial composition in 
gastrointestinal tract. Today there is a pressing need to better understand factors that 
predispose birds to NE and to develop alternative dietary strategies to control the 
incidence and severity of NE in broiler chickens in the “post-antibiotic” era.  
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Based on these observations, the overall objective of this study was to develop a 
model of C. perfringens colonization and/or NE in broiler chickens without using any 
coccidial challenge, and then use this model to investigate the effect of various dietary 
components especially amino acids on various intestinal microbes, especially C. 
perfringens and lactobacilli populations in the gastrointestinal tract of broiler chickens. 
An improved understanding of the relationship between feed chemistry and 
gastrointestinal microflora will help us to formulate poultry diets through appropriate 
ingredient selection to control or reduce various enteric pathogens including C. 
perfringens in absence of in-feed sub-therapeutic antibiotics.    
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3.0. INTESTINAL BACTERIAL POPULATIONS IN BROILER CHICKENS FED 
HIGH PROTEIN DIETS WITH AND WITHOUT ADDED GUAR GUM 
3.1. Abstract 
 An experiment was conducted to study the effects of two different dietary protein 
sources and a soluble non-starch polysaccharide (guar gum) on the intestinal bacterial 
populations of broiler chickens. Six groups of 12 birds (in duplicate) were provided with 
a medicated ideal protein-balanced corn-based starter crumble feed from days 0 to 21 of 
age. From day 21 onwards, six experimental diets  with 2 levels of guar gum (0 or 1%) 
and 3 levels of protein (40% using fish meal as the primary protein source, 40% using 
soy protein concentrate (SPC) as the main protein source, and 23% using both fish meal 
and SPC) in a 2 x 3 factorial arrangement of treatments. All birds were orally challenged 
with C. perfringens type A broth culture from days 21 to 27 and C. perfringens, 
lactobacilli, total anaerobes and total aerobes were enumerated in ileal and cecal contents 
on days 35, 39 and 42. Nine (6.25%) birds died during the first 4 days of diet shift, but 
lesions typical of NE were seen in only three birds. The birds that were given guar gum 
supplemented diets performed poorly. The viscosity and the pH of ileal contents were 
significantly (P < 0.05) higher and lower, respectively, in birds fed diets with added guar 
gum. There was a significant (P < 0.05) increase in the C. perfringens and total anaerobes 
count in cecum at all time points due to guar gum addition. However, there were no 
significant effects of protein on the C. perfringens numbers except on day 35 in ileum 
and day 42 in the cecum where counts were significantly (P < 0.05) higher in birds fed 
SPC-based diet. Significantly higher (P < 0.05) populations of lactobacilli were observed 
in the ileum and cecum of birds fed diets with added guar gum. Ileal viscosity, clostridial 
 37
counts and lactobacilli counts were significantly (P < 0.05) correlated in the ileum on day 
42. The pH of ileal contents was significantly (P < 0.05) higher in SPC-fed birds 
compared to control birds on day 35 and 39. Also there was a significant increase in 
number of total goblet cells in ileum with the addition of guar gum. Hence, it was 
concluded that the increased C. perfringens and total anaerobes growth in guar gum-fed 
birds was associated with higher intestinal viscosity and lower intestinal pH. Protein 
source had no significant effect on various bacterial populations in this experiment with 
few exceptions. 
3.2. Introduction 
 Necrotic enteritis (NE) is a common disease found in all poultry-growing areas of 
the world and was first described by Parish in 1961 (Ficken and Wages, 1997). The 
causative agent of NE is Clostridium perfringens, types A (Long and Truscott, 1976) or C 
(Shane et al., 1985). C. perfringens is a ubiquitous gram positive, spore forming 
anaerobic bacteria found in soil, dust, feces, feed, poultry litter, and intestinal contents. 
However, high populations of C. perfringens may also be detected in the gut of birds with 
no visible signs of NE, thus breaking Koch’s postulate that a disease-causing organism 
should not be present in healthy individuals. This has resulted in continuing uncertainty 
as to the etiology of NE and resulted in great deal of research to determine the factors that 
precipitate an outbreak of clinical disease.  
Disease outbreaks have been minimized to a significant extent through the use of 
in-feed antibiotics. However, the incidence of NE in broiler flocks has increased in 
Western Europe since the implementation of a ban on sub therapeutic antibiotic usage by 
the European Union. It has been estimated that the total estimated loss to the poultry 
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industry globally due to NE is nearly US$ 2 billion based on US$ 0.05 per bird 
production performance losses (Van der Sluis, 2000a, 2000b). The sub-clinical form of 
NE may be most economically important because it has been shown to impair feed 
conversion in broilers (Stutz and Lawton, 1984). Impaired feed conversion, reduced live 
weight at slaughter and increased condemnation percentage are major causes of 
production losses associated with C. perfringens infection (Lovland and Kaldhusdal, 
2001). Although an outright ban of AGPs has not occurred in North America, a growing 
consumer demand for safer foods is creating pressure on producers to limit their use. As a 
result, there is a pressing need to better understand factors that predispose birds to NE 
and to develop alternative management and dietary strategies to control the incidence and 
severity of infection. 
Although C. perfringens is recognized as the etiological agent of NE, other 
contributing factors are usually required which predispose the flocks to disease. These 
precipitating factors include management stress, sub-clinical intestinal coccidiosis, and 
diet composition (Kaldhusdal, 2000; Shane et al., 1985). Elevated concentrations of 
dietary wheat and barley (Riddell and Kong, 1992), animal proteins (Kaldhusdal and 
Skjerve, 1996) and zinc (Baba et al., 1992) may also exacerbate clostridial-induced NE, 
but the reason(s) for the increased susceptibility has not been determined. Kaldhusdal and 
Skjerve (1996) and Kaldhusdal (2000) reported that the use of animal source protein in 
broiler diets in Norway was associated with an increased incidence of NE. Previous work 
in our laboratory examined the effects of protein source (animal vs. plant) and protein 
concentration on intestinal populations of C. perfringens in broiler chickens (Drew et al., 
2004). C. perfringens counts in ileum and cecum increased significantly (P < 0.05) as 
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crude protein level increased from 23 to 40% in birds fed fish meal-based diets but not in 
birds fed SPC diets. The crude protein alone does not adequately explain the changes in 
C. perfringens populations. Other possible factors linked to this effect include lipids, 
carbohydrates, anti-nutritional factors and amino acid balance. Diets containing small 
grains, including wheat, rye, barley and oats, are associated with higher levels of NE in 
broilers than corn-based rations (Riddell and Kong, 1992). These small grains all contain 
relatively high levels of complex carbohydrates, including arabinoxylans and β-glucans, 
which may elevate the digesta viscosity, increase intestinal transit time and thus interfere 
with digestion. It has been suggested that the viscous non-starch polysaccharides may 
influence intestinal bacterial populations and broiler growth performance (Choct et al., 
1996; Langhout et al., 1999). 
Although NE is an economically important disease of broiler chickens, the 
development of a reproducible disease model has not been successful. A number of 
epidemiological as well as experimental studies have shown that there is a strong 
relationship between certain feed ingredients and the incidence of NE in poultry. Dietary 
cereal grains rich in non-starch polysaccharides (NSP) and dietary proteins especially of 
animal origin encourage the development of NE (Annett et al., 2002; Kaldhusdal and 
Skjerve, 1996; Riddell and Kong, 1992; Wilkie et al., 2005). The combination of NSP 
and protein in the diet can greatly exacerbate the problem. 
 Previously in our lab, we were able to produce high C. perfringens colonization in 
the intestinal tract of broiler chickens using high protein diets but have not produced 
clinical disease using high protein diets alone. We hypothesized that a dietary 
combination of high protein and high non-starch polysaccharides may promote the C. 
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perfringens overgrowth in the intestinal tract of broiler chickens, thus increase the risk of 
clinical NE. The objectives of this study were two pronged: to evaluate the effect of two 
sources of dietary protein (fish meal and soy protein concentrate) and a soluble dietary 
fiber, guar gum, on intestinal colonization of C. perfringens, and the development of a 
working model of clinical NE in broiler chickens.  
3.3. Materials and Methods  
 Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with recommendations of 
the Canadian Council on Animal Care as specified in the Guide to the Care and Use of 
Experimental Animals (Canadian Council on Animal Care, 1993).  
3.3.1. Experimental Animals, Diets, and Design 
 One hundred and forty four, one-day-old mixed sex conventional broiler chicks 
(Gallus gallus, Hubbard x Hubbard) were obtained from a local broiler hatchery 
(Lilydale Hatchery, Wynyard, SK, Canada) and placed randomly into 12 electrically 
heated battery cages (12 birds per cage) at the Animal Care Unit, Western College of 
Veterinary Medicine of the University of Saskatchewan. From day 1 through 21 of the 
experiment, birds were provided with a medicated, ideal protein balanced (lysine 12%) 
corn-based starter crumble (Co-op Feeds, Saskatoon, SK) (Table 3.1). On day 21, the 
birds were weighed and randomly assigned to one of the 12 battery cages. Two cages 
were assigned to one of the six experimental diets (Table 3.2) up to the end of the 
experiment (day 42). The dietary treatments were arranged in a 2 x 3 factorial design with 
2 levels of guar gum (0 or 1%) and 3 levels of crude protein (40% using fish meal as the 
primary protein source, 40% using soy protein concentrate (SPC) as the main protein 
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source, and 23% using both fish meal and SPC). The diets were isocaloric and met or 
exceeded the NRC requirements for broiler chickens (NRC, 1994). All diets contained 
250 ppm of zinc since zinc is known to increase α toxin production from C. perfringens 
in vitro and also it might protect the α toxin from inactivation by intestinal proteases.  
 The research facility was thoroughly cleaned and disinfected prior to bird 
placement. The battery cages were arranged in four tires with a wire floor and were 
equipped with external feed and water troughs. Lighting schedule was 16 L: 8 D 
throughout the experiment. Room temperature was maintained according to industry 
standards. None of the experimental diets contained antibiotics or coccidiostats and were 
not pelleted. Throughout the experimental period in each experiment, birds were fed and 
watered ad libitum. Feed consumption and body weight for each cage was recorded for 
the period days 21-28, 28-35 and 35-42 for calculation of feed conversion. When 
calculating feed conversion the body weight of dead birds was taken into account. 
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Table 3.1. Ingredient composition of starter diet used for all birds up to day 21 
of age1 
 
Ingredients Inclusion (%) 
Soybean meal 40.90 
Corn 39.50 
Wheat 10.00 
Tallow 4.52 
Dicalcium phosphate 1.53 
Calcium carbonate 1.29 
Canola oil 1.00 
DL-Methionine 0.26 
Choline chloride 0.10 
Vitamin/Mineral premix2 0.50 
Salinomycin sodium3 0.06 
Bacitracin4 0.05 
Bio-cox 1205 0.05 
 
1 Diet was formulated to contain 31.5% crude protein and meet NRC requirements for 
broiler chickens. 
2 Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 µg; vitamin E, 
30 mg; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; sodium, 511 mg; 
iron, 80 mg; maganese, 21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
3 Phibro Animal Health Ltd. 
4 Alpharma Canada Corp. 
5 Anticoccodial Premix, OzBioPharma Ltd. 
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Table 3.2. Experimental diet formulations fed to birds on days 21-42 of the experiment1 
 Without Guar Gum With Guar Gum 
Ingredients Control FM SPC Control FM SPC 
Corn 51.23 12.40 22.36 50.23 11.40 21.36 
Wheat 20.00 20.00 20.00 20.00 20.00 20.00 
Fish meal 16.99 56.96 0.00 16.99 56.96 0.00 
Soy protein conc. 7.96 0.00 53.86 79.6 0.0 53.86 
Guar gum 0.00 0.00 0.00 1.00 1.00 1.00 
Canola oil 2.00 7.42 2.00 2.00 7.42 2.00 
Calcium 
carbonate 
1.21 2.62 1.18 1.21 2.62 1.18 
Choline chloride 0.10 0.10 0.10 0.10 0.10 0.10 
Vit./Min. premix2 0.50 0.50 0.50 0.50 0.50 0.50 
 
1Diets were formulated to contain either 23% (control) or 40% crude protein (Fish meal- or Soy 
protein concentrate-based) and meet NRC requirements for broiler chickens.  
2 Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 µg; vitamin E, 30 mg; 
vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; folic acid, 0.6 
mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; sodium, 511 mg; iron, 80 mg; maganese, 
21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
Note: 100 mg/kg zinc was supplied by mineral premix. In addition to this, 150 mg/kg zinc was 
also supplemented in all diet i.e. each diet contained 250 ppm of zinc. 
FM = Fish meal, SPC = Soy protein concentrate  
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3.3.2. Clostridium perfringens Challenge Model 
 An avian C. perfringens field strain isolated from a clinical case of NE was 
obtained from Dr. Manuel Chirino, College of Veterinary Medicine, University of 
Saskatchewan and characterized by PCR technique as type A toxin producer. The 
organism was cultured anaerobically on BBLTM Blood Agar Base (Becton, Dickinson and 
Co., Sparks, MD, USA) containing 5.0% sheep blood and 100 mg/L Neomycin Sulfate 
(The Upjohn Company, Orangeville, ON, Canada) for 18 hours at 37°C, then aseptically 
inoculated into brain heart infusion (Difco Labs, Detroit, MI), and incubated 
anaerobically overnight at 37°C. All birds were orally challenged in the crop with 1.0 mL 
on days 21 to 27 inclusive with this overnight culture of C. perfringens using a 12.0 mL 
syringe equipped with vinyl tubing (I.D. 0.97mm, O.D. 1.27mm). Bacterial counts were 
performed on the culture daily prior to inoculation and the numbers ranged from 6.00 x 
104 to 9.59 x 106 CFU/mL.   
3.3.3. Pathological Examination 
 Birds were observed on a pen basis at least once daily for any sign of NE. On 
days 35, 39 and 42 of the experiment, four birds from each pen were killed by cervical 
dislocation, weighed and necropsied immediately. Intestinal tracts were removed and 
examined for any gross lesions of NE. On day 42, following postmortem examination, a 
1.5-2.0 cm long piece of intestinal tissue from ileum (just below the Mackel’s 
diverticulum) was collected in phosphate-buffered formaldehyde solution and processed 
routinely for paraffin embedding, sectioned at approximately 5 µm, and stained with 
hematoxylin and eosin. In addition to this, four randomly selected ileal tissues from each 
treatment were also processed for PAS-Alcian blue staining to differentially stain the 
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neutral and acid mucin producing goblet cells. Neutral mucin and acid mucin producing 
cells were counted differentially by digital image capture analysis per 10 random high 
power fields (40x) using Northern Eclipse Software version 6.0 (2002).   
3.3.4. Bacteriological Examination 
 On day 35, 39 and 42, four birds were selected at random from each pen, 
weighed, killed and their intestinal tracts were removed. Samples of fresh digesta (0.1 to 
0.2 g) from ileum (Meckel’s diverticulum to 1 cm proximal to ileocecal junction) and 
paired ceca were collected aseptically in pre-weighed 15 mL sterilized plastic tubes 
containing 1 mL 0.1% sterile peptone buffer with 5 g/L cysteine hydrochloride (Sigma 
Chemical Co., St. Louis MO). The samples were immediately placed and kept on ice 
until plated within 4 h of collection. The samples were weighed and diluted in peptone 
water to an initial 10-1 dilution. Ten-fold dilutions were spread in duplicate using an 
automated spiral plater (Autoplate, Spiral Biotech Inc., Bethesda MD, USA) on BBL™ 
blood agar base (Becton, Dickinson and Co., Sparks, MD, USA) containing 5.0% sheep 
blood and 100 mg/L neomycin sulfate (The Upjohn Company, Orangeville, ON, Canada) 
for C. perfringens enumerations. In addition, the digesta samples were also cultured on 
MRS agar (Becton, Dickinson and Co., Sparks, MD, USA) and blood agar (Becton, 
Dickinson and Co., Sparks, MD, USA) for the enumeration of lactobacilli, total aerobes 
and total anaerobes. The plates were incubated at 37°C for 16-24 h anaerobically for C. 
perfringens, lactobacilli and total anaerobes while aerobically for total aerobes. The α- 
and β- hemolytic colonies on blood agar/neomycin plates were counted as C. perfringens 
(Appendix 9.1A) with presumptive colonies being randomly picked, gram stained, plated 
on Mannitol Yolk Polymixin agar (Oxoid Inc., Napean, ON, Canada) and examined 
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microscopically to confirm them as C. perfringens. Counts were expressed as the Log10 
CFU/g of intestinal contents. 
3.3.5. Measurement of Viscosity and pH of Ileal Digesta 
 On day 35, 39 and 42, the viscosity and pH of ileal digesta was measured within 
5-10 min of digesta collection. Immediately after digesta collection, the ileal digesta (1-2 
g) was centrifuged at 14,000 rpm for 3 min and supernatant was diluted in water (1:1000 
w/v). Samples were then stored on ice for maximum 10 min until viscosity (centipoise) 
was determined using a digital viscometer (Brookfield digital viscometer, Model 
LVTDVCP-II,  Brookfield Engineering Laboratories, Stoughton, MA., USA). For pH 
estimation, the ileal digesta (1 g) was immediately mixed with 4.0 mL deionised water, 
vortexed well to make slurry and pH was determined using digital pH/mV/°C meter 
(Cole Palmer Instrument Company, Chicago, IL, USA). The probe of pH meter was 
washed well with deionised water between samples.  
3.3.6. Statistical Analysis 
 The data were analyzed as a 2 x 3 factorial design using the General Linear Model 
of SPSS (v.12.0, SPSS Inc, Chicago IL, USA). Individual treatment means were 
compared using the Ryan-Einot-Gabriel-Welsch multiple F test and differences between 
the means were considered significant when P < 0.05.   Bivariate correlation analysis was 
performed between C. perfringens and lactobacilli populations in ileum, and ileal pH and 
viscosity. Pearson’s correlation coefficient was considered significant when P < 0.05.  
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3.4. Results 
 The birds did not show any signs of disease subsequent to challenge with C. 
perfringens. Nine birds died (mortality 6.25%) during the course of experiment, but 
necropsy examination could be conducted only on 5 birds. The dead birds were in good 
condition and small necrotic patches in the distal ileum were seen in 3 birds, however, the 
lesions were very mild and possibly might not be the cause of death of these birds. 
Overall the intestinal lesions of NE were reported in 27 birds (18.75%) in all treatment 
groups; however, there were no treatment effects on the number of birds with NE lesions. 
The intestinal gross lesions in most of the birds were very mild and inconclusive of NE 
(e.g. intestinal wall was thin and hyperemic with engorged mesenteric blood vessels). NE 
lesion scoring was not done in this experiment. Microscopic examination of formalin 
fixed intestinal tissues from 42-day-old broiler chickens revealed no lesions specific of 
NE and there was no evidence of gram-positive rod-shaped organisms attached to the 
intestinal mucosa.   
 The average daily feed intake (ADFI) was measured during week 4, 5 and 6 while 
average daily gain (ADG) and feed:gain ratio (FC) were measured during week 4 and 5 
only. At all time points, the ADFI and ADG were significantly lower (P < 0.05) in birds 
which were fed SPC-based diets compared to the other two diets (Table 3.3). The birds 
that received guar gum supplemented diets had a significantly lower (P < 0.05) ADG and 
poor feed conversion efficiency during week 4 and 5. There was no significant interaction 
between protein source and guar gum for performance parameters except for feed 
efficiency during week 4.  
 48
 The pH and viscosity of ileal digesta were measured on day 35, 39 and 42 of the 
experiment. The birds which were fed SPC-based diets had a significantly (P < 0.05) 
lower pH of ileal digesta on day 35 and 39, but there was no effect of protein source on 
ileal pH on day 42 (Table 3.4). Also guar gum supplementation was associated with a 
significant decline (P < 0.05) in ileal pH at all three time points.  Protein source had no 
significant effect on ileal digesta viscosity, whereas guar gum supplementation resulted in 
a significant elevation (P < 0.05) in ileal viscosity at all three time points. The goblet 
cells numbers (acid, neutral or total) in the ileal tissue were not affected by dietary 
protein source, but the birds fed guar gum supplemented diets has significantly (P = 
0.007) higher number of total goblet cells (Figure 3.1) while the P-values for the effect 
of guar gum supplementation on acidic and neutral mucin producing goblet cells were 
0.072 and 0.085, respectively. 
 C. perfringens were enumerated in the ileum and ceca of these birds on day 35, 39 
and 42 of age whereas lactobacilli, total aerobes and total anaerobes were quantified on 
day 39 and 42 only. The populations of all these bacterial species were higher in ceca 
than the ileum at all time points. On day 35, the SPC-based diets resulted in a significant 
increase (P = 0.048) in C. perfringens populations in ileum compared to control diets, 
whereas on day 42 in cecum the birds fed SPC-based diets had a significantly higher (P = 
0.036) C. perfringens populations than the birds given either control or fish meal-based 
diets (Figure 3.2 A). Guar gum supplementation had no effect on C. perfringens growth 
in ileum except on day 42 where the numbers increased significantly (P = 0.005) with 
addition of guar gum. On the other hand, in cecum the C. perfringens populations  
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Table 3.3. Average daily feed intake (ADFI, g/day), average daily gain (ADG, g/day) and 
feed:gain ratio (FC, feed intake/ weight gain, g/g) of birds during weeks 4, 5 and 6 of the 
experiment. 
 ADFI ADG FC 
 Week 4 Week 5 Week 6 Week 4 Week 5 Week 4 Week 5 
Protein         
Control 82.4a 117.4b 142.3a 41.3a 58.4a 2.1 2.2 
Fishmeal 83.4a 127.6a 149.2a 41.1a 60.4a 2.1 2.2 
SPC 60.1b 90.2c 100.4b 30.4b 39.8b 1.9 2.4 
Pooled SEM 13.15 19.32 26.43 6.24 11.33 0.05 0.09 
Guar gum        
Absent 72.8 113.7 136.6 41.1 63.9 1.8 1.8 
Present 77.8 109.8 124.6 34.1 41.7 2.3 2.7 
Pooled SEM 3.55 2.69 8.49 4.96 15.75 0.34 0.63 
P-values        
Protein  0.000 0.000 0.000 0.002 0.011 0.204 0.822 
Guar gum 0.079 0.286 0.055 0.005 0.002 0.000 0.011 
Protein x guar gum 0.231 0.282 0.597 0.058 0.247 0.000 0.930 
 
abc Means with the different superscripts within a column differ significantly (P < 0.05) 
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Table 3.4. Effect of protein source and guar gum on the pH and viscosity (centipoise) 
of ileal digesta on days 35, 39 and 42 of the experiment. 
 
 Ileal pH Ileal viscosity 
 Day 35 Day 39 Day 42 Day 35 Day 39 Day 42 
Protein        
Control 7.05a 7.18a 7.79 1.76 1.59 1.77 
Fishmeal 7.21ab 7.42a 7.51 1.20 1.24 1.41 
SPC 7.65b 8.02b 7.96 1.43 1.45 1.43 
Pooled SEM 0.30 0.40 0.26 0.28 0.18 0.20 
Guar gum       
Absent 7.72 7.84 8.06 1.15 0.93 0.95 
Present 6.89 7.24 7.41 1.78 1.92 2.14 
Pooled SEM 0.52 0.41 0.43 0.41 0.69 0.78 
P value       
Protein  0.040 0.029 0.124 0.077 0.090 0.111 
Guar gum 0.001 0.018 0.002 0.007 0.000 0.000 
Protein x guar gum 0.438 0.242 0.803 0.179 0.432 0.158 
 
ab Means with the different superscripts within a column differ significantly (P < 0.05) 
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Figure 3.1. Effect of different protein sources (A) and guar gum (B) on acid, neutral 
and total goblet cell counts (per 10 random high power fields) in ileum of broiler 
chickens on day 42 of the experiment. Bars represent the mean ± SEM. SPC = Soy 
protein concentrate, GG = Guar gum 
abBars with different labels are significantly different (P < 0.05) 
a
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Figure 3.2. Effect of different protein source (A) and guar gum (B) on C. perfringens 
populations in ileum and cecum of broiler chickens on days 35, 39 and 42 of the 
experiment. Bars represent the mean ± SEM. SPC = Soy protein concentrate, GG = 
Guar gum 
abBars with different labels are significantly different (P < 0.05) 
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increased significantly (P < 0.05) in response to guar gum supplementation at all time 
points (Figure 3.2 B). Also we observed a significant (P = 0.035) interaction between 
protein source and guar gum for C. perfringens growth in cecum on day 42.  
 On day 39, the fish meal-based diets supported a significantly lower (P = 0.022) 
population of lactobacilli in cecum than control diets, whereas guar gum supplementation 
was associated with a significant increase (P < 0.05) in lactobacilli in both ileum and 
cecum on day 42 (Figure 3.3 A and B). There was no significant effect of protein source 
on total anaerobe populations except that SPC-based diets resulted in significantly higher 
(P = 0.014) total anaerobes in cecum on day 42 compared to fish meal diet. On day 42, 
we also observed a significant increase (P = 0.001) in total anaerobes in cecum of birds 
fed guar gum added diets (Figure 3.4 A and B).  On day 39, the total aerobes decreased 
significantly (P = 0.038) in the ileum of fish meal fed birds than the SPC fed birds, 
whereas guar gum supplementation was associated with a significantly higher (P = 0.004) 
total aerobes in cecum on day 42 (Figure 3.5 A and B). 
 Results of a bivariate correlation analysis between C. perfringens and lactobacilli 
populations in ileum, and ileal pH and viscosity are presented in Table 3.5. We observed 
a significant negative correlation (P < 0.05) between ileal pH and C. perfringens on day 
42 and lactobacilli on day 39. However, C. perfringens growth on day 39 and 42 was 
positively correlated (P < 0.01) with ileal viscosity. Also there was a significant (P < 
0.05) positive correlation between ileal viscosity and lactobacilli population on day 42.       
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Figure 3.3. Effect of different protein source (A) and guar gum (B) on lactobacilli 
populations in ileum and cecum of broiler chickens on days 39 and 42 of the 
experiment. Bars represent the mean ± SEM. SPC = Soy protein concentrate, GG = 
Guar gum. 
abBars with different labels are significantly different (P < 0.05) 
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Figure 3.4. Effect of different protein source (A) and guar gum (B) on total 
anaerobes in ileum and cecum of broiler chickens on days 39 and 42 of the 
experiment. Bars represent the mean ± SEM. SPC = Soy protein concentrate, GG = 
Guar gum 
abBars with different labels are significantly different (P < 0.05) 
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Figure 3.5. Effect of different protein source (A) and guar gum (B) on total aerobes 
in ileum and cecum of broiler chickens on days 39 and 42 of the experiment. Bars 
represent the mean ± SEM. SPC = Soy protein concentrate, GG = Guar gum 
abBars with different labels are significantly different (P < 0.05) 
 
 
a
ab
b
a
b
 57
Table 3.5. Pearson correlation (r) coefficients between the pH and viscosity of ileal 
digesta and ileal populations of C. perfringens and lactobacilli at different days of 
experiment. 
  C. perfringens  Lactobacilli 
  Day 35 Day 39 Day 42 Day 39 Day 42 
Ileal pH Day 35 0.247 0.276 -0.226 - - 
 Day 39 -0.020 0.351 -0.365 -0.542** -0.140 
 Day 42 0.132 0.294 -0.504* 0.020 -0.232 
Ileal viscosity Day 35 -0.151 -0.190 0.316 - - 
 Day 39 -0.069 0.640** 0.138 0.050 0.391 
 Day 42 -0.011 0.206 0.562** 0.247 0.419* 
 
**Correlation is significant at 0.01 level. 
* Correlation is significant at 0.05 level. 
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3.5. Discussion  
 The C. perfringens populations in a healthy chicken gut vary considerably from 
sporadic to low numbers to 107 CFU/g digesta or even more (Dumonceaux et al., 2006; 
Engberg et al., 2002; Ficken and Wages, 1997). Although the intestinal tracts of birds 
were highly colonized with C. perfringens, however, no overt clinical signs of NE were 
noted in the present study. Kaldhusdal et al. (1999) suggested that median counts of C. 
perfringens above one million per gram predict a high probability of concurrent NE-
specific gut lesions. Other authors found C. perfringens concentrations ranging from 105 
to 2 x 108/g sample in the small intestine of birds that died of NE (Kondo, 1988; Long et 
al., 1974). We observed some mild lesions of NE in these birds, but mortality and NE 
lesions typical of field cases were not seen. Previous controlled studies of chickens 
challenged with C. perfringens have also failed to induce mortality or other symptoms of 
NE, even though high C. perfringens populations were reported in the intestinal tract 
(Cowen et al., 1987). Takeda et al. (1995) reported that even 50% inclusion of rye in the 
diets of caged young leghorn chicks significantly increased C. perfringens populations, 
and although the chicks suffered from diarrhea and ateliosis, clinical NE did not develop 
and no NE lesions were observed. There is evidence that the normal gut microflora in 
healthy birds inhibits the pathogenicity of C. perfringens (Fukata et al., 1991; Fukata et 
al., 1988). Furthermore, digestive enzymes such as trypsin inactivate the α-toxin of C. 
perfringens type A and β-toxin of C. perfringens type C (Baba et al., 1992; Niilo, 1965). 
Since C. perfringens is the etiological agent of NE it seems reasonable to assume that 
increased populations of this organism are associated with an increased predisposition to 
clinical NE.  
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 The ADFI and ADG were significantly lower in birds which were fed SPC-based 
diets compared to control and fish meal-based diets. It seems that palatability was an 
issue with the SPC-based diets because SPC has a very fine particle size making it 
difficult to consume in a mash diet and it has a relatively poor amino acid balance.  
Although there was no effect of SPC on ileal viscosity, the pH of ileal contents was 
significantly higher in SPC-fed birds. It is possible that digestibility of SPC was reduced 
because of higher intestinal pH in these birds and that’s why ADG was lower in SPC-fed 
birds. As expected, guar gum supplementation at 1.0% level was associated with a 
significantly lower ADG and poor feed efficiency. The ADFI was very close to 
significant especially during the week 4 and 6 (P = 0.079 and 0.055, respectively). Also 
the intestinal viscosity and pH were significantly higher and lower, respectively in birds 
that received guar gum supplemented diets. Guar gum is a high molecular weight 
galactomannan polysaccharide consisting of approximately 35% galactose, 63% mannose 
and 5-7% protein (Horton, 1997) which is known to have an impact on gastrointestinal 
tract viscosity, and digestion and absorption of nutrients. On a weight basis, 
galactomannan is five times as viscous as starch, and is one of the most viscous 
polysaccharides known (Whistler and Smart, 1953). The physiological action of guar 
gum has been reported to depend on its capacity to hydrate rapidly and thus increase the 
viscosity of digesta in gizzard and small intestine (Blackburn et al., 1984).  Guar gum 
decreases growth and performance of broiler chickens even when guar gum-containing 
meals are fed at low concentrations (Vohra and Kratzer, 1964). Maisonnier et al. (2001) 
reported that guar gum addition (0, 1, 3 g/kg) in broiler chicken diets increased digesta 
viscosity and decreased nutrient digestibilities, with most pronounced effects being 
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observed for lipids, then for proteins, and lowest for starch. In the current study, we 
measured the ileal viscosity because ileal viscosities are more sensitive and consistent to 
changes in diet composition than other segments of the small intestine (Lee et al., 2003).  
Ingredients in broiler diets that cause increased intestinal viscosity, such as wheat, barley 
and rye, are cited as the cause of growth depression and poor feed efficiency (Bedford 
and Classen, 1992; Choct et al., 1995). High intestinal viscosity decreases digestibility 
coefficients of all macronutrients and decreases digestive enzyme (amylase and lipase) 
activity throughout the small intestine (Smits et al., 1997). It is apparent that some NSP 
interact with protein and glycoproteins of the epithelial tissue, causing damage or 
inducing the secretion of mucin from the tissues (Kleessen et al., 2003). A second means 
by which water soluble NSP may reduce performance of chicks is through excessive 
stimulation of the intestinal microflora which in turn increases deconjugation of bile acids 
in the small intestine which in turn reduce the formation of micelles and thus limit 
absorption of fatty acids (Coates et al., 1981). As expected, addition of guar gum resulted 
in reduced pH of ileal contents. Since guar gum is a soluble NSP, it is easily, rapidly and 
completely fermented mainly in terminal ileum releasing various short chain fatty acids, 
in particular acetate, propionate, butyrate, lactate and succinate thus aids in reducing the 
pH of ileal digesta (Nyman et al., 1986, Langhout et al., 2000). 
 In the current experiment, we observed a significantly higher numbers of total 
goblet cells in the ileum of guar gum fed birds, however, acid and neutral mucin cells did 
not differ significantly due to guar gum supplementation. It is well known that the 
intestinal epithelial surface is covered with a mucus gel secreted by epithelial goblet cells 
that acts as a protective barrier against harmful intraluminal components. Dietary factors 
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have a profound effect on the goblet cell numbers and mucin composition (Smirnov et 
al., 2005). In agreement with our results, Schneeman et al. (1982) reported a significant 
increase in the number of mucin-producing goblet cells in the epithelium of small 
intestine of rats fed a diet containing 200 g wheat bran/kg compared to a fibre-free diet. 
Improved capacity of mucin synthesis stimulated by dietary fibre intake can be regarded 
as an adaptation to a chronic mechanical irritation caused by dietary fibre. This effect 
may also occur by way of SCFA production that favors secretion of mucins in the colon 
(Montagne et al., 2003). Mucus offers a number of ecological advantages to intestinal 
bacteria e.g. it is a source of carbohydrates and peptides for microbes and it protects 
bacteria from rapid expulsion due to peristalsis. In this regard, it is possible that mucus 
secretion is typically enhanced in response to intestinal microbes. So both commensals 
and pathogenic bacteria regulate mucus synthesis, secretion and composition from host 
goblet cells (Deplancke and Gaskins, 2001).   
 In contrast to our previous findings (Drew et al., 2004), there was no significant 
effect of fish meal on C. perfringens growth in ileum and cecum in the present study. 
Whereas birds fed SPC-based diets had significantly elevated numbers of C. perfringens 
in ileum on day 35 and in cecum on day 42 compared to birds given control diets. The C. 
perfringens lacks the ability to produce at least 13 amino acids out of 20 essential amino 
acids, and its growth is therefore enhanced in an environment rich with protein (Mcdevitt 
et al., 2006). The clostridial overgrowth and thus an increased risk of NE is often 
associated with animal protein ingredients such as fish meal or meat and bone meal 
(Kocher, 2003). One possible explanation may be that the very high quantities of fish 
meal (around 57.0%) used in these diets might be responsible for some physio-chemical 
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changes in the GIT of these birds which do not support C. perfringens growth. It is also 
possible that it may not be fish meal per se, but rather the use of poor quality fish meal, 
which aids in the proliferation of C. perfringens and thus contributes to the development 
of NE, possibly via production of biogenic amines. 
 We observed that SPC fed birds had significantly higher numbers of total aerobes 
in ileum on day 39 and total anaerobes in cecum on day 42. Diets that contain relatively 
high concentration of proteins, as well as those with imbalanced profile of amino acids, 
have reduced digestibility in upper GIT and thus larger concentrations of these 
compounds, as well as their metabolites, are found in the lower GIT (Mcdevitt et al., 
2006). Similarly, poorly digested proteins concentrate in the lower GIT and thus act as 
substrates for microflora (Williams et al., 2001). The proteins can be degraded to 
ammonia and amines, thus encouraging the proliferation of pathogenic bacteria such as 
C. perfringens (Juskiewicz et al., 2004). The birds fed SPC-based diets had 
comparatively higher intestinal pH and C. perfringens counts than the other two groups. 
It is possible that the presence of various nitrogenous degradation products (e.g. ammonia 
and amines) may raise the pH of lower GIT because of their high pKa values and 
counteract pH changes that would normally occur due to bacterial production of lactic 
and acetic acids, thereby enhancing proliferation of C. perfringens (Juskiewicz et al., 
2004; Lan et al., 2005). It is interesting to note that lactobacilli populations were higher 
in SPC fed birds on day 39 and 42 (P = 0.022 and 0.081, respectively). It is very 
important because lactobacilli are known to protect against colonization of various 
enteric pathogens. Fukata et al.  (1991) reported that pathogenic effect of C. perfringens 
could be reduced by feeding chicks a monoflora of Lactobacillus acidophilus or 
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Streptococcus faecalis. The probiotic strains of lactobacilli which are able to colonize the 
human intestinal tract induce epithelial cells to secret mucins that diminish enteric 
pathogens binding to mucosal epithelial cells (Johansson et al., 1993).  
 Feeding guar gum diets increased the intestinal microflora (C. perfringens, 
lactobacilli, total aerobes and anaerobes) of broiler chickens in the current study. The 
increase in intestinal microflora corresponds with the increase in intestinal viscosity due 
to added guar gum. A similar increase in microbial activity in the small intestine has 
previously been reported in birds fed with diets containing rye (Wagner and Thomas, 
1978), wheat pentosans (Choct et al., 1996), highly methylated citrus pectin (Wagner and 
Thomas, 1978) or caroxymethyl cellulose (Smits et al., 1998). Different hypotheses have 
been put forward concerning effect of NSP on C. perfringens growth and NE. Barley, 
wheat, rye and oats contain high levels of soluble NSP, which are known to increase 
digesta viscosity, decrease digesta passage rate and nutrient digestibility, in contrast to 
corn (Choct et al., 1996). This is proven to lead to increase in intestinal anaerobic 
populations (Hubener et al., 2002; Kocher, 2003). The NSP compounds also act as 
substrates for microflora within the GIT and thus allow the proliferation of pathogenic 
bacteria (Choct et al., 1996) including C. perfringens.   
3.6. Conclusions           
 This experiment suggests that diet is only one of the numerous factors 
predisposing birds to NE. Not only protein source and concentration per se, but the 
quality of protein is important in terms of C. perfringens overgrowth, α toxin production 
and thus NE predisposition. Various dietary factors (e.g. protein and fibre) have profound 
effects on intestinal physiology and morphology which in turn influence the microbial 
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colonization in the GIT.  With such as multi-factorial disease, a working and reproducible 
experimental model is an essential tool to determine various control or management 
strategies. The NE challenge model used in this study was not successful in producing 
clinical disease, so we decided to make some significant changes in our subsequent 
model. The first important change was that in our subsequent experiments, we also 
challenged the birds with C. perfringens when they were one day old because early stage 
of post-hatch is a critical period for the establishment of the gut microbial community in 
broiler chickens. Newly-hatched chicks are particularly vulnerable to invasion by 
pathogens before their intestinal microbial communities become established. Therefore, it 
seems reasonable to administer C. perfringens to chicks during the early period after 
hatching to achieve high intestinal colonization of C. perfringens and thus clinical 
disease. Second important change was that instead of using overnight culture of C. 
perfringens in brain heart infusion agar, we decided to use cooked meat media (CMM) to 
grow C. perfringens for challenging the birds. It was decided on the basis of the results of 
our in vitro experiments (Appendices 9.2A and 9.2B). Also all the subsequent 
experiments were conducted only for day 28 of age instead of day 42 because most of the 
field cases of NE have been reported during that period.           
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4.0. EFFECT OF DIFFERENT DIETARY METHIONINE SOURCES ON 
INTESTINAL MICROBIAL POPULATIONS IN BROILER CHICKENS 
 
4.1. Abstract 
 Previous work in our laboratory showed a significant reduction in C. perfringens 
growth in media containing DL-Methionine (DL-Met). Two experiments were therefore 
conducted to study the effect of various levels of DL-Met or 2-hydroxy-4-
methylthiobutoanic acid (MHA-FA) on C. perfringens and other intestinal bacteria in 
broiler chickens. In each experiment, two cages of 6 birds (14 day post-hatch) were 
assigned to one of 7 different diets in a 2 x 4 factorial arrangement. The main effects 
were methionine source (either DL-Met or MHA-FA) and methionine level (0, 0.2, 0.4 or 
0.8% DL-Met or 0, 0.227, 0.454 and 0.908% MHA-FA, thus providing 4 corresponding 
equimolar levels of each methionine source). All birds were orally gavaged with a C. 
perfringens type A broth culture on day 1 as well as from days 14 to 20 and euthanized 
on day 28. Intestinal populations of C. perfringens, lactobacilli, Streptococcus group D 
and coliforms were enumerated in ileum and cecum, and NE intestinal lesions were 
scored. There were no significant differences in growth of various bacterial species in the 
intestinal tract of broiler chickens fed two different methionine sources. However, we 
observed a significant reduction (P < 0.05) in C. perfringens growth with methionine 
supplementation in cecum (Experiment 1), or both in ileum and cecum (Experiment 2).  
Also there was a significant interaction (P < 0.05) between methionine source and level 
in experiment 2. C. perfringens populations were generally higher both in ileum and 
cecum in experiment 2 compared to experiment 1. In experiment 2, the lactobacilli 
populations were significantly higher (P < 0.05) in ceca of birds receiving 0.80% 
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methionine than the birds given diets with other levels of methionine tested. Significantly 
lower (P < 0.05) coliforms and Streptococcus group D were enumerated in ileum of birds 
fed 0.80% methioinine supplemented diet than the other dietary treatments. There were 
no significant differences (P > 0.05) in NE intestinal lesion scores and performance of 
birds fed different methionine sources and concentrations. The results suggest that both 
DL-Met and MHA-FA may reduce intestinal populations of C. perfringens in broiler 
chickens when used in relatively high concentrations and thus may reduce the risk of NE. 
4.2. Introduction 
 Clostridial or necrotic enteritis (NE), caused by Clostridium perfringens type A 
and C (Ficken and Wages, 1997), is a potentially fatal poultry disease of global 
significance, and is both an animal welfare and economic problem. Outbreaks of NE are 
sporadic and may result in high mortality, reduced growth rate, impaired feed conversion 
and increased condemnation rates (Lovland and Kaldhusdal, 2001). NE is estimated to 
cost the poultry industry as much as US$ 0.05 per bird with total global loss of almost 
US$ 2 billion (Van der Sluis, 2000a, 2000b). However, this might be an underestimate, 
given the difficulty in diagnosing mild or sub clinical forms of NE. In the recent years, 
the banning of prophylactic use of antibiotics in Europe, as well as consumer concerns 
about their use in other jurisdictions, has stimulated interest in finding alternative 
management or dietary strategies to control the incidence and severity of this disease in 
post-antibiotic era. 
C. perfringens is frequently found in the intestinal tract of healthy poultry, usually 
at low levels (< 104 CFU/g digesta) and is spread in poultry production units and 
processing through feces and intestinal rupture. Although C. perfringens is recognized as 
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main etiological agent of NE, but some other co-factors are usually required to precipitate 
an outbreak of NE. The physical and chemical composition of broiler diets have been 
reported to have a marked effect on intestinal microflora of chickens and it has been 
shown to have important impact on the incidence of NE in broiler chickens (Branton et 
al., 1987; Dahiya et al., 2006b; Drew et al., 2004; Riddell and Kong, 1992). Branton et 
al. (1987) found that the mortality due to NE was increased in birds fed ground feed 
(hammer-mill) compared with coarsely ground feed (roller-mill). Dietary cereal grains 
rich in non-starch polysaccharides (NSP) and dietary proteins especially proteins of 
animal origin encourage the development of NE (Annett et al., 2002; Kaldhusdal and 
Skjerve, 1996; Riddell and Kong, 1992; Wilkie et al., 2005). Kaldhusdal and Skjerve 
(1996) reported that two major outbreaks of NE in broiler chickens in Norway from 
1969-1989 were associated with increased use of barley and wheat in broiler diets. Drew 
et al. (2004) observed a significant increase in C. perfringens counts in birds fed 400 g/kg 
crude protein fish meal diet, however,  C. perfringens counts were low in ileum of birds 
fed SPC-based diets at all levels of crude protein. Dahiya et al. (2005) and Wilkie et al.  
(2005) reported a significant positive correlation between glycine content of the diets and 
digesta, and C. perfringens populations in ileum and cecum of broiler chickens. There are 
some in vitro studies showing the association between certain amino acids and C. 
perfringens growth and/or α toxin production (Ispolatovskaya, 1971; Muhammed et al., 
1975; Titball et al., 1999). Although Muhammed et al. (1975) documented that 
methionine was stimulatory for growth of C. perfringnes in vitro; however, previous 
experiments in our lab demonstrated an antibacterial effect of DL-Met against C. 
perfringens in an in vitro experiment (Wilkie et al., 2005). These researchers reported a 
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significantly (P < 0.05) reduced growth of C. perfringens after 24 h of incubation of 
mixed bacterial culture in minimal salt media supplemented with 10 mg/mL solution of 
DL-Met compared to unsupplemented media.  
Methionine is the first limiting amino acid in poultry diets and protein synthesis 
will come to a halt in the absence of methionine. It is commonly supplemented as dry 
DL-Met (99% pure) or as liquid MHA-FA at a concentration of around 0.10 to 0.25% in 
poultry diets. We hypothesized that high dietary concentrations of methionine are 
responsible for reduced C. perfringens growth in the gastrointestinal tract of boiler 
chickens and thus may decrease the risk of NE. Hence, the purpose of this experiment 
was to determine the effect of nutritional and supranutritional levels of two methionine 
sources (DL-Met and MHA-FA) on intestinal C. perfringens and other microbial 
populations, and NE lesion scores in broiler chickens using previously established C. 
perfringens challenge model with slight modifications.  
4.3. Materials and Methods 
 Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with recommendations of 
the Canadian Council on Animal Care as specified in the Guide to the Care and Use of 
Experimental Animals (Canadian Council on Animal Care, 1993).  
4.3.1. Experimental Animals, Diets, and Design 
 In each experiment, a total of 84 one-day old conventional male broiler chicks 
(Ross 308) were obtained from a local broiler hatchery (Lilydale Hatchery, Wynyard, 
SK, Canada) and housed randomly in seven electrically heated battery cages for the first 
2 weeks of age (12 birds per cage) at the Animal Care Unit, Western College of 
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Veterinary Medicine of the University of Saskatchewan. The birds received a medicated, 
ideal protein-balanced (1.20% lysine) corn-based starter crumble diet (Co-op feeds, 
Saskatoon, Canada) for the first 14 days of the experiment (Table 4.1). On day 14, the 
birds were weighed and 2 cages of 6 birds each were assigned in a completely 
randomized design to one of the seven different ideal protein-balanced experimental diets 
in a 2 x 4 factorial arrangment.  The main effects were methionine source (DL-Met or 
MHA-FA) and methionine level (0, 0.2, 0.4 and 0.8% DL-Met or 0.227, 0.454 and 
0.908% MHA-FA, thus providing 4 corresponding equimolar levels of each methionine 
source) (Table 4.3 and 4.4). The control diet was formulated to contain 23% crude 
protein, 1.2% lysine, 0.38% methionine and 3200 Kcal/kg ME. The control diet was then 
supplemented with either dry DL-Met or liquid MHA-FA to achieve four equimolar 
levels of each methionine source (0, 0.2, 0.4 and 0.8%). The calculations were based on 
the fact that the commercial product contained 88% MHA-FA (Table 4.2). The diets met 
or exceeded the NRC nutrient requirements for broiler chickens for all other nutrients 
(NRC, 1994). 
 The research facility was thoroughly cleaned and disinfected prior to bird 
placement. The battery cages were arranged in four tires with a wire floor and were 
equipped with external feed and water troughs. Lighting schedule was 16L:8D 
throughout the experiment with controlled temperature and humidity. Room temperature 
was maintained according to industry standards. None of the experimental diets contained 
antibiotics or coccidiostats and were not pelleted. Throughout the experimental period in 
each experiment, birds were fed and watered ad libitum. Feed consumption and body 
weight for each cage was recorded for the period day 14-21 and day 21-28 in each 
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experiment for calculation of feed conversion. When calculating feed conversion the 
body weight of dead birds was taken into account. Amino acid analysis of the different 
diets was performed by Degussa Corporation (Degussa Canada Inc., Burlington, ON, 
Canada).  
4.3.2. Clostridium perfringens Challenge Model 
 An avian C. perfringens field strain isolated from a clinical case of NE was 
obtained from Dr. Manuel Chirino, College of Veterinary Medicine, University of 
Saskatchewan and characterized by PCR technique as a type A toxin producer. The 
organism was cultured anaerobically on BBLTM Blood Agar Base (Becton, Dickinson and 
Co., Sparks, MD, USA) containing 5.0% sheep blood and 100 mg/L neomycin sulfate 
(The Upjohn Company, Orangeville, ON, Canada) for 18 h at 37°C, then aseptically 
inoculated into either brain heart infusion (Difco Labs, Detroit, MI, USA) (experiment 1) 
or cooked meat medium (Difco Labs, Detroit, MI, USA) (experiment 2) and incubated 
anaerobically overnight (experiment 1) or for 8 h (experiment 2) at 37°C. All birds were 
orally challenged in the crop with 0.5 mL on day 1 and 1.0 mL on days 14 to 20 inclusive 
with this actively growing culture of C. perfringens using a 12.0 mL syringe equipped 
with vinyl tubing (I.D. 0.97mm, O.D. 1.27mm). Bacterial counts were performed on the 
culture daily prior to inoculation and the numbers ranged from 4.51 x 104 to 3.73 x 106 
CFU/mL. 
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Table 4.1. Composition of starter diet used in both experiments up to day 14 of 
age1. 
 
Ingredients Inclusion (%) 
Soybean meal 40.90 
Corn 39.50 
Wheat 10.00 
Tallow 4.52 
Dicalcium phosphate 1.53 
Calcium carbonate 1.29 
Canola oil 1.00 
DL-Methionine 0.26 
Choline chloride 0.10 
Vitamin/Mineral premix2 0.50 
Salinomycin sodium3 0.06 
Bacitracin4 0.05 
Bio-cox 1205 0.05 
 
1 Diet was formulated to contain 31.5% crude protein and meet NRC requirements for 
broiler chickens. 
2 Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 µg; vitamin E, 
30 mg; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; sodium, 511 mg; 
iron, 80 mg; maganese, 21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
3 Phibro Animal Health Ltd. 
4 Alpharma Canada Corp. 
5 Anticoccodial Premix, OzBioPharma Ltd. 
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Table 4.2. Experimental design. 
Treatment Methionine source1 Addition of Met Source 
(% of product) 
Addition of Met 
equivalents (%) 
1 Control diet - - 
2 DL-Met 0.200 0.200 
3 DL-Met 0.400 0.400 
4 DL-Met 0.800 0.800 
5 Liquid MHA-FA 0.2272 0.200 
6 Liquid MHA-FA 0.4542 0.400 
7 Liquid MHA-FA 0.9082 0.800 
 
1 DLM = DL-Methionine; Liquid MHA-FA = Liquid Methionine hydroxyl analog-free 
acid 
2 Based on a liquid MHA-FA content of 88% in the commercial product 
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Table 4.3. Ingredient composition of experimental diets used in experiments 1 and 2 (% as is 
basis). 
 
 Experimental diets 
Ingredients Control 0.2 DL-
Met 
0.4 DL-
Met 
0.8 DL-
Met 
0.2 
MHA-
FA 
0.4 
MHA-
FA 
0.8 
MHA-
FA 
Corn 63.75 63.55 63.35 62.95 63.52 63.30 62.84 
Meat/Bone meal 14.16 14.16 14.16 14.16 14.16 14.16 14.16 
PPCx 6.88 6.88 6.88 6.88 6.88 6.88 6.88 
Soybean meal 6.65 6.65 6.65 6.65 6.65 6.65 6.65 
Wheat 5.90 5.90 5.90 5.90 5.90 5.90 5.90 
Canola oil 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Cal. carbonate 0.88 0.88 0.88 0.88 0.88 0.88 0.88 
Dical. phosphate 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
L-threonine 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
L-lysine HCl 0.10 0.10 0.10 0.10 0.10 0.10 0.10 
DL-methionine 0.00 0.20 0.40 0.80 0.00 0.00 0.00 
MHA-FAz 0.00 0.00 0.00 0.00 0.23 0.45 0.91 
Choline chloride 0.10 0.10 0.10 0.10 0.10 0.10 0.10 
Vit/Min premix1 0.50 0.50 0.50 0.50 0.50 0.50 0.50 
 
1Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 µg; vitamin E, 30 mg; 
vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; folic acid, 0.6 
mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; sodium, 511 mg; iron, 80 mg; maganese, 
21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
xPPC = Potato protein concentrate  
zMHA-FA = Methionine hydroxy analog 
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Table 4.4. Crude protein and amino acid composition (analyzed) of experimental diets 
used in experiments 1 and 2 (% as is basis). 
 
 Experimental diets 
 Control 0.2 DL-
Met 
0.4 DL-
Met 
0.8 DL-
Met 
0.2 
MHA-
FA 
0.4 
MHA-
FA 
0.8 
MHA-
FA 
Crude protein 23.23 23.37 23.21 23.03 22.83 23.42 23.15 
Essential amino acids 
Arginine 1.31 1.36 1.28 1.30 1.28 1.32 1.36 
Histidine 0.52 0.53 0.52 0.52 0.51 0.52 0.53 
Isoleucine 0.90 0.92 0.89 0.90 0.88 0.91 0.91 
Leucine 2.05 2.06 2.04 2.04 2.02 2.05 2.05 
Lysine 1.24 1.28 1.24 1.28 1.24 1.28 1.34 
MHA-FAx - - - - 0.22 0.50 0.86 
Methionine 0.43 0.63 0.78 1.19 0.43 0.43 0.43 
Meth. + cystine 0.77 0.95 1.12 1.51 0.75 0.75 0.76 
Phenylalanine 1.08 1.10 1.07 1.07 1.04 1.08 1.09 
Threonine 0.98 1.03 0.96 1.01 0.95 0.97 1.00 
Valine 1.11 1.15 1.10 1.12 1.09 1.13 1.13 
Nonessential amino acids 
Alanine 1.47 1.51 1.47 1.46 1.46 1.48 1.49 
Aspartate 2.11 2.14 2.08 2.11 2.04 2.12 2.12 
Cysteine 0.33 0.33 0.33 0.32 0.32 0.32 0.33 
Glycine 1.63 1.72 1.60 1.62 1.60 1.63 1.69 
Glutamate 3.56 3.60 3.56 3.56 3.53 3.58 3.57 
Proline 1.51 1.56 1.50 1.50 1.50 1.54 1.55 
Serine 1.15 1.16 1.14 1.16 1.12 1.17 1.15 
 
xMHA-FA = Methionine hydroxy analog 
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4.3.3. Pathological Examination 
 Birds were observed on a pen basis at least once daily for any signs of NE and all 
birds that died during the course of experiments were necropsied to determine the cause 
of death. On day 28, the surviving chickens were euthanized by cervical dislocation, 
weighed and necropsied immediately. Intestinal tracts were removed and intestinal 
lesions were scored blindly according to the method of Truscott and Al-Sheikhly (1977) 
with slight modifications on a scale 0 to 4 where 0 was apparently normal, no lesion; 0.5, 
severely congested serosa and mesentery engorged with blood; 1, thin walled and friable 
intestines with small red petechiae (> 5); 2, focal necrotic lesions; 3, patches of necrosis 
(1-2 cm long); and 4, diffused necrosis typical of field cases. Following postmortem 
examination, if the score was ≥1 then a 1.5-2.0 cm long piece of intestinal tissue with the 
gross NE lesion was collected in phosphate-buffered formaldehyde solution and 
processed routinely for paraffin embedding, sectioned at approximately 5 µm, and stained 
with hematoxylin and eosin.  
4.3.4. Bacterial Enumeration   
 On day 28, birds were selected at random from each pen, weighed and killed by 
cervical dislocation and their intestinal tracts were removed. Samples of fresh digesta (0.1 
to 0.2 g) from ileum (Meckel’s diverticulum to 1 cm proximal to ileocecal junction) and 
ceca were collected aseptically in pre-weighed 15 mL sterilized plastic tubes containing 1 
mL 0.1% sterile peptone buffer with 5 g/L cysteine hydrochloride (Sigma Chemical Co., 
St. Louis MO). The digesta samples were pooled from two birds from each cage. The 
samples were immediately placed and kept on ice until plated within 3 h of collection. 
The samples were weighed and diluted in peptone water to an initial 10-1 dilution. Ten-
 76
fold dilutions were spread in duplicate using an automated spiral plater (Autoplate, Spiral 
Biotech Inc., Bethesda MD, USA) on BBL™ blood agar base (Becton, Dickinson and 
Co., Sparks, MD, USA) containing 5% sheep blood and 100 mg/L neomycin sulfate (The 
Upjohn Company, Orangeville, ON, Canada) for C. perfringens enumerations. In 
addition, all the digesta samples were also cultured on MRS agar (Becton, Dickinson and 
Co., Sparks, MD, USA), MacConkey’s agar (Becton, Dickinson and Co., Sparks, MD, 
USA) and Bile esculin agar (Becton, Dickinson and Co., Sparks, MD, USA) for the 
enumeration of lactobacilli, coliforms and Streptococci group D, respectively. The plates 
were incubated at 37°C for 16-24 h anaerobically for C. perfringens and lactobacilli 
while aerobically for coliforms and Streptococcus group D bacteria. The α- and β- 
hemolytic colonies on blood agar/neomycin plates were counted as C. perfringens with 
presumptive colonies being randomly picked, gram stained, plated on Mannitol Yolk 
Polymixin agar (Oxoid Inc., Napean, ON, Canada) and examined microscopically to 
confirm them as C. perfringens. Counts were expressed as the Log10 CFU/g of intestinal 
contents. 
4.3.5. Statistical Analysis  
 The data were analyzed using the General Linear Model procedure of SPSS 
(v.12.0, SPSS Inc, Chicago IL, USA) as a 2 x 4 factorial (two methionine sources each 
with 4 levels). All the effects were considered as fixed and the interaction between 
methionine source and levels were used in the model with pen was the experimental unit. 
The treatment means were compared using Ryan-Einot-Gabriel-Welch multiple F-test 
and comparisons were deemed significant at P < 0.05. 
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4.4. Results 
 The crude protein and amino acid composition of the experimental diets used in 
this study from day 14-28 of age is shown in Table 4.4. The dietary CP, DL-Met and 
MHA-FA concentrations were very close to that of our planned levels. The Rest of the 
amino acids and MHA-FA were in similar concentrations in all experimental diets in both 
experiments.  
 Subsequent to challenge with C. perfringens some of the birds were dull, 
depressed and had abnormally wet droppings for the first 3-5 days of each experiment. 
During the course of this study, 2 birds died in experiment 1 (one each from control and 
0.4% DL-Met supplemented groups) and 3 birds died in experiment 2 (one each from 
control, 0.2 and 0.8% MHA-FA supplemented groups) of unknown causes.  Majority of 
the dead birds were in good condition and did not have any full blown gross lesions of 
NE either in intestine or any other organ which might cause the death. Only one bird had 
distended jejunum and ileum with thin and friable intestinal wall, and the lumen was 
filled with gas and dark brown fluid content. Rest of the dead birds had few petechial 
hemorrhages in distal jejunum and proximal ileum. Surviving birds had no apparent signs 
of morbidity 7-10 day post-challenge. 
In both experiments, the average daily feed intake (ADFI), average daily gain 
(ADG) and feed conversion efficiency (FC) at the end of 14-21 and 21-28 day period 
were not significantly different among various dietary treatments (Table 4.5). The only 
exception is that the ADG increased significantly (P < 0.05) with methionine 
supplementation during 21-28 day period in experiment 2 and there was significant 
interaction between methionine source and level for ADG. However, there was no 
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difference in ADG of the birds fed either DL-Met or MHA-FA at various dietary 
concentrations. Also, there was no difference in performance of these birds fed either 
DL-Met or MHA-FA in any of the experiments at any time point.  
 Various bacterial species (C. perfringens, lactobacilli, Streptococcus group D and 
coliforms) were enumerated in ileum and cecum of chickens on day 28 of the two 
experiments. The populations of all four bacterial species enumerated in this study were 
higher in cecum than ileum. There were no significant differences in growth of various 
bacterial species in the intestinal tract of broiler chickens fed two different methionine 
sources, whereas methionine concentration had significant effect on various bacterial 
species either in ileum or cecum or both. There was no significant interaction between 
methionine source and methionine concentration for various bacterial species populations 
either in ileum or cecum in both experiments. The only exception is C. perfringens 
growth in ileum and cecum in experiment 2 where there was a significant (P < 0.05) 
interaction between methionine source and level. There was decrease in C. perfringens 
numbers with increase in dietary DL-Met both in ileum and cecum whereas C. 
perfringens counts were higher in ileum (3.38 versus 3.90 log10 CFU/g wet digesta) and 
cecum (3.98 versus 4.98 log10 CFU/g wet digesta) when dietary MHA-FA increased from 
0.2 to 0.4% (Figure 4.1). However, there were no significant differences in C. 
perfringens counts between DL-Met and MHA-FA at 0.2 or 0.4% inclusion rates. 
 In experiment 2, significantly higher (P < 0.05) C. perfringens numbers were 
observed in ileum of birds fed control diet compared to birds given methionine 
supplemented diets. Also the C. perfringens populations in ileum decreased significantly 
(P < 0.05) when methioine supplementation increased from 0.2 to 0.8%. Whereas, in 
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experiment 1, the C. perfringens growth in ileum was not significantly different among 
various dietary treatments. In experiment 1, the ceca of birds fed either 0.2 or 0.4% 
methionine contained significantly lower (P < 0.05) C. perfringens counts than those 
received control diet with no supplemental methionine. The control diet supported a 
significantly higher growth of C. perfringens than methionine supplemented diets in 
experiment 2.  An important point to be noted is that the C. perfringens populations were 
generally higher both in ileum and cecum in experiment 2 compared to experiment 1.  
 The lactobacilli populations were not significantly altered in ileum of 
broiler chickens fed different levels or sources of methionine in both experiments (Figure 
4.2). Similarly, there were no significant differences in lactobacilli growth in cecum in 
experiment 1. However, in experiment 2, the lactobacilli populations were significantly 
higher (P < 0.05) in ceca of birds receiving 0.8% methionine than the birds given diets 
with other levels of methionine tested.  
 In experiment 2, Streptococcus group D populations were significantly lower (P < 
0.05) in ileum of birds receiving 0.8% methionine supplemented diets compared to those 
given either control or 0.4% methionine supplemented diets (Figure 4.3). We observed a 
significant difference in Streptococcus group D growth in ceca of control and 0.2% added 
methionine fed birds in experiment 1, whereas there were no significant differences in 
experiment 2.   
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abc Means with the different superscripts within a column (within an experiment) differ 
significantly (P < 0.05) 
 
 
 
 
Table 4.5. Average daily feed intake (ADFI, g/day), average daily gain (ADG, g/day) 
and feed:gain ratio (FC, feed intake/weight gain, g/g) of birds during days 14-21 and 
21-28 in both experiments. 
 Days 14-21 Days 21-28 
Experiment 1 ADFI ADG FC ADFI ADG FC 
Level (%)       
0.0 66.4 40.5 1.6 140.6 66.3a 2.1 
0.2 75.9 42.3 1.8 135.7 76.7b 1.8 
0.4 77.0 42.4 1.8 147.6 76.3b 1.9 
0.8 76.6 43.8 1.7 126.4 77.9b 1.6 
Pooled SEM 5.43 1.10 0.06 12.44 4.09 0.18 
Source       
DLM 72.9 43.2 1.7 140.8 75.3 1.9 
MHA-FA 77.2 41.8 1.8 133.6 75.4 1.8 
Pooled SEM 5.28 2.74 0.19 5.86 1.72 0.12 
P value       
Level 0.403 0.879 0.532 0.279 0.007 0.131 
Source 0.245 0.441 0.086 0.329 0.352 0.463 
Level*Source 0.093 0.607 0.459 0.624 0.011 0.429 
Experiment 2       
Level (%)       
0.0 71.7 39.9 1.8 113.9 57.2 2.0 
0.2 73.7 40.7 1.8 121.3 57.2 2.2 
0.4 81.5 45.3 1.8 119.8 51.6 2.4 
0.8 72.0 41.1 1.7 119.9 57.6 2.1 
Pooled SEM 4.41 2.27 0.05 2.53 2.84 0.13 
Source       
DLM 76.9 42.7 1.8 121.1 54.3 2.3 
MHA-FA 73.3 41.4 1.7 117.8 57.1 2.1 
Pooled SEM 4.30 1.84 0.08 4.73 2.97 0.19 
P value       
Level 0.560 0.778 0.738 0.775 0.701 0.555 
Source 0.571 0.740 0.506 0.449 0.622 0.418 
Level*Source 0.935 0.760 0.171 0.575 0.133 0.099 
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 In experiment 2, the coliforms counts were significantly higher (P < 0.05) in 
ileum of broiler chickens which were given control diets with no added methionine 
compared to birds receiving rest of the experimental diets with different concentrations of 
methionine. Methioine source or level had no significant impact on coliforms counts in 
cecum either in experiment 1 or 2 (Figure 4.4). The coli form counts were substantially 
lower than those of lactobacilli and streptococci in the intestines of chickens on day 28 of 
age.      
The mean NE lesion scores of chickens fed different experimental diets and killed 
on day 28 are presented in Figure 4.5. Dietary methionine source or concentration had no 
significant effect (P > 0.05) on NE specific intestinal lesion scores in any of the 
experiments. Irrespective of the dietary treatment, a large number of birds had thin and 
friable intestinal wall with congested serosa with blood engorged mesenteric vessels. 
Some birds had focal patches of hemorrhagic lesions in various intestinal regions, more 
frequently in distal jejunum, proximal ileum and cecal tonsils. But typical field type 
lesions specific to NE were not observed in any of the birds in either experiments. 
Although methionine source or concentration had no significant effect on intestinal lesion 
scores, however, there was a trend of decreasing the lesions with increase in methionine 
concentration which corresponds well with C. perfringens colonization in these birds.  
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Figure 4.1.  Effect of different methionine sources (A) and levels (B) on C. 
perfringens populations in ileum and cecum of broiler chickens on day 28 of both 
experiments. Bars represents the mean ± SEM.  
abcBars with different labels are significantly different (P < 0.05) 
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Figure 4.2.  Effect of different methionine sources (A) and levels (B) on lactobacilli 
populations in ileum and cecum of broiler chickens on day 28 of both experiments. 
Bars represents the mean ± SEM. 
abBars with different labels are significantly different (P < 0.05) 
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Figure 4.3.  Effect of different methionine sources (A) and levels (B) on 
Streptococcus group D populations in ileum and cecum of broiler chickens on day 28 
of both experiments. Bars represents the mean ± SEM. 
abBars with different labels are significantly different (P < 0.05) 
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Figure 4.4.  Effect of different methionine sources (A) and levels (B) on coliforms 
populations in ileum and cecum of broiler chickens on day 28 of both experiments. 
Bars represents the mean ± SEM. 
abcBars with different labels are significantly different (P < 0.05) 
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Figure 4.5. Mean necrotic enteritis lesion scores in experiments 1 and 2 in 28-day-
old broiler chickens given experimental diets (days 14 to 28) containing different 
levels/sources of methionine. 
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Histological examination of formalin fixed intestinal tissues from 28-day-old 
broiler chickens euthanized in both experiments revealed no frank lesions of NE. The 
lesions include only slight edema and diffuse hemorrhages in lamina propria in some 
sections. There was no necrosis or desquamation of epithelial cells in the villi. There was 
no evidence of gram-positive rod-shaped organisms attached to intestinal mucosa. PMN 
cells infiltration in the lamina propria was not seen in any of the sections. We did not find 
any evidence of coccidial oocysts in any sections examined.  
4.5. Discussion 
 Amino acid composition of various protein sources might be an important 
determinant of intestinal microbial growth in broiler chickens (Dahiya et al. 2006a). 
Excessive concentration of some amino acids might have a toxic effect on some bacterial 
species. Wlikie (2005) demonstrated a reduced growth of C. perfringens in the presence 
of methionine in vitro. In one of his studies, he demonstrated that C. perfringens counts 
were virtually reduced to zero in minimal salt media supplemented with 10 mg/mL of 
DL-Met after 24 h incubation. So the current study was designed to determine whether 
two commonly used methioinine sources have the similar antibacterial effects against C. 
perfringens in vivo. The two experiments reported in this study support our hypothesis 
that high levels of methionine supplementation may reduce C. perfringens populations in 
the intestinal tract and, thus decrease the risk of NE in broiler chickens. 
 No significant differences in ADFI, ADG and FC were observed during the 
period day 14-21 or 21-28 in either of the experiments. One exception was that ADG 
increased significantly with methionine supplementation during day 21-28 in experiment 
1. The overall performance of the birds was relatively poor in both experiments and that 
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might be due to the fact that there was more feed wastage. Another explanation for poor 
performance is that the birds were under stress of C. perfringens challenge and they had 
high C. perfringens populations in their intestinal tract which is evident from Figure 4.1.   
The ADFI and ADG were lower and FC was comparatively poor in experiment 2 during 
the period day 21-28. As evidenced by intestinal lesion scores and high intestinal 
colonization of C. perfringens, most of the birds in present study had a subclinical NE as 
documented by Lovland and Kaldhusdal (2001). A highly significant inverse correlation 
was obtained between the number of C. perfringens in the ileum and weight gain of 
chicks fed the glucose, sucrose, fructose and practical diets (Stutz and Lawton, 1984). 
Decreased growth rate and poor feed conversion efficiency have already been reported in 
broilers having high numbers of C. perfringens in the intestinal tract (Dahiya et al., 2005; 
Kaldhusdal and Hofshagen, 1992; Stutz et al., 1983).  
Numerous studies have been conducted to compare the efficacy of DL-Met and 
liquid MHA-FA in broiler chickens (Baker and Boebel, 1980; Waldroup et al., 1981; 
Rostagno and Barbosa, 1995; Lemme et al., 2002). These studies have been inconsistent 
in the value assigned to the efficacy of MHA-FA due to a number of reasons. The 
differences in the efficacy between DL-Met and MHA-FA might be due to both 
differences in absorption in intestinal tract, in microbial conversion in the intestinal tract 
and to differences in post-absorptive conversion of two molecules for metabolic purposes 
(Maenz and Engele-Schaan, 1996; Drew et al., 2003). It is well known that DL-Met is 
transported by the System B amino acid transporter, whereas it’s hydroxy analog (MHA-
FA) is absorbed by a +H-dependent nonstereospecific lactate transport system. A number 
of studies with broilers using radiolabeled methionine sources indicated a significantly 
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lower absorption of MHA-FA compared to DL-Met, which means that the DL-Met is 
removed more quickly from the intestinal lumen than MHA-FA and therefore has less 
exposure to intestinal bacteria resulting in decreased methionine uptake (Maenz and 
Engele-Schaan, 1996; Drew et al., 2003). In agreement with Esteve-Garcia and Austic 
(1993), Maenz and Engele-Schaan (1996) concluded that there is a substantial conversion 
of dietary MHA-FA, during passage through the small intestine, to compounds that 
cannot be used as a source of methionine by the bird. This might be due to degradation of 
a substantial fraction of the hydroxy analog by microbial fermentation during passage 
through the small intestine (Lemme et al., 2001). Drew et al. (2003) compared the 
apparent absorption of 3H-labelled L-methionine with MHA-FA in germ-free and 
conventionally reared broiler chickens and observed a significantly lower residual MHA-
FA in distal ileum of germ-free birds than in conventional birds whereas there was no 
difference in residual methionine level. Questions remain regarding the effect of these 
two methionine sources on intestinal microbial ecology of the birds. As far as we know 
this is the first study where we directly examine the impact of these two methionine 
sources on intestinal microflora in broiler chickens.  
As evident in Figure 4.1, C. perfringens populations were higher in ileum and 
cecum of birds in experiment 2 than in experiment 1. It might be due to the fact that in 
experiment 2, the cooked meat media was used for culturing the C. perfringens, which 
supports the C. perfringens growth and α toxin production much better than brain heart 
infusion which was used in experiment 1 (See Appendices 9.2A and 9.2B). In the 
present study, we observed a significant reduction in C. perfringens growth with 
methionine supplementation in cecum (Experiment 1), or both in ileum and cecum 
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(Experiment 2). However, there were no significant differences between the two 
methionine sources. We could not find any literature regarding the toxic effects of 
methionine on C. perfringens in vivo. Earlier, in in vitro experiments, Wilkie et al.  
(2005) reported a significantly reduced growth of C. perfringens in minimal salt media 
supplemented with 10 mg/mL DL-Met compared to control. In contrast to this, 
Muhammed et al. (1975) reported that alanine, aspartic acid and methionine are 
stimulatory for the growth and sporulation of C. perfringens in vitro. But we cannot 
extrapolate the results of in vitro to in vivo because the conditions are entirely different in 
the gastrointestinal tract. It should be remembered that there are differences in amino acid 
and vitamin requirements among various strains of C. perfringens (Fuchs and Bonde, 
1957). They also reported a significant increase in C. perfringens growth in the presence 
of glycine, lysine and serine, and proved that not only individual amino acid but the 
balance of amino acids is important for maximum growth of C. perfringens. There might 
be antagonism between amino acids i.e. the action of certain amino acids being prevented 
by several other amino acids. Previously, we have found that amino acid glycine supports 
the C. perfringens growth and α toxin production both in vitro as well as in vivo (Dahiya 
et al., 2005; Wilkie et al., 2005). Glycine accelerated the C. perfringens growth 
(Ispolatovskaya, 1971) while α toxin production required the presence of glycine-
containing peptides in defined media (Nakamura et al., 1968; Stevens and Rood, 2000).  
We are aware of no study that directly examines the effect of methionine 
sources/concentration on C. perfringens growth in broiler chickens. The methionine level 
used in this study was much higher (2 to 4 times) than commonly used in commercial 
poultry diets. The supranutritional concentrations of methionine were associated with 
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reduced C. perfringens growth in broiler chickens, however, it might not be 
commercially viable method to control NE due to high cost of synthetic methionine. The 
mode of action by which methionine influences the intestinal populations of these 
important groups of bacteria in broiler chickens is unclear. Not all bacteria have the 
ability to utilize DL-Met or MHA-FA. Intestinal microflora of the bird might be involved 
in nitrogen recycling mechanism (Mattocks, 1971). Schmidt et al. (1952) reported that C. 
perfringens are involved in degradation of arginine into ammonia and carbon dioxide 
through citrulline and ornithine. As C. perfringens is strictly dependent on carbohydrates, 
the effect of higher levels of dietary methionine on intestinal C. perfringens populations 
might be indirect. It is possible that high dietary methionine concentration might cause an 
excessive growth of lactic acid producing bacteria (mainly Lactobacillus, Streptococci, 
and Staphylococci) which are predominant in the intestines of normal healthy chickens 
and generally considered to be protective against colonization of pathogenic micro-
organisms.  
 In the present study, we observed a significant elevation in lactobacilli population 
in cecum of birds fed 0.8% methionine supplemented diets compared to rest of the diets 
in experiment 2. In contrast to this, Streptococcus group D populations were decreased 
with methionine supplementation in ileum (experiment 2) and cecum (experiment 1). 
Hofshagen and Kaldhusdal (1992) reported a higher population of lactobacilli in 
intestinal tract of broiler chickens fed corn-based diets and hypothesized that higher 
lactobacilli colonization impeded the development of NE. This effect might be indirect 
through inhibition of C. perfringens colonization. We observed substantially lower 
populations of coliforms than of lactobacilli and streptococci in the intestines of chickens 
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which is in corresponding with the findings of Barnes et al. (1972) and Stutz et al. (1983) 
and opposed to the similar levels of the three bacterial species reported by Hofshagen and 
Kaldhusdal (1992). This discrepancy may be attributed to variations in bacteriological 
isolation procedures, feed composition, feed antibiotics, or environmental conditions 
between the studies. Hegedus et al.  (1993) documented that some lactic acid producing 
bacteria (Lactobacillus plantarum, Leuconostoc mesenteriodes, Lactobacillus casei) have 
the ability to utilize DL-Met for their growth. An antagonistic effect of lactobacilli 
against Helicobacter pylori (Aiba et al., 1998), Salmonella spp. (Gill et al., 2001) and 
E.coli (Mangell et al., 2002) has been demonstrated in murine model.  Lactic acid 
bacteria can significantly affect both the systemic and mucosal-associated immune 
responses and lactobacilli have been characterized for their potential as probiotic agents 
against Salmonella and Campylobacter in poultry (Chang and Chen, 2000; Gusils et al., 
2003; Lan et al., 2003). Fukata et al.  (1991) reported that pathogenic effect of C. 
perfringens could be reduced by feeding chicks a monoflora of Lactobacillus acidophilus 
or Streptococcus faecalis. The antagonistic activity may be mediated either directly by 
the  production of inhibitory substances such as lactic acid, hydrogen peroxide and 
bacteriocins or by competing with the pathogen for binding sites on the epithelial cell 
surface. It is possible that the protein/amino acids are serving as energy and/or nitrogen 
source for other community members that in turn modify the intestinal environment in a 
favorable way for lactobacilli proliferation. This may occur by providing positive 
selection pressure on those gastrointestinal microbes which can directly ferment amino 
acids for carbon and nitrogen. Alternatively, the high methionine diets might affect the 
 93
physiochemical characteristics of gastro-intestinal tract of host in such a manner that the 
gastrointestinal milieu is made less favorable for C. perfringens proliferation.    
 Irrespective of the dietary treatments, some birds were dull, depressed and 
diarrheic for first 4-5 days after we start challenging them on 14 day of age. But the signs 
of illness disappeared after some days and all birds looked apparently healthy during the 
rest of period. There were some mortalities but necropsy examination showed that none 
of them was NE-specific. So despite inoculation of very high doses of C. perfringens, we 
did not observe any NE-specific mortality in any of the experiments. This is in agreement 
with some previous studies where chickens challenged with C. perfringens have also 
failed to induce mortality or other signs of NE, even though high C. perfringens 
colonization was reported in the intestinal tract of the birds (Craven, 2000; Pedersen et 
al., 2003). In contrast to this, Al-Sheikhly and Truscott (1977a) and Vissiennon et al. 
(2000) were able to induce various pathological changes and mortality in chickens when 
inoculated orally with C. perfringens directly into the duodenum. It is therefore possible 
that some of the vegetative cells are inactivated by the acidic pH in the gizzard when 
given orally. Kaldhusdal et al. (1999) documented that lesions are more sensitive disease 
indicator than mortality, and subclinical NE is more frequent than clinical disease in 
broiler chickens. Since C. perfringens is the etiological agent of NE it seems reasonable 
to assume that increased numbers of this organism in the gut are associated with an 
increased predisposition to clinical NE.  
 In the present study, gross intestinal lesions of varying degrees among various 
treatment groups were observed although there were no significant differences among 
various dietary treatments i.e. dietary methionine source or concentration had no 
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significant effect (P > 0.05) on NE specific intestinal lesion scores in any of the 
experiments. However, there was a trend of decreasing the lesions with increase in 
methionine concentration which corresponds well with C. perfringens colonization in 
these birds. The lesion scores were higher and there were more differences among 
various groups in experiment 2 compared to experiment 1. The differences might be 
attributed to the fact that cooked meat media (used in experiment 2) supports the C. 
perfringens growth and α toxin production much better than the brain heart infusion used 
in experiment 1 (Appendices 9.2A and 9.2B). The demonstration of a relationship 
between NE lesion scores, performance data and C. perfringens numbers is an important 
feature of both experiments. Al-Sheikhly and Truscott (1977a) and Vissiennon et al. 
(2000) suggested that high C. perfringens populations and slight intestinal damage were 
apparently necessary for disease production when a broth culture was used. We believe 
that whereas the aforementioned may be major factors, other factors, including the 
chemical/physical nature of the diet and the interaction of other intestinal microflora, may 
contribute to pathogenesis of the disease. In the present study, even clinically healthy 
birds were highly colonized with C. perfringens which confirms the sub clinical nature of 
the disease because high numbers of C. perfringens with macroscopically visible, focal 
necrotic lesions in the small intestine is a strong indicator of an occurrence of NE 
(Kaldhusdal and Hofshagen, 1992). 
 In contrast to some earlier findings, the microscopic lesions in intestine were not 
conclusive of NE in the present study (Fukata et al., 1988; Kaldhusdal et al., 1995; Long 
et al., 1974; Shane et al., 1985). Presence of slight edema and hemorrhages in lamina 
propria were observed in quite a few numbers of birds. However, desquamated epithelial 
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cells and polymorphonuclear cells (PMN) were not detected in any of the sections. 
Bryant et al. (1993) and Stevens et al. (1997) also demonstrated an absence of PMN cells 
at the site of C. perfringens infection. In the absence of host response (suppression of 
PMN influx), clostridia proliferates rapidly, leading to local accumulation of toxins. 
Higher in situ concentrations of C. perfringens toxins, especially α toxin, further inhibit 
PMN influx and reach concentration sufficient to cause membrane destruction (Stevens 
and Rood, 2000). So in spite of high numbers of C. perfringens in the intestinal tract of 
these birds, the clinical disease could not be produced. It is possible that it is not high C. 
perfringens counts per se, but some other factors possibly associated with high C. 
perfringens colonization that are required to produce a full blown disease. Intestinal 
damage caused by toxins of C. perfringens could represent such a factor. Lesions of NE 
were produced by the administration of either purified α toxin or the supernatant of broth 
cultures of C. perfringens to conventional (Al-Sheikhly and Truscott, 1977c) and germ 
free chicks (Fukata et al., 1988), whereas no lesions were detected in birds receiving 
supernatant of broth cultures neutralized by anti-α toxin serum. 
4.6. Conclusions 
Results of the present study demonstrated an antibacterial effect of both 
methionine sources against C. perfringens when used in high concentrations. Thus, the 
understanding of the effects of different dietary methionine sources and levels on 
intestinal microbial ecology including C. perfingens growth is important for developing 
dietary formulations for broiler chickens that may reduce the risk of an outbreak of 
clinical NE. There was no difference in bird’s performance under stress of C. perfringens 
challenge when these two methionine sources are fed on equimolar basis. Because there 
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are some limitations with the culture based methods used in the present study for 
bacterial enumeration, it would be interesting to use culture-independent approaches such 
as PCR with denaturing gradient gel electrophoresis in studying wide group of microbiota 
with respect to different methionine sources. A further assessment of the putative 
associations between these methionine sources and NE is of considerable interest. Further 
studies to determine which bacterial species are involved in competition for these two 
methionine sources with the host would be an interesting addition to the present study.  
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5.0. DIETARY GLYCINE CONCENTRATION AFFECTS INTESTINAL 
CLOSTRIDIUM PERFRINGENS AND LACTOBACILLI POPULATIONS IN 
BROILER CHICKENS 
5.1. Abstract 
 Previous studies have reported that intestinal populations of C. perfringens, the 
causative agent of necrotic enteritis (NE), are correlated with diets high in glycine. To 
establish a direct causative link, three experiments were conducted to examine the effect 
of dietary glycine levels on gut C. perfringens populations, α-toxin production and NE 
lesion scores in broiler chickens. In experiments 1 and 2, 12 groups of 4 birds were fed 4 
different ideal protein-balanced diets formulated to contain 0.75, 1.58, 3.04 or 4.21% 
glycine on day 14-28 of age. In experiment 3, 24 groups of 4 birds were given 6 different 
ideal protein-balanced diets formulated to contain 0.50, 0.75, 1.00, 1.50, 2.00 or 4.00% 
glycine. All birds were orally challenged with broth culture of C. perfringens type A on 
day 1 and between days 14 - 21 of age, and killed on day 28. The majority of birds 
showed clinical signs of NE with 4.16-8.33% mortality in the 3 experiments. The highest 
mortality and intestinal lesion scores were observed in chickens receiving 3.04% glycine 
in experiments 1 and 2; and 4.00% glycine in experiment 3. C. perfringens populations in 
the cecum varied quadratically with increasing dietary glycine with the maximal response 
seen at 3.30, 3.89 and 3.51% dietary glycine in experiments 1, 2 and 3, respectively. 
Number of lactobacilli in cecum declined significantly (P < 0.05) with increasing levels 
of glycine. The results suggest that dietary glycine level has a significant effect on C. 
perfringens and lactobacilli populations and may be a predisposing factor for NE in 
broiler chickens. 
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5.2. Introduction 
 Necrotic enteritis is a worldwide disease of poultry caused by Clostridium 
perfringens, usually belonging to toxin type A (Ficken and Wages, 1997). C. perfringens 
is a ubiquitous, spore-forming anaerobic bacteria found in soil, dust, feces, feed, poultry 
litter, and in the intestinal tract of poultry and other animals. Although C. perfringens is a 
normal inhabitant of the intestine, under certain circumstances it proliferates rapidly 
increasing to 107 to 109 CFU/g of digesta, and may cause sub clinical or clinical NE. 
Impaired feed conversion, reduced growth rate, increased condemnation rates and 
mortality are major causes of production losses associated with NE (Lovland and 
Kaldhusdal, 2001). The α toxin of C. perfringens has been detected in feces and intestinal 
contents of chickens and other birds with NE and is believed to be responsible for the 
intestinal mucosal necrosis that is characteristics of this disease. More α toxin is produced 
by isolates from birds with NE than by isolates from birds not displaying symptoms 
(Hofshagen and Stenwig, 1992). 
NE may be controlled prophylactically with certain in-feed antibiotic growth 
promoters and ionophore coccidiostats. However, in the recent years, growing political 
and consumer demands for safer foods have put pressure on the prophylactic use of AGPs 
and ionophore coccidiostats as feed additives. Hence, there is a pressing need to better 
understand the factors that cause the overgrowth of C. perfringens in the intestine and 
predispose birds to NE in order to develop alternative management or dietary strategies to 
control the incidence and severity of this disease. 
 Diet composition has a great influence on the gastrointestinal microbial ecology 
of birds and several dietary factors have been shown to contribute to the incidence of NE. 
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There appear to be two major dietary factors which predispose birds to NE. The first 
factor is dietary cereal grains rich in water soluble non-starch polysaccharides such as 
wheat (Branton et al., 1997; Riddell and Kong, 1992), barley and rye (Annett et al., 2002; 
Kaldhusdal and Hofshagen, 1992; Kaldhusdal and Skjerve, 1996; Riddell and Kong, 
1992). The second dietary factor predisposing broilers to NE is high protein diets, 
particularly those consisting of high percentage of protein from animal sources (Drew et 
al., 2004; Kaldhusdal and Skjerve, 1996; Truscott and Al-Sheikhly, 1977).  A number of 
studies have demonstrated that source and level of protein in diets had a profound effect 
on the number of C. perfringens in intestinal contents in chickens (Drew et al., 2004; 
Kaldhusdal, 2000), pigs (Mansson and Olhagen, 1967; Mansson and Smith, 1962) and 
dogs (Zentek et al., 1998). 
 There are various studies in literature that show the mechanism(s) behind the 
effect of cereal grains on C. perfringens numbers and NE but little is known about the 
factors or mechanisms responsible for the increased incidence of NE in broilers fed high 
protein diets. Previous work has shown that there might be a correlation between certain 
amino acids, especially glycine, and C. perfringens populations and/or α toxin production 
(Drew et al., 2004; Muhammed et al., 1975; Titball et al., 1999). Ispolatovskaya (1971) 
reported that glycine accelerated the growth of C. perfringens and production of α toxin 
in vitro. In defined media, there was increased production of α toxin in the presence of 
glycine-containing peptides (Nakamura et al., 1968; Stevens and Rood, 2000). Drew et 
al. (2004) reported a significantly greater population of C. perfringens in the intestinal 
tract of chickens fed fish meal-based diets versus soy protein concentrate diets, and 
significantly higher levels of glycine were reported in fish meal diets compared to soy 
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protein diets. More recently, Wilkie et al. (2005) documented a significant correlation 
between dietary glycine and C. perfringens populations in ileum and cecum of broiler 
chickens. Corzo et al. (2004) documented that dietary glycine might become a limiting 
factor in all-vegetable diets fed to broiler chicks when crude protein is low and suggested 
that the current NRC recommendations (NRC, 1994) for glycine + serine of 1.25% may 
be insufficient.  
Taken together, the results of previous studies and preliminary results of our 
laboratory suggest that an increase in the concentration of glycine in the lower small 
intestine may be a triggering event for the proliferation of C. perfringens and/or up 
regulation of virulence factors chiefly α toxin which may ultimately lead to clinical 
disease. The purpose of the current study was to examine the effect of various levels of 
dietary glycine on intestinal C. perfringens populations, α toxin production and NE lesion 
scores in broiler chickens.  
5.3. Materials and Methods 
 Experimental protocols were approved by Institutional Animal Care and Use 
Committee (IACUC) and were performed in accordance with recommendations of the 
Canadian Council on Animal Care as specified in the Guide to the Care and Use of 
Experimental Animals (Canadian Council on Animal Care, 1993).  
5.3.1. Animal Management and Experimental Diets 
5.3.1.1. Experiments 1 and 2  
 In each of these two experiments, a total of 48, one-day old conventional male 
broiler chicks (Ross 308) were obtained from a local broiler hatchery (Lilydale Hatchery, 
Wynyard, SK, Canada) and housed randomly in two electrically heated battery cages for 
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the first 2 weeks of age (24 birds per cage). The birds received a medicated, ideal protein-
balanced (1.20% lysine) corn-based starter crumble (Co-op feeds, Saskatoon, Canada) for 
the first 14 days of experiment (Table 5.1). On day 14 the birds were randomized and 3 
cages of 4 birds each were assigned to one of four different ideal protein-balanced 
experimental diets formulated to contain 0.75, 1.58, 3.04 or 4.21% glycine (Tables 5.2 
and 5.3). The diets were isocaloric (3,200 Kcal of ME/kg), contained 1.20% lysine with 
other essential amino acid levels formulated to be within 10 per cent of ideal protein 
ratio. The diets met or exceeded requirements for broiler chickens for all other nutrients 
(NRC, 1994).  
5.3.1.2. Experiment 3  
 Ninety six one-day old conventional male broiler chicks (Ross 308) were placed 
randomly into four electrically heated battery cages (24 birds per cage) for first 2 weeks 
of age. On day 1 through 14 of the experiment, birds were provided with the same starter 
diet described above. On day 14, birds were randomly assigned to one of the 24 battery 
cages (4 birds per cage). Four cages were assigned in a randomized complete block 
design to one of the six ideal protein-balanced experimental diets up to the end of 
experiment (day 28). Diets were formulated to contain six different glycine 
concentrations viz. 0.50, 0.75, 1.00, 1.50, 2.00 and 4.00% glycine (Tables 5.4 and 5.5).  
The diets were isocaloric (3,200 Kcal ME/kg), contained 1.20% lysine with other 
essential amino acid levels formulated to be within 10 per cent of ideal protein ratio. The 
diets met or exceeded the NRC nutrient requirements for broiler chickens for all other 
nutrients (NRC, 1994).  
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 In all the three experiments, the experimental diets did not contain antibiotics or 
coccidiostats and were not pelleted. An indigestible marker, Celite (Celite Corporation, 
Lompoc, California, USA) was mixed in each diet in all the three experiments at a 
concentration of 2%. Throughout the experimental period in each experiment, birds were 
provided continous lighting, and were fed and watered ad libitum. Feed intakes and 
individual bird weights were recorded on day 14, 21 and 28 of the experiment. Amino 
acid analysis of the different diets was performed by Degussa Corporation (Degussa 
Canada Inc., Burlington, ON). 
5.3.2. Clostridium perfringens Challenge  
 An avian C. perfringens field strain isolated from a clinical case of NE was 
obtained from Dr. Manuel Chirino, College of Veterinary Medicine, University of 
Saskatchewan and characterized by PCR technique as a type A toxin producer. The 
organism was cultured anaerobically on BBLTM Blood Agar Base (Becton, Dickinson and 
Co., Sparks, MD, USA) containing 5.0% sheep blood and 100 mg/L neomycin sulfate 
(The Upjohn Company, Orangeville, ON, Canada) for 18 h at 37°C, then aseptically 
inoculated into cooked meat medium (Difco Labs, Detroit, MI, USA) and incubated 
anaerobically for 8 h at 37°C. All birds were orally challenged in the crop with 0.5 mL on 
day 1 and 1.0 mL on days 14 to 21 inclusive with this actively growing culture of C. 
perfringens using a 12.0 mL syringe equipped with vinyl tubing (I.D. 0.97mm, O.D. 
1.27mm). Bacterial counts were performed on the culture daily prior to inoculation and 
the numbers ranged from 3.95 x 106 to 4.64 x 106 CFU/mL.  
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Table 5.1. Composition of starter diet used in each of the three experiments from 
0-14 days of age1.  
 
Ingredients Inclusion (%) 
Soybean meal 40.90 
Corn 39.50 
Wheat 10.00 
Tallow 4.52 
Dicalcium phosphate 1.53 
Calcium carbonate 1.29 
Canola oil 1.00 
DL-Methionine 0.26 
Choline chloride 0.10 
Vitamin/Mineral premix2 0.50 
Salinomycin sodium3 0.06 
Bacitracin4 0.05 
Bio-cox 1205 0.05 
 
1 Diet was formulated to contain 31.5% crude protein and meet NRC requirements for 
broiler chickens. 
2 Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 µg; vitamin E, 
30 mg; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; sodium, 511 mg; 
iron, 80 mg; maganese, 21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
3 Phibro Animal Health Ltd. 
4 Alpharma Canada Corp. 
5 Anticoccodial Premix, OzBioPharma Ltd. 
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Table 5.2. Ingredient composition of experimental diets used in experiments 1 and 2 
(% as is basis). 
 Experimental diets 
Ingredients 0.75% Gly 1.58% Gly 3.04% Gly 4.21% Gly
Gelatin 0.00 5.54 14.09 20.10 
Corn gluten meal 0.17 0.00 0.00 2.34 
Soy protein concentrate 13.59 6.24 0.00 0.00 
Barley 80.37 77.08 73.20 63.82 
Canola oil 1.00 4.03 4.50 4.22 
Limestone 1.67 2.32 2.27 2.26 
Dicalcium phosphate 1.63 2.82 2.93 2.95 
L-threonine 0.21 0.29 0.38 0.56 
L-tryptophan 0.01 0.03 0.07 0.19 
DL-methionine 0.30 0.33 0.49 0.70 
L-lysine 0.26 0.46 0.48 0.67 
L-valine 0.07 0.05 0.11 0.45 
L-isoleucine 0.12 0.16 0.44 0.62 
L-leucine 0.00 0.05 0.44 0.52 
Choline choride 0.10 0.10 0.10 0.10 
Vit./Min. premix1 0.50 0.50 0.50 0.50 
 
1 Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; selenium, 
0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
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Table 5.3. Crude protein and amino acid composition (analyzed) of experimental diets 
for experiments 1 and 2 (% as is basis). 
 
 Experiment 1 Experiment 2 
 0.75% 
Gly 
1.58% 
Gly 
3.04% 
Gly 
4.21% 
Gly 
0.75% 
Gly 
1.58% 
Gly 
3.04% 
Gly 
4.21% 
Gly 
Crude protein (%) 19.49 19.88 24.42 32.54 19.45 20.23 24.31 32.91 
Essential amino acids 
Arginine 1.12 1.20 1.52 2.00 1.13 1.24 1.45 2.06 
Histidine 0.45 0.36 0.32 0.37 0.44 0.36 0.31 0.37 
Isoleucine 0.85 0.71 0.90 1.13 0.85 0.73 0.83 1.14 
Leucine 1.36 1.15 1.40 1.79 1.34 1.16 1.37 1.82 
Lysine 1.18 1.16 1.22 1.52 1.15 1.26 1.21 1.55 
Methionine 0.54 0.57 0.74 0.98 0.56 0.61 0.70 0.98 
Meth. + cystine 0.86 0.83 0.94 1.18 0.89 0.86 0.90 1.18 
Phenylalanine 0.92 0.78 0.72 0.86 0.89 0.76 0.69 0.85 
Threonine 0.87 0.87 0.92 1.15 0.89 0.89 0.88 1.12 
Valine 0.97 0.82 0.86 1.29 0.95 0.82 0.85 1.31 
Non essential amino acids 
Alanine 0.79 1.07 1.58 2.21 0.80 1.11 1.62 2.31 
Aspartate 1.55 1.35 1.33 1.70 1.64 1.42 1.38 1.77 
Cysteine 0.32 0.25 0.20 0.20 0.33 0.26 0.21 0.21 
Glycine 0.78 1.87 3.48 4.87 0.76 1.95 3.45 5.07 
Glutamate 3.80 3.44 3.45 4.07 3.61 3.31 3.30 4.02 
Serine 0.83 0.79 0.83 1.07 0.86 0.81 0.85 1.10 
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Table 5.4. Ingredient composition of experimental diets used in experiment 3 (% as is 
basis). 
 
 Experimental diets 
Ingredients 0.50% 
Gly 
0.75% 
Gly 
1.00% 
Gly 
1.50% 
Gly 
2.00% 
Gly 
4.00% 
Gly 
Gelatin 0.00 0.00 1.67 3.34 5.01 14.09 
Casein 9.43 0.00 0.00 0.00 0.00 0.00 
Corn gluten meal 0.00 0.17 0.12 0.07 0.02 0.00 
SPC 0.00 13.59 11.38 9.16 6.95 0.00 
Barley 77.92 80.37 79.37 78.38 77.37 73.20 
Canola oil 3.91 1.00 1.91 2.83 3.74 4.50 
Limestone 2.33 1.67 1.87 2.06 2.26 2.27 
Dical. phosphate 2.55 1.63 1.99 2.35 2.71 2.93 
L-threonine 0.46 0.21 0.23 0.26 0.28 0.38 
L-tryptophan 0.06 0.01 0.02 0.02 0.03 0.07 
DL-methionine 0.50 0.30 0.31 0.32 0.33 0.49 
L-lysine 0.54 0.26 0.32 0.38 0.44 0.48 
L-valine 0.23 0.07 0.06 0.06 0.05 0.11 
L-arginine 0.93 0.00 0.00 0.00 0.00 0.00 
L-isoleucine 0.31 0.12 0.13 0.14 0.16 0.44 
L-leucine 0.23 0.00 0.02 0.03 0.05 0.44 
Choline chloride 0.10 0.10 0.10 0.10 0.10 0.10 
Vit./Min. premix1 0.50 0.50 0.50 0.50 0.50 0.50 
 
1 Supplied per kilogram of diet: vitamin A, 11,000 IU; cholecalciferol, 2,200 IU; vitamin 
E, 30 IU; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; pantothenic acid 
0.02 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg; manganese, 21.8 mg; selenium, 
0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
SPC = Soy protein concentrate 
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Table 5.5. Crude protein and amino acid composition (analyzed) of experimental diets for 
experiment 3 (% as is basis) 
 
 Experimental diets 
 0.50% 
Gly 
0.75% 
Gly 
1.00% 
Gly 
1.50% 
Gly 
2.00% 
Gly 
4.00% 
Gly 
Crude protein (%) 23.70 22.07 22.41 22.78 23.94 29.43 
Essential amino Acids 
Arginine 1.74 1.30 1.32 1.35 1.45 1.54 
Histidine 0.51 0.49 0.46 0.43 0.41 0.35 
Isoleucine 1.25 0.98 0.93 0.89 0.84 1.02 
Leucine 1.89 1.53 1.47 1.40 1.35 1.64 
Lysine 1.60 1.22 1.19 1.27 1.28 1.29 
Methionine 1.02 0.68 0.64 0.65 0.67 0.91 
Methionine+cystine 1.26 1.03 0.96 0.95 0.95 1.12 
Phenylalanine 1.05 1.08 1.05 0.99 0.94 0.88 
Threonine 1.26 0.97 0.97 0.95 0.97 0.99 
Valine 1.44 1.10 1.06 1.00 0.97 1.01 
Non essential amino acids 
Alanine 0.71 0.87 0.96 1.05 1.11 1.44 
Aspartate 1.32 1.65 1.67 1.59 1.57 1.51 
Cysteine 0.24 0.35 0.32 0.31 0.28 0.21 
Glycine 0.58 0.84 1.20 1.59 2.14 4.35 
Glutamate 4.52 4.39 4.34 4.19 4.06 4.07 
Serine 0.98 0.93 0.93 0.91 0.92 0.96 
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5.3.3. Pathological Examination 
 Birds were kept under constant observation for any signs of NE and all birds that 
died during the course of experiments were necropsied. On day 28, the surviving 
chickens were euthanized by cervical dislocation, weighed and necropsied immediately. 
Intestinal tracts were removed and intestinal lesions were scored blindly according to the 
method of Truscott and Al-Sheikhly (1977) with slight modifications on a scale 0 to 4 
where 0 was apparently normal, no lesion; 0.5, severely congested serosa and mesentery 
engorged with blood; 1, thin walled and friable intestines with small red petechiae (> 5); 
2, focal necrotic lesions; 3, patches of necrosis (1-2 cm long); and 4, diffused necrosis 
typical of field cases. Following postmortem examination, if the score was ≥1 then a 1.5-
2.0 cm long piece of intestinal tissue with the gross NE lesion was collected in 
phosphate-buffered formaldehyde solution and processed routinely for paraffin 
embedding, sectioned at approximately 5 µm, and stained with hematoxylin and eosin.  
5.3.4. Bacteriological Examination 
 In experiment 1 and 2, the fresh intestinal contents were collected aseptically 
from jejunum (distal duodenal loop to 1 cm proximal to Meckel’s diverticulum), ileum 
(Meckel’s diverticulum to 1 cm proximal to ileocecal junction) and paired ceca into 
sterilized plastic dram vials and mixed well. In experiment 3 samples were not collected 
from the jejunum. Using a sterile spatula, pea-sized samples were transferred into pre-
weighed 15 mL sterile plastic tubes containing 1 mL 0.1% sterile peptone buffer with 5 
g/L cysteine hydrochloride (Sigma Chemical Co., St. Louis MO.). The ceca samples were 
directly collected into the pre-weighed 15 mL sterile tubes. The samples were 
immediately placed and kept on ice until plated within 3 h of collection. The samples 
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were weighed and diluted in peptone water to an initial 10-1 dilution. Ten-fold dilutions 
were spread in duplicate using an automated spiral plater (Autoplate, Spiral Biotech Inc., 
Bethesda MD, USA) on BBL™ Blood Agar Base (Becton, Dickinson and Co., Sparks, 
MD, USA) containing 50 mL/L sheep blood and 0.01% neomycin sulfate (The Upjohn 
Company, Orangeville, ON, Canada) for the enumeration of C. perfringens and MRS 
agar (Becton, Dickinson and Co., Sparks, MD, USA) for the enumeration of lactobacilli. 
The blood agar/neomycin plates were incubated anaerobically for 24 h at 37°C while 
MRS agar plates were incubated anaerobically for 48 h at 37°C. The α- and β- hemolytic 
colonies on blood agar/neomycin plates were counted as C. perfringens with presumptive 
colonies being randomly picked, gram stained, plated on Mannitol Yolk Polymixin agar 
(Oxoid Inc., Napean, ON, Canada) and examined microscopically to confirm them as C. 
perfringens. Bacterial populations were expressed as Log10 CFU/g of intestinal contents.  
5.3.5. Samples Collection and Processing for Alpha Toxin Estimation 
 The concentrations of α toxin were estimated in ileal contents in experiments 2 
and 3. About 1.0 g of fresh ileal content from each bird was collected into 2.0 mL sterile 
Eppendorf tubes (Eppendorf AG, Hamburg, Germany), and immediately stored at -80° C. 
The α toxin activity was estimated in ileal digesta using Amplex Red 
Phosphatidylcholine-Specific Phospholipase C Assay Kit (Molecular Probes; Cedarlane 
Lab. Ltd., ON, Canada) according to the manufacture’s instructions. Briefly, 100µl of 1X 
reaction buffer diluted sample was used in duplicate for each reaction into separate wells 
of a fluorescence multiwell plate. 100µl of 10µM H2O2 solution was used as positive 
control while 1X reaction buffer without PC-PLC served as negative control. Standard 
was prepared by diluting the 10 U/mL PC-PLC stock solutions into 1X reaction buffer to 
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produce a 0.1 U/mL PC-PLC solution and then two fold serial dilutions were prepared for 
the calibration curve. 100µl of working buffer containing Amplex Red 
reagent/HRP/alkaline phosphatase/choline oxidase/lecithin was added to each well 
containing the samples, controls and standard. Plate was incubated for 1 h at 37°C 
protected from light and then fluorescence was measured with a fluorescence mircoplate 
reader (Fluoroskan Ascent FL 2.5) using excitation at 544 nm and emission detection at 
612 nm. 
5.3.6. Samples for Amino Acids Digestibility Determination 
 In each of the three experiments, the remainder of the ileal contents of 4 birds 
from each pen were pooled, lyophilized and analyzed for amino acid content (Degussa 
Canada Inc., Burlington, ON). The acid insoluble ash in experimental diets and freeze 
dried ileal digesta samples was determined using method of MaCarthy et al.  (1974). 
Digestibilities of various amino acids were calculated using the formula: 
  (Amino acid/acid insoluble ash) diet - (Amino acid/acid insoluble ash) digesta    
                 (Amino acid/acid insoluble ash) diet 
5.3.7. Statistical Analysis 
Data were analyzed using General Linear Model procedure of SPSS (Version 12.0, 
SPSS Inc, Chicago IL, USA). Treatment means were compared using the Ryan-Einot-
Gabriel-Welsch multiple F test. The linear and quadratic effects of dietary glycine on 
growth parameters and bacterial populations were determined using regression analysis. 
Comparisons were considered significant when P < 0.05.  
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5.4. Results 
 The amino acid composition of the experimental diets is shown in Tables 5.3 
(experiments 1 and 2) and 5.5 (experiment 3) while protein and amino acid analyses of 
ileal digesta in each of the three experiments are depicted in Tables 5.6 (experiments 1 
and 2) and 5.7 (experiment 3). The ileal digestibilities of various amino acids have been 
presented in Tables 5.8 and 5.9. Approximately 70-80 per cent of the birds were dull, 
depressed and diarrheic for first 5-10 days post-challenge (i.e. after day 14) in each of the 
three experiments. Huddling, ruffled feathers and apathy were obvious. NE-specific 
deaths occurred in all the three experiments with 8.33, 6.25 and 4.16% mortality in 
experiments 1, 2 and 3, respectively. Together in experiments 1 and 2, three birds died in 
the groups fed the 3.04% glycine while two birds fed 1.58% glycine and two birds fed 
4.21% glycine diets also died. There was no mortality in the 0.75% glycine group in 
either of the experiments. In experiment 3, two birds died in the group that received 
4.00% glycine diet, while one bird died each from group fed 0.75 and 2.00% glycine 
diets. Most of these birds that died during the course of experiment had marked 
distension of jejunum and ileum, and the lumen was filled with gas and foul-smelling 
dark brown fluid content. Some birds had small necrotic ulcers (0.5-1.5 cm long), mainly 
in the proximal ileum, though not as pronounced as in typical field cases. At places, 
petechial hemorrhages were also noticed chiefly in the duodenum and proximal jejunum. 
No detectable gross lesions were observed in any other organ. Surviving birds had no 
apparent signs of morbidity 7 to 10 days post-challenge. 
 The experimental diets were readily accepted in each of the three experiments and 
there were no significant differences in feed intake except on day 21 to 28 in experiment 
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3 where feed intake was significantly higher in chickens receiving diets with 1.00, 1.50 
and 4.00% glycine compared to rest of the diets (Table 5.10). The linear and quadratic 
effects of glycine on feed intake were significant during days 14-21 in experiments 1 and 
2 and during days 21-28 in experiment 3. In experiments 1 and 2, a significant decline in 
the average daily gain (ADG) was observed in birds fed 3.04 and 4.21% glycine diets 
compared to those with 0.75% glycine diets both on day 14-21 and day 21-28. The linear 
and quadratic effects of glycine on average daily gain were significant in both time 
periods in experiments 1 and 2 and the quadratic effect was significant during days 14-21 
in experiment 3. There were no significant differences in the feed:gain ratio in 
experiments 1 and 2, however there was a significant linear effect of glycine on feed:gain 
ratios in both periods for experiment 1. In experiment 3 during the day 14-21 and 21-28 
periods, a significantly higher feed:gain ratio was observed in birds on the 4.00% glycine 
diets compared to those receiving the other 5 diets. The linear and quadratic effects of 
glycine on feed:gain ratio were significant for both periods during experiment 3. 
Bacterial populations in the digestive tracts of chickens on day 28 of the three 
experiments are presented in Table 5.11. The number of lactobacilli and C. perfringens 
increased from proximal part to the distal part of the intestine with highest counts 
measured in the ceca. No C. perfringens were enumerated in the jejunum and ileum from 
birds in experiment 1 because the numbers were below the detection limit of the assay. In 
the jejunum, no significant difference was noticed among various treatment groups in 
lactobacilli counts in experiment 1, and both lactobacilli and C. perfringens populations 
in each of the first two experiments so lactobacilli and C. perfringens were not 
enumerated in the jejunum in experiment 3.  
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In each of the three experiments, there was a decrease in population of lactobacilli 
with increase in the dietary glycine concentration, and this effect was more pronounced in 
the cecum than in the ileum. A significant decline in the lactobacilli populations was 
observed in ileum of chickens fed 3.04% dietary glycine compared to the diet with 1.58% 
glycine in experiment 1 while in experiment 3, the numbers were significantly less in 
chickens which were provided with 4.00% dietary glycine than in those with other levels 
of dietary glycine tested (Table 5.11). In experiment 2, no statistically significant 
difference was observed in the lactobacilli populations in the ileum although there was 
decrease in the numbers ranging from 7.22 to 6.84 log10 CFU/g digesta with a 
corresponding increase in dietary glycine level from 0.75 to 4.21%. 
The effect of dietary glycine concentration on lactobacilli populations in cecum of 
28-day-old broiler chickens was statistically significant in experiment 1 and 2. There was 
a significant decrease in the lactobacilli counts in cecum between chickens that received 
4.21% glycine and those that received 0.75 or 1.58% glycine diets. No difference was 
detected among various treatments groups with respect to lactobacilli populations in 
cecum in experiment 3 except in birds which received diets with 4.00% glycine where the 
numbers declined significantly (P < 0.05) compared to other experimental groups.  
  Mean C. perfringens counts in the jejunum were not influenced by the level of dietary 
glycine in experiment 2 (Table 5.11). Significantly higher C. perfringens numbers were 
observed in the ileum of day-28-old birds fed 1.58, 3.04 or 4.21% dietary glycine 
compared with those given 0.75% glycine in experiment 2. In experiment 3, C. 
perfringens counts in ileum increased from 3.14 to 4.57 log10 CFU/g of intestinal 
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contents as dietary glycine concentration increased from 0.50 to 2.00% but the counts 
decreased again with 4.00% glycine.  
Glycine supplementation resulted in a significant quadratic response for C. 
perfringens growth in cecum of 28-day-old broiler chickens with maximum response at 
3.30, 3.89 and 3.51% dietary glycine concentration with r2 values of 0.95, 0.99 and 0.95 
in experiments 1, 2 and 3, respectively (Figure 5.1). Compared with 0.75 and 1.58% 
glycine-fed chickens the population of C. perfringens was significantly greater in the 
ceca of 3.04% glycine-fed chickens both in experiment 1 and 2, however, no difference 
was noticed in birds that received either 1.58 or 4.21% glycine diets. In experiment 3, 
cecal C. perfringens counts were significantly greater in the birds fed 1.50, 2.00 and 
4.00% glycine diets compared to those fed 0.50, 0.75 or 1.00% glycine diets and there 
was an almost 2 log difference in cecal C. perfringens populations when dietary glycine 
concentrations were increased from 0.50 to 2.00%.  
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Table 5.6. Protein and amino acid content (%) of ileal digesta in experiments 1 and 2.  
 
 Experiment 1 Experiment 2 
 0.75% 
Gly 
1.58% 
Gly 
3.04% 
Gly 
4.21% 
Gly 
0.75% 
Gly 
1.58% 
Gly 
3.04% 
Gly 
4.21% 
Gly 
CP (%) 9.86 10.68 13.60 18.01 9.21 9.98 11.94 14.91 
Essential amino acids 
Arginine 0.43 0.43 0.45 0.53 0.37 0.36 0.38 0.42 
Histidine 0.19 0.18 0.17 0.22 0.18 0.16 0.16 0.18 
Isoleucine 0.33 0.29 0.25 0.29 0.28 0.24 0.20 0.21 
Leucine 0.57 0.49 0.45 0.54 0.47 0.40 0.35 0.39 
Lysine 0.37 0.36 0.37 0.35 0.33 0.31 0.31 0.34 
Methionine 0.13 0.12 0.12 0.16 0.10 0.10 0.10 0.11 
Meth. + Cyst. 0.35 0.31 0.29 0.35 0.32 0.29 0.26 0.29 
Phenylalanine 0.60 0.52 0.51 0.56 0.36 0.33 0.28 0.29 
Threonine 0.47 0.42 0.42 0.51 0.43 0.39 0.36 0.40 
Valine 0.44 0.39 0.37 0.43 0.38 0.34 0.31 0.33 
Non essential amino acids 
Alanine 0.45 0.48 0.62 0.82 0.39 0.40 0.50 0.59 
Aspartate 0.87 0.88 1.09 1.49 0.85 0.89 0.97 1.26 
Cysteine 0.23 0.19 0.17 0.19 0.21 0.19 0.16 0.17 
Glycine 0.51 0.91 2.00 2.95 0.47 0.87 1.64 2.36 
Glutamate 1.44 1.39 1.56 1.96 1.18 1.15 1.28 1.46 
Proline 0.61 0.83 1.54 2.36 0.56 0.88 1.41 2.13 
Serine 0.46 0.44 0.54 0.70 0.42 0.43 0.46 0.57 
 
Gly = Dietary glycine; CP = Crude protein 
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Table 5.7. Protein and amino acid content (%) of ileal digesta in experiment 3. 
Experimental diets 
0.50% 
Gly 
0.75% 
Gly 
1.00% 
Gly 
1.50% 
Gly 
2.00% 
Gly 
4.00% 
Gly 
CP (%) 10.02 10.75 11.00 10.99 11.32 14.40 
Essential amino acids 
Arginine 0.43 0.50 0.51 0.50 0.48 0.61 
Histidine 0.19 0.22 0.23 0.21 0.20 0.24 
Isoleucine 0.37 0.34 0.33 0.31 0.30 0.34 
Leucine 0.51 0.58 0.57 0.55 0.53 0.62 
Lysine 0.38 0.42 0.42 0.41 0.40 0.42 
Methionine 0.14 0.12 0.12 0.12 0.11 0.15 
Meth. + Cys. 0.33 0.37 0.35 0.34 0.31 0.34 
Phenylalanine 0.60 0.68 0.64 0.64 0.61 0.68 
Threonine 0.49 0.52 0.50 0.48 0.46 0.51 
Valine 0.47 0.46 0.46 0.44 0.42 0.50 
Non essential amino acids 
Alanine 0.42 0.45 0.48 0.48 0.47 0.65 
Aspartate 0.74 1.19 1.14 1.12 1.09 1.22 
Cysteine 0.19 0.26 0.23 0.22 0.20 0.19 
Glycine 0.49 0.56 0.67 0.76 0.87 1.69 
Glutamate 1.63 1.56 1.66 1.57 1.46 1.82 
Proline 0.73 0.70 0.78 0.82 0.91 1.13 
Serine 0.57 0.51 0.49 0.49 0.48 0.60 
 
Gly = Dietary glycine; CP = Crude protein 
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Table 5.8. Ileal digestibilities (%) of various amino acids in experiments 1 and 21.  
 
 Experiment 1 Experiment 2 
 0.75% 
Gly 
1.58% 
Gly 
3.04% 
Gly 
4.21% 
Gly 
0.75% 
Gly 
1.58% 
Gly 
3.04% 
Gly 
4.21% 
Gly 
Essential amino acids 
Arginine 78.47 81.90 87.07 89.25 85.41 86.96 87.10 91.25
Histidine 76.10 74.75 77.42 76.04 82.10 79.62 75.12 78.95
Isoleucine 78.18 79.61 87.80 89.78 85.49 85.43 88.34 92.03
Leucine 76.55 78.63 86.07 87.77 84.26 84.51 87.42 90.65
Lysine 82.71 84.47 86.73 88.16 87.34 89.06 87.25 90.60
Methionine 86.95 89.37 92.77 93.56 91.78 92.88 92.97 94.99
Meth. + Cyst. 77.36 81.14 86.63 88.16 83.97 84.85 85.60 89.49
Phenylalanine 63.51 66.12 69.49 73.91 82.14 80.69 80.26 85.23
Threonine 79.73 75.62 80.21 82.13 78.47 80.14 80.05 84.67
Valine 74.57 75.98 81.35 86.46 82.17 81.19 82.05 88.99
Non essential amino acids 
Alanine 68.54 77.50 82.90 85.05 78.46 83.67 84.81 88.88
Aspartate 68.77 67.21 64.36 64.60 76.99 71.73 65.28 69.19
Cysteine 60.59 61.62 63.87 61.71 71.19 67.17 62.49 64.28
Glycine 63.39 75.43 75.09 75.59 72.63 79.88 76.65 79.83
Glutamate 78.92 79.55 80.44 80.56 85.47 84.44 80.96 84.32
Serine 69.17 71.66 71.97 73.63 78.23 75.96 73.55 77.70
 
1 Ileal digestibilities were calculated using the formula: 
    (Amino acid/acid insoluble ash) diet - (Amino acid/acid insoluble ash) digesta    
                    (Amino acid/acid insoluble ash) diet 
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Table 5.9. Ileal digestibilities (%) of various amino acids in experiment 31. 
Experimental diets 
0.50% 
Gly 
0.75% 
Gly 
1.00% 
Gly 
1.50% 
Gly 
2.00% 
Gly 
4.00% 
Gly 
Essential amino acids 
Arginine 89.00 82.88 81.03 83.15 86.42 86.02 
Histidine 83.30 80.84 75.74 77.40 79.74 71.48 
Isoleucine 86.99 85.69 82.27 83.94 85.22 86.08 
Leucine 88.00 83.86 80.69 82.04 83.82 84.05 
Lysine 89.63 84.89 82.71 85.24 88.18 85.33 
Methionine 93.93 92.33 91.09 91.56 93.11 93.20 
Meth + Cys. 88.50 85.93 81.92 83.64 86.50 87.20 
Phenylalanine 74.71 73.81 69.77 70.32 73.38 67.57 
Threonine 82.88 78.25 74.69 76.90 80.75 78.41 
Valine 85.63 82.30 78.48 80.00 82.24 79.26 
Non essential amino acids 
Alanine 73.82 74.95 75.46 79.21 84.06 85.18 
Aspartate 85.92 71.25 66.07 67.86 71.65 66.02 
Cysteine 64.51 73.84 63.97 67.55 71.06 61.17 
Glycine 62.42 62.12 72.41 78.29 83.37 83.65 
Glutamate 92.76 84.55 81.06 82.89 85.22 81.14 
Serine 74.15 76.20 74.14 75.63 78.71 73.79 
 
1 Ileal digestibilities were calculated using the formula: 
   (Amino acid/acid insoluble ash) diet - (Amino acid/acid insoluble ash) digesta    
                    (Amino acid/acid insoluble ash) diet 
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Table 5.10. Average daily feed intake (ADFI, g/day), average daily gain (ADG, 
g/day) and feed:gain ratio (FC, feed intake/ weight gain, g/g) of birds during days 
14-21 and 21-28 of the three experiments. 
 
 
Days 14-21 Days 21-28 
Glycine (%) ADFI ADG FC ADFI ADG FC 
Experiment 1       
0.75 193.9 54.6a 3.6 357.9 81.6a 4.4 
1.58 187.2 53.9a 3.5 333.2 79.4a 4.2 
3.04 166.6 33.8b 5.0 352.7 64.5b 5.5 
4.21 164.1 30.9b 5.7 345.8 62.5b 5.5 
Pooled SEM 5.04 3.97 0.38 9.07 2.69 0.25 
Linear  0.006 0.003 0.015 0.845 0.000 0.030 
Quadratic 0.029 0.017 0.050 0.888 0.001 0.105 
Experiment 2       
0.75 220.5 81.8a 2.7 264.5 87.9a 3.0 
1.58 235.5 74.4ab 3.2 248.6 71.8ab 3.5 
3.04 193.4 49.9bc 4.7 223.6 59.3bc 3.8 
4.21 185.7 42.7c 4.4 224.6 53.2c 4.4 
Pooled SEM 7.84 5.92 0.40 10.88 4.39 0.29 
Linear  0.028 0.002 0.062 0.144 0.000 0.084 
Quadratic 0.071   0.009 0.170 0.338 0.000 0.242 
Experiment 3       
0.50  182.2 74.3a 2.5a 241.3a 66.7ab 3.6a 
0.75 177.4 68.3a 2.6a 247.3a 63.9a 3.9a 
1.00 174.7 74.4a 2.4a 303.6b 81.3c 3.7a 
1.50 182.5 73.3a 2.5a 313.0b 80.0bc 3.9a 
2.00 188.4 74.4a 2.5a 243.6a 61.3a 3.9a 
4.00 177.9 51.4b 3.6b 321.9b 60.6a 5.4b 
Pooled SEM 2.18 2.36 0.11 8.73 2.21 0.16 
Linear  0.665 0.077 0.036 0.000 0.326 0.010 
Quadratic 0.906 0.026 0.006 0.000 0.156 0.006 
 
abc Means with the different superscripts within a column (within a experiment) differ 
significantly (P < 0.05)   
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 Table 5.11. Mean Lactobacilli and C. perfringens populations1 in jejunum, ileum 
and cecum of broiler chickens on day 28 of the experiments. 
 Lactobacilli2 C. perfringens2 
Glycine (%) Jejunum Ileum Cecum Jejunum Ileum Cecum 
Experiment 1       
0.75 6.57 7.13ab 9.36a BD BD 4.88c 
1.58 6.75 7.30a 9.33ab BD BD 5.87bc 
3.04 6.43 6.90b 8.99bc BD BD 6.91a 
4.21 6.46 6.92ab 8.77c BD BD 5.91ab 
Pooled SEM 0.05 0.05 0.06   0.18 
Experiment 2       
0.75 6.35 7.22 9.21a 2.54 3.39b 5.83c 
1.58 6.74 7.07 8.93ab 3.73 4.35a 7.35b 
3.04 6.24 6.95 8.71b 3.37 3.99a 8.11a 
4.21 6.36 6.84 8.31c 3.57 4.28a 7.89ab 
Pooled SEM 0.07 0.07 0.06 0.18 0.11 0.16 
Experiment 3       
0.50 ND 7.64a 9.09a ND 3.14e 5.27c 
0.75 ND 7.45a 9.01a ND 3.30de 5.82bc 
1.00 ND 7.67a 9.01a ND 3.55cd 6.10b 
1.50 ND 7.56a 8.81a ND 3.79bc 7.23a 
2.00 ND 7.49a 8.75a ND 4.57a 7.23a 
4.00 ND 7.28b 8.33b ND 4.12b 7.01a 
Pooled SEM  0.07 0.05  0.06 0.12 
 
1Means are Log10 CFU/g of intestinal contents. 
2Means with the different superscripts within a column (within an experiment) differ 
significantly (P < 0.05)   
BD: Below detection; ND: Not determined 
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The mean NE lesion scores of chickens fed different experimental diets and killed 
on day 28 are presented in Figure 5.2.  In a majority of birds, the intestinal serosa was 
congested and mesentery engorged with blood. Focal necrotic lesions were observed in 
various intestinal regions, including the cecal tonsils (Appendix 9.3A).  In experiments 1 
and 2, there was a significant elevation (P < 0.05) in the intestinal lesion score in birds 
that received 3.04% glycine diets compared to those receiving the 0.75% glycine diet. 
Intestinal lesion scores were less in chickens receiving 4.21% glycine than those 
receiving 3.21% glycine diets.  In experiment 3, significantly higher (P < 0.05) intestinal 
lesion scores were observed in birds receiving 4.00% glycine diet compared to rest of the 
diets. Chickens that consumed 0.50% glycine diet exhibited the lowest lesion score and 
the mean intestinal lesion score of this treatment group was significantly different (P < 
0.05) from scores of chickens that consumed any of the five diets. No significant 
difference in the lesion score was observed with increase in dietary glycine concentration 
from 0.75 to 2.00% in experiment 3.    
Histological examination of fixed intestinal tissues from 28-day-old broiler 
chickens euthanized in each of the three experiments revealed lesions of NE at various 
stages. The intestinal lesions varied from slight edema and congestion in lamina propria 
(Appendix 9.3B); mild necrosis to desquamation of epithelial cells at the tips of villi. In 
some cases, especially in terminal jejunum and proximal ileum, the mucosa was devoid 
of villi completely and was covered with a homogenous diphtheritic membrane 
comprising of debris of necrotic epithelial cells, mucous membrane and fibrin.  
Interestingly, there were very few areas of polymorphonuclear cells (PMN) infiltration in 
the lamina propria. There was no evidence of coccidial oocysts in any sections examined.   
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The concentration of α toxin in the ileal contents of the birds from experiments 2 
and 3 is presented in Table 5.12. The α toxin concentration was significantly higher in 
chickens given 1.58% glycine diets compared to rest of the diets in experiment 2 while no 
significant difference was observed among various treatment groups in experiment 3. 
5.5. Discussion 
 Glycine is an essential amino acid in growing broiler chickens and Corzo et al. 
(2004) determined that chicks optimized body weight gain and feed conversion at 0.98% 
and 1.02% dietary glycine, respectively. In the current study, there was a significant 
decline in growth performance of birds with an increase in the dietary glycine content 
above the requirement level. Although the essential amino acid content of the diets was 
balanced for ideal protein, the increasing levels of glycine would have resulted in an 
imbalance of some nonessential amino acids and this may have been responsible for the 
decrease in growth performance. However, it is also possible that the effect of dietary 
glycine was indirect and mediated through the increase in the number of intestinal C. 
perfringens. As evidenced from the intestinal lesion scores and high numbers of C. 
perfringens in ileum and cecum, most of these birds had a sub-clinical form of NE 
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Figure 5.1. Relationship between dietary glycine concentration and C. perfringens 
populations in the ceca of 28-day-old broiler chickens in all the three experiments. 
Maximum numbers of C. perfringens were observed at 3.30, 3.89 and 3.51% dietary 
glycine concentration with r2 values of 0.95, 0.99 and 0.95 in experiments 1, 2 and 3, 
respectively. 
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Figure 5.2. Mean necrotic enteritis lesion score in 28-day-old broiler chickens given 
experimental diets (day 14-28) containing different levels of glycine. 
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Table 5.12. Mean phospholipase C (PLC) concentration in the ileal contents of 28-
day-old broiler chickens fed different experimental diets. 
Glycine (%) PLC concentration (mU/g of ileal digesta) 
Experiment 2  
0.75 13971b 
1.58 16321a 
3.04 14076 b 
4.21 12738 b 
Pooled SEM 333.25 
Experiment 3  
0.50 10643  
0.75 10631  
1.00 10656  
1.50 10766  
2.00 10692  
4.00 10652  
Pooled SEM 14.91 
 
ab Means with the different superscripts within a column (within a experiment) differ 
significantly (P < 0.05)   
 
 
 
 
 
 126
as described by Lovland and Kaldhusdal (2001). Kaldhusdal and Hofshagen (1992) and 
Stutz et al. (1983) also reported a decreased growth rate and increased feed conversion 
rate in broilers having high number of C. perfringens in the gut. Increased populations of 
C. perfringens in the gut (as much as log 4.57 in ileum and log 8.11 in cecum) were 
observed even in the clinically healthy birds, which confirms the sub clinical nature of 
this disease because higher C. perfringens populations with grossly visible, focal necrotic 
lesions in the small intestine is strong indicator of an occurrence of NE (Kaldhusdal and 
Hofshagen, 1992; Kaldhusdal et al., 1999). 
 A previous study in broiler chickens examining the effect of different protein 
sources (animal vs. plants) and dietary amino acid profile on intestinal populations of C. 
perfringens  documented a significant correlation (P < 0.05) between the level of dietary 
glycine and the number of C. perfringens in both ileum and cecum (Wilkie et al., 2005). 
They also observed a significant correlation between lysine and glycine content of ileal 
digesta and C. perfringens numbers in both ileum and cecum. However, no other ileal 
amino acids were significantly correlated with C. perfringens populations in ileum or 
cecum. In the present study, the lysine concentration of ileal digesta was constant 
(ranging from 0.31 to 0.37% in experiment 1 and 2, and from 0.38 to 0.42% in 
experiment 3) regardless of the diet and the lysine content of the diets with 0.75 to 3.04% 
glycine was also almost constant in each of the three experiments. Although gelatin is a 
rich source of glycine, it also contains high levels of alanine and proline (9.65 and 
13.09% in CP). There was an increase in dietary alanine and ileal proline content with the 
addition of gelatin in the experimental diets, however, our results indicate that unlike 
glycine, alanine or proline do not enhance C. perfringens growth in vivo (Drew et al., 
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2004) or in vitro (Wilkie et al., 2005).  Drew et al.  (2004) reported that there was no 
difference in C. perfringens populations in ileum and cecum of broiler chickens that 
received soy protein concentrate-based diets containing 23.0, 31.5 or 40.0% CP. 
However, C. perfringens numbers increased significantly with fishmeal-based diets. It 
was concluded that it was not the protein, but the glycine concentration of fishmeal diets 
that was responsible for C. perfringens overgrowth in ileum and cecum of these birds.    
In the current study, the number of lactobacilli decreased with increasing dietary 
glycine concentration, and this effect was clearer in the cecum than ileum. Interestingly, 
the effect of various dietary treatments on intestinal C. perfringens populations was 
opposite to that on lactobacilli populations. The mode of action by which glycine affects 
the intestinal populations of these important groups of bacteria in broiler chickens is 
unclear. Some strict anaerobic bacteria have a unique energy conserving mechanism and 
they catalyze glycine as substrate using an internal Stickland reaction by which glycine 
serves as electron donor during oxidation by a glycine cleavage system or as electron 
acceptor being reduced by glycine reductase. The glycine reductase system is present in 
several clostridia (C. sticklandii, C. difficile, C. litorale and Eubacterium 
acidaminophilum) and catalyzes the reductive deamination of glycine to acetylphosphate 
and ammonia (Andreesen, 1994; Costilow, 1977). As C. perfringens is not a protein 
fermentor, the effect of higher levels of dietary glycine on intestinal C. perfringens 
populations might be indirect. It is possible that high dietary glycine concentration might 
cause a reduction in lactic acid producing bacteria (mainly Lactobacillus, Streptococci, 
and Staphylococci) which are predominant in the intestines of normal healthy chickens 
and generally considered to be protective against colonization of pathogenic micro-
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organisms. An antagonistic effect of lactobacilli against Helicobacter pylori (Aiba et al., 
1998), Salmonella spp. (Gill et al., 2001) and E.coli (Mangell et al., 2002) has been 
demonstrated in murine model.  
It is conceivable that the protein/amino acids are serving as energy and/or 
nitrogen source for other community members that in turn modify the intestinal 
environment in a favorable way for C. perfringens proliferation. This may occur by 
providing positive selection pressure on those gastrointestinal microbes which can 
directly ferment amino acids for carbon and nitrogen. Alternatively, the high glycine diets 
might affect the host in such a manner that the gastrointestinal milieu is made more 
favorable for C. perfringens proliferation i.e. by the induction of an inflammatory 
response, which in turn leads to leakage of serum proteins into the gut lumen. This 
leakage of serum protein may ultimately provide the environmental stimulus required for 
an expansion of C. perfringens population, and perhaps even the up regulation of 
virulence factors (Shane et al., 1985). Titball et al. (1999) documented that growth of C. 
perfringens and production of α toxin are influenced by various amino acids. Methinone 
is highly stimulatory for the growth and sporulation of C. perfringens (Muhammed et al., 
1975). Glycine accelerated the C. perfringens growth (Ispolatovskaya, 1971) while α 
toxin production required the presence of glycine-containing peptides in defined media 
(Nakamura et al., 1968; Stevens and Rood, 2000). Drew et al. (2004) observed a positive 
correlation between glycine and methionine content of the diet, and intestinal C. 
perfringens counts in broiler chickens fed high protein diets. While several studies have 
been conducted to determine the effects of different dietary compositions on intestinal C. 
perfringens populations but we are aware of no study that directly examines the effect of 
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various concentrations of dietary glycine on C. perfringens proliferation and NE 
production in broiler chickens.         
 In the present experiments, gross intestinal lesions of varying degrees among 
various treatment groups were observed although we did not observe the typical field-
type lesions of NE. Reason for absence of field-type lesions is unknown; one possible 
explanation may be that some of the vegetative cells are inactivated by the low pH in the 
gizzard when given orally. Al-Sheikhly and Truscott (1977a) and Vissiennon et al. 
(2000) were able to detect severe necrotic lesions and induce high mortality by inoculated 
fresh cultures directly into the duodenum. They suggested that high C. perfringens 
populations and slight intestinal damage were apparently necessary for disease 
production when a broth culture was used. However, the results of current experiments 
indicate that even though the aforementioned may be major factors, other factors, 
including the chemical/physical nature of the diet and the interaction of other intestinal 
microflora, may contribute to pathogenesis of the disease. On day 28, the mean gross 
intestinal NE lesion scores were highest in the chickens given the diets with 3.04% 
glycine in experiment 1 and 2; and 4.00% glycine in experiment 3. Interestingly, C. 
perfringens counts and lesion scores were comparatively less in groups that received 
4.21% dietary glycine than those in 3.04% glycine level both in experiment 1 and 2. It 
might be due to the fact that very high level of dietary glycine (above 3.04%) may 
modify the intestinal environment in a way which is not favorable for C. perfringens 
proliferation and/or α toxin production.  
The histological examination of the affected intestinal tissues indicated that 
pathological lesions were more or less similar to those of previous investigations of 
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spontaneous (Helmboldt and Bryant, 1971; Long et al., 1974) as well as experimental 
(Al-Sheikhly and Truscott, 1977a; Kaldhusdal et al., 1995; Shane et al., 1985) NE, 
indicating that necrosis starts in apical villous epithelium. Presence of slight edema in 
lamina propria and detachment of the epithelial layer from the underlying tissues 
especially from tips of the villi indicate the initial changes in NE. It is of interest that the 
cellular response was not evident in this study in contrast to some other studies 
(Kaldhusdal et al., 1995; Shane et al., 1985). However, Bryant et al. (1993) and Stevens 
et al. (1997) also demonstrated an absence of PMN cells at the site of C. perfringens 
infection. In the absence of host response (suppression of PMN influx), clostridia 
proliferates rapidly, leading to local accumulation of toxins. Higher in situ concentrations 
of C. perfringens toxins, especially α toxin, further inhibit PMN influx and reach 
concentration sufficient to cause membrane destruction (Stevens and Rood, 2000). From 
the current experiments, it is not clear whether the intestinal lesions were produced by 
vegetative cells or C. perfringens toxins.  
 Lesions can be reproduced by the administration of a crude preparation of α toxin 
to conventional (Al-Sheikhly and Truscott, 1977c) and germ free chicks (Fukata et al., 
1988). In the current study, in spite of a constant increase in the number of C. perfringens 
with increase in dietary glycine content, there was no significant difference in α toxin 
concentration in the ileal contents among various treatment groups, except in chickens 
fed 1.58% glycine diets in experiment 2. However, this does not rule out the possibility 
that a higher concentration of α toxin is present in the lower intestinal tract especially in 
cecum. There is evidence that various digestive enzymes such as trypsin inactivates the α 
toxin of C. perfringens type A and the β toxin of C. perfringens type C (Baba et al., 
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1992; Niilo, 1965). The production of α toxin by various non C. perfringens members of 
the gastrointestinal microflora such as C. sordellii, C. bifermentans, Pseudomonas 
aeruginosa and Bacillus spp. makes this analysis even more difficult. To overcome this 
limitation, we are investigating measuring C. perfringens α toxin gene transcript 
abundance using quantitative real-time PCR.  
5.6. Conclusions 
 The results of the present study support our hypothesis that dietary glycine level 
plays a significant role in increasing C. perfringens populations in the intestinal tract of 
broiler chickens. Because animal-source proteins contain from 2 to 4 times as much 
glycine as a percentage of crude protein compared to plant based proteins, glycine 
content may be one factor in animal protein-based diets that could predispose chickens to 
clinical NE. However, there are two confounding factors in this study. The crude protein 
and proline levels were also increasing with increase in quantity of geltin in the 
experimental diets. So we could not conclusively establish a direct causative link between 
dietary glycine and C. perfringens growth in this study. The NE challenge model used in 
this study was effective in inducing death, C. perfringens colonization, intestinal lesions, 
poor feed utilization, and reduced body weight gain in broiler chickens. This model can 
be used further for assessing various other factors in animal proteins that increase 
susceptibility of broiler chickens to NE and will allow the development of dietary 
formulations for broiler chickens that reduce clinical outbreaks of this disease. 
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6.0. INTESTINAL CLOSTRIDIUM PERFRINGENS AND LACTOBACILLI 
POPULATIONS IN BROILER CHICKENS FED PROTECTED GLYCINE 
AND PROLINE SUPPLEMENTED DIETS 
6.1. Abstract 
 This study was conducted to determine if there is a causative relationship between 
dietary glycine concentration and C. perfringens growth in broiler chickens. Since 
crystalline glycine is rapidly absorbed in the duodenum, fat encapsulated glycine was 
therefore used to slowly release the amino acid along the entire length of the gut. An 
initial study showed that glycine concentrations were significantly higher (P < 0.05) in 
jejunum and ileum of birds fed encapsulated glycine compared to crystalline glycine. In 
the main study, two experiments were conducted to examine the effect of dietary 
encapsulated glycine or proline on gut C. perfringens growth and necrotic enteritis (NE) 
lesion scores in broiler chickens. In experiment 1, two cages of 6 birds (14 day post-
hatch) were assigned to one of 6 experimental diets formulated to contain 7.6 and 10.6 
(control), 17.8 and 40.6 (G1P3), 27.8 and 30.6 (G2P2), 37.8 and 20.6 (G3P1), 47.7 and 
10.6 (G4P0) and 7.8 and 50.6 (G0P4) g/kg total glycine and proline, respectively, 
provided primarily by supplementing with encapsulated glycine or proline as required. In 
experiment 2, 12 groups of 6 birds were fed 4 different diets formulated to contain 7.6 
(LG), 21.0 (MG), 34.3 (HG) or 47.7 (UHG) g/kg glycine with same level of proline. The 
birds were orally challenged with C. perfringens type A on day 1 and day 14-21 and 
killed on day 28. In experiment 1, significantly higher (P < 0.05) C. perfringens 
populations were observed in ileum and cecum of birds which received either 37.8 or 
47.7 g/kg dietary glycine compared to those given 7.6 g/kg glycine. Lactobacilli counts in 
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ileum declined significantly (P < 0.05) in the ceca of birds fed 47.7 g/kg glycine 
compared to rest of the diets. In experiment 2, C. perfringens numbers were significantly 
higher (P < 0.05) in ileum of birds which were fed either 7.6 or 21.0 g/kg dietary glycine 
than those given either 34.3 or 47.7 g/kg glycine.  Lactobacilli populations were 
significantly higher in both ileum and cecum of chickens which were provided with 7.6 
g/kg glycine than those with other levels of dietary glycine tested. The mean NE lesion 
score increased significantly (P < 0.05) in birds receiving 47.7 g/kg glycine than those 
fed either 7.6 or 21.0 g/kg glycine in experiment 2.  Also birds having higher C. 
perfringens colonization and lesion scores had poor performance in both experiments. 
There was no significant effect of dietary proline concentration on C. perfringens as well 
as lactobacilli populations in either of the experiments. We conclude that glycine is an 
important determinant of C. perfringens growth in the intestinal tract of broiler chickens.  
6.2. Introduction 
Enteric pathogens result in huge losses to poultry industry annually, and their 
control or reduction could potentially save the producers millions of dollars. Recognized 
as the causative agent of necrotic enteritis (NE), Clostridium perfringens is one such 
pathogen. C. perfringens is a nearly ubiquitous gram positive, spore forming, extremely 
prolific, toxigenic anaerobic bacteria affecting many warm-blooded animals including 
humans (Ficken and Wages, 1997). High populations of C. perfringens may be present in 
the intestinal tract of animals with no visible signs of disease, thus breaking Koch’s 
postulate that a disease-causing organism should not be present in healthy individuals. 
Most workers, therefore, consider various predisposing factors to be of major importance 
in spontaneous outbreaks of NE in poultry (Dahiya et al., 2006b). Despite considerable 
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investigation of this disease, the predisposing factors that promote overgrowth of C. 
perfringens, excessive release of α toxin, and thus subsequent progression to disease are 
numerous and ill-defined. The long list of contributing factors includes management and 
environmental conditions (Cowen et al., 1987; Kaldhusdal et al., 1999; Kaldhusdal and 
Skjerve, 1996), stress and immunosuppression (Fukata et al., 1991; McReynolds et al., 
2004), co-infection with Eimeria spp. (Al-Sheikhly and Al-Saieg, 1980; Shane et al., 
1985), and diet composition. The estimated cost of clostridial enteritis to the poultry 
industry is as much as US$ 0.05 per bird with total global loss pegged at almost US$ 2 
billion (Van der Sluis, 2000a; Van der Sluis, 2000b). Others have suggested this is an 
underestimate, given the difficulty in diagnosing mild forms of clostridial enteritis 
(Lovland and Kaldhusdal, 2001). Furthermore, C. perfringens-associated NE and 
subclinical infection is expected to emerge in broiler chickens after European ban on 
antimicrobial growth promoters increasing its economic impact. Concerns also arise on 
the high contamination rates of poultry by C. perfringens and risk of transmission to the 
food chain, posing public health problems (Immerseel et al., 2004). These factors have 
stimulated interest in finding alternative management or dietary strategies to control the 
incidence and severity of clostridial enteritis in post-antibiotic era. 
 The physical and chemical attributes of diet can modify the gastrointestinal 
microbial ecology of birds and are important determinants of NE (Dahiya et al., 2006a; 
Kaldhusdal and Skjerve, 1996; Riddell and Kong, 1992). Birds fed diets based on wheat, 
rye, oats or barley have increased risk of NE compared with birds fed corn-based diets 
(Branton et al., 1997; Kaldhusdal and Hofshagen, 1992; Riddell and Kong, 1992). 
Proteins of animal origin are favorable substrates for clostridial growth, and high 
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concentrations in broiler feeds are often associated with NE (Drew et al., 2004; 
Kaldhusdal and Skjerve, 1996; Truscott and Al-Sheikhly, 1977; Wilkie et al., 2005).  
Although there are sufficient evidences regarding the mechanism(s) behind the effect of 
cereal grains on C. perfringens growth and NE, relatively little information are available 
in peer-reviewed literature regarding the factors or mechanisms responsible for the 
increased incidence of NE in broilers fed high protein diets. 
 Previous work has shown that there is a significant correlation between certain 
amino acids, specially glycine and C. perfringens numbers and/or phospolipase C 
production (Dahiya et al., 2005; Drew et al., 2004; Muhammed et al., 1975, Titball et al., 
1999; Wilkie et al., 2005). Drew et al. (2004) reported a positive association between 
crude protein derived from fish meal and numbers of ileal and cecal C. perfringens, but 
no such association existed for soy-derived proteins. Glycine and methionine levels are 
higher in fish meal than in soya concentrate, and these amino acids are known to 
stimulate C. perfringens growth and phospolipase C production in vitro (Ispolatovskaya, 
1971; Muhammed et al., 1975; Nakamura et al., 1968; Stevens and Rood, 2000). Wilkie 
et al. (2005) documented a significant correlation of dietary glycine with C. perfringens 
numbers in ileum and cecum of broiler chickens when fed different plant and animal 
protein based diets.  Recently, we reported a positive correlation between dietary protein-
bound glycine content and gut C. perfringens growth in broiler chickens when gelatin 
was used as protein source, however, since gelatin also contains high levels of proline, a 
causative link between glycine and clostridial growth could not be conclusively 
established (Dahiya et al., 2005). This study was therefore conducted to determine if a 
causative relationship exists between dietary glycine/proline and intestinal clostridial 
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growth in broiler chickens. Since crystalline glycine/proline is rapidly absorbed in the 
duodenum, it is largely unavailable to C. perfringens populations in the distal gut. Fat 
(hydrogenated palm oil) encapsulated glycine/proline was therefore used to slowly 
release the amino acid along the entire length of the gut. The purpose of the current study 
was to examine the effect of feeding encapsulated glycine and proline based diets on 
intestinal C. perfringens colonization and NE lesion scores in broiler chickens.  
6.3. Materials and Methods 
 Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with recommendations of 
the Canadian Council on Animal Care as specified in the Guide to the Care and Use of 
Experimental Animals (Canadian Council on Animal Care, 1993).  
6.3.1. Animal Management, Experimental Diets, and Design 
6.3.1.1. Pilot Study  
 A pilot study was carried out to determine the effect of fat encapsulation on the 
release of glycine in the intestinal tract of broiler chickens. A total of thirty six, one-day 
old male Ross broiler chicks (Gallus domesticus) were obtained (Lilydale Hatchery, 
Wynyard, SK, Canada), housed randomly in four electrically heated battery cages and 
provided a medicated, ideal protein-balanced (12.0 g/kg lysine) corn-based starter 
crumble feed (Co-op feeds, Saskatoon, Canada) ad libitum for 20 days of age (Table 
6.1). The birds were subsequently fasted overnight and refed one of the two experimental 
diets for 3 h on day 21 (9 birds per cage x 2 cages per diet). The experimental diets 
contained either 40 g/kg crystalline glycine or 40 g/kg fat encapsulated glycine (Table 
6.2). A basal diet (190 g/kg CP, 12.8 MJ/kg ME) was formulated and then appropriate 
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quantities of either crystalline glycine (Degussa Corporation) or encapsulated glycine 
(JEFO Nutrition Inc., St. Hyacinthe, Quebec, Canada) were added to provide 40 g/kg of 
supplemental glycine. The encapsulated glycine contained 342.6 g/kg crude protein and 
625.0 g/kg lipid and the diets were formulated to provide equal levels of ME and glycine. 
After 3 h of feeding experimental diets, the birds were euthanized by cervical dislocation 
and their intestinal tracts were carefully removed to collect fresh digesta from jejunum, 
ileum and cecum. Samples were pooled from 3 birds in each cage at each intestinal 
location, lyophilized and analyzed for amino acid content (Degussa Canada Inc., 
Burlington, ON). 
6.3.1.2. Challenge Study  
 Two experiments were conducted to study the effect of feeding encapsulated 
glycine or proline on intestinal C. perfringens and lactobacilli colonization, and NE 
lesion scores in broiler chickens.  
6.3.1.2.1. Experiment 1  
  Seventy two, one-day old conventional male broiler chicks (Gallus domesticus, 
Ross 308) were obtained (Lilydale Hatchery, Wynyard, SK, Canada) and placed 
randomly into four electrically heated battery cages (18 birds per cage).  On day 1 
through 14 of the experiment, birds were provided with the same corn-based starter 
crumble used in pilot study (Table 6.1). On day 14, birds were weighed and randomly re-
assigned to one of the 12 battery cages at 6 birds per cage. Two cages were assigned in a 
randomized complete block design to one of the six ideal protein-balanced experimental 
diets (Table 6.3) up to the end of experiment (day 28). Diets were formulated to contain 
7.6 and 10.6 (control), 17.8 and 40.6 (G1P3), 27.8 and 30.6 (G2P2), 37.8 and 20.6 
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(G3P1), 47.7 and 10.6 (G4P0) and 7.8 and 50.6 (G0P4) g/kg total glycine and proline, 
respectively, provided primarily by supplementing with encapsulated glycine or proline 
as required (JEFO Nutrition Inc., St. Hyacinthe, Quebec, Canada). The control diet was 
formulated to contain 190 g/kg crude protein, and remainder of the diets contained 230 
g/kg crude protein. The diets were isocaloric (12.8 MJ/kg ME), contained 11.6 g/kg 
lysine with other essential amino acid levels formulated to be within 10 per cent of ideal 
protein ratio. The diets met or exceeded the NRC requirements for broiler chickens for all 
other nutrients (NRC, 1994). 
6.3.1.2.2. Experiment 2  
 On the basis of results of experiment 1, encapsulated proline was excluded from 
experiment 2.  A total of forty eight, one-day old male Ross broiler chicks (Gallus 
domesticus) were housed randomly into 4 electrically heated battery cages (12 birds per 
cage) and received the same starter diet as described above for first 14 days of life. On 
day 14, birds were weighed; randomized and 2 cages of 6 birds each were assigned to one 
of 4 different ideal protein-balanced experimental diets formulated to contain 7.6 (LG), 
21.0 (MG), 34.3 (HG) or 47.7 (UHG) g/kg glycine mainly provided by supplemented 
encapsulated glycine (Table 6.4). The diets were isocaloric (12.8 MJ/kg ME) and 
contained 11.5 g/kg proline and 11.6 g/kg lysine with other essential amino acid levels 
formulated to be within 10 per cent of ideal protein ratio. The diets met or exceeded the 
NRC nutrient requirements for broiler chickens for all other nutrients (NRC, 1994).  
 The research facility was thoroughly cleaned and disinfected prior to bird 
placement. The battery cages were arranged in four levels with a wire floor and were 
equipped with external feed and water troughs. The cages were continuously illuminated 
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(24 h/day) and located in a room with controlled temperature and humidity. Room 
temperature was maintained according to industry standards. None of the experimental 
diets contain antibiotics or coccidiostats and were not pelleted. An indigestible marker, 
Celite (Celite Corporation, Lompoc, California, USA) was mixed in each diet in both 
experiments at a concentration of 2%. Throughout the experimental period in each 
experiment, birds were fed and watered ad libitum. Feed consumption and body weight 
for each cage was recorded for the period day 14-21 and day 21-28 in each experiment 
for calculation of mortality-corrected feed conversion. Amino acid analysis of the 
different diets was performed by Degussa Corporation (Degussa Canada Inc., Burlington, 
ON, Canada).  
6.3.2. Clostridium perfringens Challenge 
 The C. perfringens-challenge model was based on that developed originally by 
Dahiya et al. (2005). Briefly, an avian C. perfringens field strain isolated from a clinical 
case of NE was obtained from Dr. Manuel Chirino, College of Veterinary Medicine, 
University of Saskatchewan and characterized by PCR technique as type A toxin 
producer. The organism was cultured anaerobically on BBLTM Blood Agar Base (Becton, 
Dickinson and Co., Sparks, MD, USA) containing 5.0% sheep blood and 100 mg/L 
Neomycin Sulfate (The Upjohn Company, Orangeville, ON, Canada) for 18 h at 37°C, 
then aseptically inoculated into cooked meat medium (Difco Labs, Detroit, MI), and 
incubated anaerobically for 8 h at 37°C. All birds were orally challenged in the crop with 
0.5 mL on day 1 and 1.0 mL on days 14 to 21 inclusive with this actively growing culture 
of C. perfringens using a 12.0 mL syringe equipped with vinyl tubing (I.D. 0.97mm, O.D. 
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1.27mm). Bacterial counts were performed on the culture daily prior to inoculation and 
the numbers ranged from 6.38 x 105 to 7.29 x 106 CFU/mL. 
6.3.3. Pathological Parameters 
Birds were observed on a pen basis at least once daily for any sign or symptom of 
NE and all birds that died during the course of experiments were necropsied to determine 
the cause of death. On day 28, the surviving chickens were euthanized by cervical 
dislocation, weighed and necropsied. Intestinal tracts were removed immediately and 
intestinal lesions were scored blindly according to the method of Truscott and Al-
Sheikhly (Truscott and Al-Sheikhly, 1977) with slight modifications on a scale 0 to 4 
where 0 was apparently normal, no lesion; 0.5 severely congested serosa and mesenteric 
vessels engorged with blood; 1 thin walled and friable intestines with small red petechiae 
(> 5); 2 focal necrotic lesions; 3 patches of necrosis (1-2 cm long); and 4 diffused 
necrosis typical of field cases. Following postmortem examination, a 1.5-2.0 cm long 
intestinal tissues piece from the ileum with the gross NE lesion was collected in 
phosphate-buffered formaldehyde solution and processed routinely for paraffin 
embedding, sectioned at approximately 5 µm, and stained with haematoxylin and eosin. 
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Table 6.1. Ingredient composition of starter diet used in pilot study (up to day 20 
of age) as well as in definitive study (up to day 14 of age)1. 
Ingredients Inclusion (g/kg) 
Soybean meal 409.0 
Corn 395.0 
Wheat 100.0 
Tallow 45.2 
Dicalcium phosphate 15.3 
Calcium carbonate 12.9 
Canola oil 10.0 
DL-methionine 2.6 
Choline chloride 1.0 
Vit/Min. premix2 5.0 
Salinomycin sodium3 0.6 
Bacitracin4 0.5 
Bio-cox 1205 0.5 
 
1 Diet was formulated to contain 315 g/kg crude protein and meet NRC requirements 
for broiler chickens. 
2 Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 µg; vitamin E, 
30 mg; vitamin K, 0.5 mg; vitamin B12, 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; 
folic acid, 0.6 mg; biotin, 0.15 mg; niacin, 60 mg; pyridoxine, 5 mg; sodium, 511 mg; 
iron, 80 mg; maganese, 21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
3 Phibro Animal Health Ltd. 
4 Alpharma Canada Corp. 
5 Anticoccodial Premix, OzBioPharma Ltd. 
 
 
 
 
 
 
 
 142
 
Table 6.2. Composition of experimental diets used in pilot study (g/kg as is basis). 
 
Ingredients  Crystalline glycine diet Encapsulated glycine diet 
Corn, yellow grain                     500.0 500.0 
Barley grain, western                260.8 260.8 
Soybean meal dehulled 48%     118.8 118.8 
Fish meal, herring 72%             58.7 58.7 
Encapsulated glycine 0.0 118.0 
Crystalline glycine 40.0 0.0 
Canola oil1 73.7 0.0 
Calcium carbonate           18.2 18.2 
Dicalcium phosphate                 10.6 10.6 
Arginine                                 12.0 12.0 
L-lysine                               6.1 6.1 
DL-methionine                          3.0 3.0 
L-tryptophan                             2.5 2.5 
L-threonine                              2.2 2.2 
L-isoleucine                               0.6 0.6 
Vit./Min. premix2                      5.0 5.0 
Choline chloride                        1.0 1.0 
Analyzed Composition   
Crude Protein 232.5 231.8 
Essential amino acids   
Arginine 18.1 18.3 
Histidine 3.9 4.0 
Isoleucine 6.8 7.2 
Leucine 13.9 14.3 
Lysine 13.4 13.2 
Methionine 5.3 5.7 
Methionine + Cystine 8.0 8.4 
Phenylalanine 7.6 7.8 
Threonine 7.9 7.8 
Valine 7.9 7.5 
Nonessential amino acids   
Alanine 8.8 9.1 
Aspartate 14.0 14.3 
Cysteine 2.7 2.7 
Glycine 43.9 45.3 
Glutamate 28.1 28.5 
Serine 7.3 7.3 
 
1Canola oil is added in crystalline glycine diet to make the diets isoenergetic because 
encapsulated glycine contains 342.6 g/kg CP and 625.0 g/kg ether extract. 
2Composition is the same as shown in Table 6.1. 
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Table 6.3. Composition of experimental diets fed to broiler chickens from day 14-28 
of age in experiment 1 (g/kg as is basis)1. 
 
 Control G1P3 G2P2 G3P1 G4P0 G0P4 
Corn, yellow, grain 466.4 417.7 418.0 418.3 394.5 417.5 
Barley, grain, western 200.0 181.0 180.5 179.9 200.0 181.5 
Soybean meal dehulled 171.8 174.2 174.3 174.4 177.0 174.0 
Encapsulated glycine 0.0 29.3 58.7 88.1 117.4 0.0 
Encapsulated proline 0.0 86.7 57.8 28.9 0.0 115.6 
Fish meal, herring 45.1 53.4 53.4 53.4 50.7 53.4 
Dicalcium phosphate 21.8 21.7 21.7 21.7 21.8 21.7 
Calcium carbonate 12.8 13.5 13.5 13.5 13.6 13.5 
Canola oil 67.9 8.5 8.3 8.0 10.8 8.8 
Vit/Min. premix2 5.0 5.0 5.0 5.0 5.0 5.0 
L-lysine 2.5 2.2 2.2 2.2 2.4 2.2 
DL-methionine 1.9 1.9 1.9 1.9 2.0 1.9 
L-threonine 1.7 1.8 1.8 1.8 1.9 1.8 
L-isoleucine 1.0 1.1 1.0 1.0 1.1 1.0 
L-arginine 1.0 0.9 0.9 0.9 1.0 0.9 
Choline chloride 1.0 1.0 1.0 1.0 1.0 1.0 
Analyzed Composition       
Crude Protein 207.7 246.0 249.4 251.4 250.5 240.2 
Essential amino acids       
Arginine 12.7 13.0 12.9 12.6 12.8 12.8 
Histidine 5.2 5.2 5.1 5.2 5.1 5.1 
Isoleucine 9.1 9.5 9.7 9.3 9.2 9.2 
Leucine 17.3 16.9 16.7 16.8 16.8 16.8 
Lysine 12.5 12.8 12.6 12.4 12.6 12.3 
Methionine 5.7 5.9 6.4 5.7 6.1 5.9 
Methionine + Cystine 8.8 8.9 9.4 8.7 9.0 8.9 
Phenylalanine 9.9 9.8 9.7 9.8 9.7 9.8 
Threonine 9.4 9.5 9.6 9.3 9.3 9.4 
Valine 9.8 9.8 9.9 9.8 9.8 9.7 
Nonessential amino acids       
Alanine 10.8 10.7 10.6 10.6 10.6 10.6 
Aspartate 18.3 18.6 18.6 18.4 18.4 18.6 
Cysteine 3.1 3.0 3.0 3.0 2.9 3.0 
Glycine 8.5 21.7 31.8 41.9 51.0 10.2 
Glutamate 36.9 36.1 36.2 36.3 36.3 36.4 
Proline 12.8 43.2 35.5 22.7 12.1 56.2 
Serine 9.4 9.3 9.2 9.1 9.1 9.4 
 
1 Diet abbreviations are as follows: Control, 7.6 g/kg glycine and 10.6 g/kg proline with 190 g/kg CP; 
G1P3, 17.8 g/kg glycine and 40.6 g/kg proline with 230 g/kg CP; G2P2, 27.8 g/kg glycine and 30.6 g/kg 
proline with 230 g/kg CP; G3P1, 37.8 g/kg glycine and 20.6 g/kg proline with 230 g/kg CP; G4P0, 47.7 
g/kg glycine and 10.6 g/kg proline with 230 g/kg CP, G0P4, 7.8 g/kg glycine and 50.6 g/kg proline with 
230 g/kg CP. 
2 Composition is same as shown in Table 6.1.  
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Table 6.4. Composition of experimental diets fed to broiler chicken from day 14-28 of 
age in experiment 2 (g/kg as is basis)1. 
 
 LG MG HG UHG 
Barley, grain, western 200.0 200.0 200.0 200.0 
Corn, yellow, grain 466.4 442.4 418.4 394.5 
Fish meal, herring 45.1 47.0 48.8 50.6 
Soybean meal dehulled 171.9 173.6 175.3 176.9 
Encapsulated glycine 0.0 39.1 78.3 117.4 
Canola oil 67.9 48.9 29.9 10.8 
Calcium carbonate 12.8 13.1 13.3 13.6 
Dicalcium phosphate 21.8 21.8 21.8 21.8 
Lysine HCl 2.5 2.5 2.4 2.4 
DL-methionine 1.9 1.9 2.0 2.0 
L-threonine 1.7 1.8 1.8 1.9 
L-arginine 1.0 1.0 1.0 1.0 
L-isoleucine 1.0 1.0 1.1 1.1 
Vit/Min. premix2 5.0 5.0 5.0 5.0 
Choline chloride 1.0 1.0 1.0 1.0 
Analyzed composition     
Crude Protein 187.0 203.2 218.9 220.8 
Essential amino acids     
Arginine 11.4 11.3 11.9 11.7 
Histidine 4.5 4.5 4.7 4.5 
Isoleucine 8.1 8.0 8.3 8.1 
Leucine 15.4 15.3 15.4 15.1 
Lysine 11.5 11.9 12.2 11.8 
Methionine 5.0 5.4 5.3 5.7 
Methionine + Cystine 7.8 8.2 8.1 8.4 
Phenylalanine 8.4 8.2 8.4 8.2 
Threonine 8.2 8.5 8.5 8.7 
Valine 8.6 8.5 8.8 8.6 
Nonessential amino acids     
Alanine 9.1 9.2 9.5 9.4 
Aspartate 16.3 16.2 17.0 16.5 
Cysteine 2.8 2.8 2.7 2.7 
Glycine 7.6 22.3 34.6 45.4 
Glutamate 32.6 31.9 32.5 31.9 
Proline 11.9 11.6 11.0 11.3 
Serine 8.3 8.3 8.5 8.3 
 
1 Diet abbreviations are as follows: LG, low glycine diet i.e. 7.6 g/kg glycine and 190 g/kg CP; MG, 
medium glycine diet i.e. 21.0 g/kg glycine and 203 g/kg CP; HG, high glycine diet i.e. 34.3 g/kg glycine 
and 217 g/kg CP; UHG, ultra high glycine diet i.e. 47.7 g/kg glycine and 230 g/kg CP. 
2 Composition is same as shown in Table 6.1.  
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6.3.4. Quantification of C. perfringens and Lactobacilli 
 In both experiments, the fresh intestinal contents from ileum (Meckel’s 
diverticulum to 1 cm proximal to ileocecal junction) and ceca were collected aseptically 
into sterilized plastic dram vials and mixed well. Using sterile spatula, the subsamples 
were transferred into pre-weighed 15 mL sterile plastic tubes containing 1mL 0.1% 
sterile peptone buffer with 5 g/L cysteine hydrochloride. The ceca samples were directly 
collected into the pre-weighed 15 mL sterile tubes. The samples were immediately placed 
and kept on ice until plated within 3 h of collection. The samples were weighed and 
diluted in peptone water to an initial 10-1 dilution. Ten-fold dilutions were spread in 
duplicate using an automated spiral plater (Autoplate, Spiral Biotech Inc., Bethesda MD, 
USA) on BBL Blood Agar Base (VWR International, Mississauga ON) containing 50 
mL/L sheep blood and 100 mg/L neomycin sulfate (The Upjohn Company, Orangeville, 
ON, Canada) for the enumeration of C. perfringens and MRS agar (Becton, Dickinson 
and Co., Sparks, MD, USA) for the enumeration of lactobacilli. The blood agar/neomycin 
plates were incubated anaerobically for 24 h at 37°C while MRS agar plates were 
incubated anaerobically for 48 h at 37°C.  The α- and β- hemolytic colonies on blood 
agar/neomycin plates were counted as C. perfringens with presumptive colonies being 
randomly picked, Gram stained, plated on Mannitol Yolk Polymixin agar (Oxoid Inc., 
Napean, ON, Canada) and examined microscopically to confirm them as C. perfringens. 
Bacterial counts were expressed as the Log10 CFU/g of intestinal contents. 
6.3.5. Samples for Amino Acids Digestibility Determination 
In both experiments, the remainder of the ileal contents of 3 birds from each pen 
was pooled, lyophilized and analyzed for amino acid content (Degussa Canada Inc., 
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Burlington, ON). The acid insoluble ash in experimental diets and freeze dried ileal 
digesta samples was determined using method of MaCarthy et al.  (1974). Amino acid 
digestibilities were calculated using the formula: 
  (Amino acid/acid insoluble ash) diet - (Amino acid/acid insoluble ash) digesta    
                 (Amino acid/acid insoluble ash) diet 
6.3.6. Whole Blood Chemiluminescence Assay  
 In experiment 2, three mL peripheral blood was collected into 4 mL sodium 
heparin tubes (Vacutainer®, BD) from all birds before killing on day 28 from the brachial 
vein. Hanks’ balanced salt solution (HBSS, Sigma) was used for the dilution of blood and 
for preparing working solutions of various reagents used during the assay. Zymosan A 
from Saccharomyces cerevisiae (Sigma) was prepared as described by (Marnila et al., 
1995), and was used non-opsonized as a stimulator of cells, whereas Lucigenin (N, N’-
Dimethyl-9, 9’-biacridium dinitrate; Sigma) was used as a light enhancer.  
Briefly, blood was first diluted in HBSS and added to clear Polysorp microplates 
(Nunc, Denmark). Working solution of zymosan was added to the diluted blood samples 
followed by addition of lucigenin, both within 2 min before starting test run in a Novostar 
(BMG Labtech) luminometer. The final reaction volume was 150 μL in each well, with 
final blood dilutions of 1:15, final zymosan dilution of 0.3 mg/mL and a final lucigenin 
concentration of 0.3 mM. Light emission was recorded over a 2-3 h period, at 4 min 
intervals and 1.5 sec/reading at 39 ºC. Plates were shaken for 5 sec before each interval. 
Light emission results are presented as counts per min (light units measured per min). 
Background light emission was subtracted.  
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6.3.7. Statistical Analyses 
 In pilot study, the effects of two diets (crystalline versus encapsulated glycine 
based) on the concentration of glycine in intestinal contents of birds were compared using 
one-way analysis of variance and differences between means were considered significant 
when P < 0.05.  In experiment 1 and 2, each cage was considered an experimental unit. 
Bacterial counts, growth performance and lesion scores were analyzed using General 
Linear Model procedure of SPSS (v.12.0, SPSS Inc, Chicago IL, USA). Treatment means 
were compared using the Ryan-Einot-Gabriel-Welch multiple F test, and were considered 
significantly different when P < 0.05. 
6.4. Results 
6.4.1. Effect of Encapsulation on Amino Acid Level in Intestinal Contents 
 The analyzed amino acid content of the experimental diets used in the pilot study 
was similar between diets including similar glycine content whether provided in 
crystalline or encapsulated form (Table 6.2). Glycine concentration was significantly 
higher (P < 0.05) in jejunum and ileum of birds fed encapsulated glycine (12.6 and 10.5 
g/kg) compared to crystalline glycine (9.8 and 6.2 g/kg) whereas there was no significant 
difference in glycine concentration in cecum (Figure 6.1). The rests of amino acids were 
in similar concentrations in both diets at all locations in the intestinal tract of these birds 
(data not shown). For diets used in the challenge experiment, analyzed dietary glycine 
and proline content were in reasonable concordance with supplemented levels and 
analyzed content of all other amino acids were similar (Tables 6.3 and 6.4). In agreement 
with results of the pilot study, glycine and proline content in ileal digesta collected during 
the challenge studies varied directly with the amount of encapsulated amino acid 
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supplemented in the diet (Table 6.5). In contrast, ileal content of all other amino acids 
was similar. The ileal digestibilities of various amino amino acids in both experiments are 
shown in Table 6.6. 
6.4.2. Performance Data 
 The experimental diets were readily accepted in both challenge experiments and 
there were no significant differences in feed consumption either during day 14-21 or day 
21-28 of age. In both experiments, diets did not affect average daily gain (ADG) and feed 
conversion (FC) at the end of 14-21 day period, whereas dietary treatments had a 
significant effect on ADG and FC at the end of 21-28 day period.  In experiment 1, ADG 
tended to be lower in the 230 g/kg CP diets supplemented with encapsulated amino acids 
(Table 6.7) compared with the 190 g/kg CP unsupplemented control diet. This response 
was significant (P < 0.05) in birds receiving G3P1 and G4P0 diets. Conversely, FC was 
significantly increased in all supplemented 230 g/kg CP diets. In experiment 2, ADG and 
FC was significantly lower (P < 0.05) in birds provided with UHG diets.  
6.4.3. Quantification of Lactobacilli and C. perfringens 
 Bacterial counts in ileum and cecum of chickens on day 28 of the two challenge 
experiments are presented in Figures 6.2 and 6.3. The number of lactobacilli and C. 
perfringens increased from the proximal to the distal part of the intestine with the highest 
counts measured in the ceca. In both experiments, we observed a decrease in number of 
lactobacilli and increase in C. perfringens with increased dietary glycine concentration.  
Significantly higher (P < 0.05) C. perfringens numbers were observed in the 
ileum and cecum of day-28-old chickens fed either G3P1 or G4P0 diets compared with 
those given either control or G0P4 diets in experiment 1 (Figure 6.2.B). Additionally, C. 
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perfringens numbers were not significantly different in birds fed lowest glycine diets with 
either 190 g/kg (control) or 230 g/kg (G0P4) crude protein which indicates that C. 
perfringens growth was not influenced by dietary crude protein or proline concentrations. 
In experiment 2, C. perfringens counts in ileum increased from 3.12 to 4.52 log10 CFU/g 
of intestinal contents as dietary glycine concentration increased from 7.6 to 47.7 g/kg, 
and the differences were significant (P < 0.05) among the birds which were fed either LG 
or MG diets and those fed either HG or UHG diets (Figure 6.3.B). The birds which were 
fed HG and UHG diets contained significantly elevated counts of C. perfringens in ceca 
compared to those fed LG diets. It should be noted that there was more than 2 log 
difference in cecal C. perfringens numbers when dietary glycine concentrations were 
increased from 7.6 to 47.7 g/kg.  
In experiment 1, a significant decline (P < 0.05) in the lactobacilli counts were 
observed in ileum of chickens fed G4P0 diet compared to rest of the dietary treatments 
while in cecum, the lactobacilli growth was significantly lower in birds fed G1P3 diet 
than those fed either control or G0P4 diets (Figure 6.2.A). However, there was a no 
significant difference in the lactobacilli numbers either in ileum or cecum of birds 
receiving either control or G0P4 diets i.e. low glycine diets (7.6 or 7.8 g/kg glycine) with 
low and high dietary crude proteins (either 190 or 230 g/kg).  In experiment 2, the 
lactobacilli numbers were significantly higher (P < 0.05) in ileum as well as cecum of 
chickens which were given LG diets than those with other levels of dietary glycine tested 
(Figure 6.3.A). Also there was no significant difference in lactobacilli growth in ileum 
and cecum among birds fed MG, HG or UHG diets. 
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Figure 6.1. Glycine concentration (g/kg) of digesta at different intestinal 
locations in chickens fed diets supplemented with either crystalline or fat 
encapsulated glycine in the pilot study. 
 a 
   b 
  a 
 b 
Table 6.5. Protein and amino acid contents (g/kg) of ileal digesta in experiments 1 and 2.   
 
 Experiment 11 Experiment 22 
 Control G1P3 G2P2 G3P1 G4P0 G0P4 LG MG HG UHG 
Crude Protein 106.9 109.1 122.3 133.3 113.8 133.4 122.5 117.1 116.1 111.2 
Essential amino acids          
Arginine 4.9 4.8 5.3 5.6 4.8 5.8 4.9 4.6 4.3 4.2 
Histidine 2.5 2.5 2.8 3.0 2.6 3.0 2.6 2.6 2.4 2.3 
Isoleucine 3.8 4.0 4.5 4.9 4.2 5.1 4.3 4.1 3.8 3.8 
Leucine 6.7 7.0 8.0 8.6 7.5 9.1 8.1 7.9 7.4 7.0 
Lysine 4.7 5.0 5.6 5.7 4.9 6.2 5.0 4.8 4.6 4.4 
Methionine 1.4 1.5 1.8 1.8 1.5 2.0 1.5 1.5 1.4 1.7 
Meth.+ Cyst. 3.4 3.5 4.0 4.2 3.6 4.4 3.7 3.8 3.5 3.8 
Phenylalanine 3.8 4.0 4.6 4.9 4.2 5.1 5.1 4.9 4.6 4.5 
Threonine 5.1 5.1 5.7 5.9 5.2 6.1 5.4 5.3 5.0 5.0 
Valine 4.7 5.0 5.4 6.0 5.2 6.2 5.3 5.2 4.8 4.8 
Nonessential amino acids          
Alanine 4.7 5.0 5.7 5.9 5.2 6.4 5.2 5.1 4.7 4.6 
Aspartate 10.3 10.4 11.5 12.4 10.6 12.4 11.3 10.5 10.1 9.9 
Cysteine 2.0 2.1 2.3 2.4 2.1 2.3 2.2 2.3 2.1 2.1 
Glycine 5.7 8.3 11.5 16.2 21.4 7.9 6.0 7.8 14.7 20.5 
Glutamate 12.1 12.5 14.4 15.8 13.7 16.0 14.9 13.9 13.1 12.4 
Proline 5.8 15.6 12.3 7.8 5.7 19.4 7.0 6.8 6.6 6.2 
Serine 5.1 5.1 5.7 5.9 5.1 6.1 5.5 5.6 5.1 5.0 
1 Diet abbreviations are as follows: Control, 7.6 g/kg glycine and 10.6 g/kg proline with 190 g/kg CP; G1P3, 17.8 g/kg glycine and 40.6 g/kg proline with 230 
g/kg CP; G2P2, 27.8 g/kg glycine and 30.6 g/kg proline with 230 g/kg CP; G3P1, 37.8 g/kg glycine and 20.6 g/kg proline with 230 g/kg CP; G4P0, 47.7 g/kg 
glycine and 10.6 g/kg proline with 230 g/kg CP, G0P4, 7.8 g/kg glycine and 50.6 g/kg proline with 230 g/kg CP. 
2 Diet abbreviations are as follows: LG, low glycine diet i.e. 7.6 g/kg glycine and 190 g/kg CP; MG, medium glycine diet i.e. 21.0 g/kg glycine and 203 g/kg 
CP; HG, high glycine diet i.e. 34.3 g/kg glycine and 217 g/kg CP; UHG, ultra high glycine diet i.e. 47.7 g/kg glycine and 230 g/kg CP. 
Table 6.6. Ileal digestibilities (%) of various amino acids in experiments 1 and 2.   
 
 Experiment 11 Experiment 22 
 Control G1P3 G2P2 G3P1 G4P0 G0P4 LG MG HG UHG 
Crude Protein 106.9 109.1 122.3 133.3 113.8 133.4 122.5 117.1 116.1 111.2 
Essential amino acids          
Arginine 87.28 86.63 84.12 81.12 85.39 83.29 86.17 85.63 85.29 85.42 
Histidine 84.15 82.32 78.48 75.60 80.24 78.23 81.04 80.10 79.12 79.13 
Isoleucine 86.18 84.58 82.18 77.95 82.20 79.55 82.84 82.11 81.47 81.30 
Leucine 87.20 84.92 81.39 78.42 82.70 80.06 82.96 81.81 80.62 81.21 
Lysine 87.48 85.85 82.66 80.48 85.00 81.50 85.80 85.76 84.91 84.94 
Methionine 91.82 90.74 89.38 87.02 90.31 87.40 90.25 90.41 89.31 87.96 
Meth.+ Cyst. 87.04 85.58 83.47 79.83 84.50 82.06 84.48 83.62 82.52 81.73 
Phenylalanine 87.38 85.14 81.58 78.86 83.12 81.08 80.17 79.02 78.08 77.71 
Threonine 81.93 80.36 76.84 73.40 78.43 76.28 78.69 78.00 76.44 77.02 
Valine 83.94 81.43 78.72 74.22 79.34 76.54 79.97 78.62 78.04 77.46 
Nonessential amino acids          
Alanine 85.43 83.07 79.30 76.46 81.08 77.92 81.43 80.63 79.98 80.34 
Aspartate 81.35 79.60 75.98 71.56 77.67 75.48 77.57 77.35 75.90 75.89 
Cysteine 78.51 75.12 70.54 66.52 72.27 71.55 74.17 70.84 68.15 68.59 
Glycine 77.57 89.47 92.95 93.74 94.36 71.48 74.44 87.72 91.81 92.76 
Glutamate 89.08 87.39 84.58 81.62 85.37 83.91 85.12 84.67 83.75 84.37 
Proline 84.91 95.30 92.07 87.43 81.66 95.72 81.02 79.42 75.91 77.84 
Serine 82.11 80.23 76.04 72.70 78.39 76.28 78.46 76.52 75.72 75.79 
1 Diet abbreviations are as follows: Control, 7.6 g/kg glycine and 10.6 g/kg proline with 190 g/kg CP; G1P3, 17.8 g/kg glycine and 40.6 g/kg proline with 230 
g/kg CP; G2P2, 27.8 g/kg glycine and 30.6 g/kg proline with 230 g/kg CP; G3P1, 37.8 g/kg glycine and 20.6 g/kg proline with 230 g/kg CP; G4P0, 47.7 g/kg 
glycine and 10.6 g/kg proline with 230 g/kg CP, G0P4, 7.8 g/kg glycine and 50.6 g/kg proline with 230 g/kg CP. 
2 Diet abbreviations are as follows: LG, low glycine diet i.e. 7.6 g/kg glycine and 190 g/kg CP; MG, medium glycine diet i.e. 21.0 g/kg glycine and 203 g/kg 
CP; HG, high glycine diet i.e. 34.3 g/kg glycine and 217 g/kg CP; UHG, ultra high glycine diet i.e. 47.7 g/kg glycine and 230 g/kg CP. 
Table 6.7. Average daily feed intake (ADFI, g/day), average daily gain (ADG, g/day) 
and feed:gain ratio (FC, feed intake/ weight gain, g/g) of birds during days 14-21 
and 21-28 of the main experiments. 
Days 14-21 Days 21-28  
Experimental 
diets 
ADFI ADG FC ADFI ADG FC 
Experiment 11      
Control 76.4 40.1 1.9 82.7 52.2a 1.6a 
G1P3 66.9 35.8 1.9 89.9 40.7ab 2.2b 
G2P2 68.1 36.2 1.9 94.0 44.4ab 2.1b 
G3P1 68.2 33.3 2.1 91.3 39.5b 2.3b 
G4P0 70.4 29.5 2.4 86.6 40.4b 2.1b 
G0P4 67.9 35.8 1.8 86.8 41.2ab 2.1b 
Pooled SEM 1.15 1.08 0.06 1.80 1.48 0.07 
P value 0.11 0.54 0.72 0.63 0.04 0.007 
Experiment 22      
LG 77.7 43.0 1.8 92.4 55.2a 1.7a 
MG 72.0 38.9 1.8 87.7 49.3a 1.8a 
HG 75.8 39.9 1.9 96.5 50.9a 1.9a 
UHG 68.4 33.5 2.0 90.4 42.6b 2.1b 
Pooled SEM 1.64 1.26 0.06 2.16 1.94 0.08 
P value 0.19 0.21 0.73 0.77 0.03 0.01 
 
abc Means with the different superscripts within a column (within a trial) differ significantly (P < 0.05)   
1 Diet abbreviations are as follows: Control, 7.6 g/kg glycine and 10.6 g/kg proline with 190 g/kg CP; 
G1P3, 17.8 g/kg glycine and 40.6 g/kg proline with 230 g/kg CP; G2P2, 27.8 g/kg glycine and 30.6 g/kg 
proline with 230 g/kg CP; G3P1, 37.8 g/kg glycine and 20.6 g/kg proline with 230 g/kg CP; G4P0, 47.7 
g/kg glycine and 10.6 g/kg proline with 230 g/kg CP, G0P4, 7.8 g/kg glycine and 50.6 g/kg proline with 
230 g/kg CP. 
2 Diet abbreviations are as follows: LG, low glycine diet i.e. 7.6 g/kg glycine and 190 g/kg CP; MG, 
medium glycine diet i.e. 21.0 g/kg glycine and 203 g/kg CP; HG, high glycine diet i.e. 34.3 g/kg glycine 
and 217 g/kg CP; UHG, ultra high glycine diet i.e. 47.7 g/kg glycine and 230 g/kg CP. 
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6.4.4. Clinical Symptoms and Necrotic Enteritis Lesions 
Subsequent to challenge with C. perfringens some of the birds were dull, 
depressed and had abnormally wet droppings for first 3-5 days (i.e. after day 14) in both 
experiments. During the course of this study, 3 birds died in experiment 1 (two from 
G3P1 while one from G1P3 groups) and 4 birds died in experiment 2 (three from UHG 
while one from MG groups) of causes unrelated to C. perfringens challenge.  Most dead 
birds were in good body condition and did not have any detectable gross lesions of NE 
either in intestine or any other organ with the exception of occasional petechial 
hemorrhages in distal jejunum and proximal ileum. Surviving birds had no apparent signs 
of morbidity 7-10 days post-challenge. 
The mean NE lesion scores of chickens fed different experimental diets and killed 
on day 28 are presented in Figure 6.4.  Some birds had very thin and friable intestinal 
wall with congested mucosa and mesenteric vessels engorged with blood having focal 
hemorrhagic lesions in various intestinal regions. In experiment 2, intestines of at least 
two birds were grossly hemorrhagic throughout with blood-stained fluid in the lumen. 
However, typical field type lesions specific to NE were not observed in any of the birds 
in either experiment. In experiment 1, there was no significant difference (P > 0.05) in 
the intestinal lesion scores in chickens among various dietary treatments although there 
was a tendency of increasing the NE lesions with increase in dietary glycine 
concentration with maximum score in birds fed G3P1 diet.  In experiment 2, intestinal 
lesion scores were significantly higher (P < 0.05) in birds which received UHG diet than 
those fed either LG or MG diets; no significant difference in the lesion score was 
observed with increase in dietary glycine concentration from 34.3 to 47.7 g/kg. 
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6.4.5. Histological Examination 
 Histological examination of formalin fixed intestinal tissues from 28-day-old 
broiler chickens euthanized in both experiments revealed no frank lesions of NE except 
slight edema and diffuse hemorrhages in lamina propria in some sections. There was no 
evidence of gram-positive rod-shaped organisms attached to intestinal mucosa. 
Polymorphonuclear cell infiltration in the lamina propria was not seen in any of the 
sections. There was no evidence of coccidial oocysts in any sections examined. 
6.4.6. Whole Blood Chemiluniscence Response 
 The WBCL assay was done only in experiment 2 and the results are presented in 
Figure 6.5.  The chemiluniscence response increased significantly (P < 0.05) in birds fed 
HG and UHG diets compared to LG diets. 
6.5. Discussion  
 Glycine is considered as a semi-essential amino acid in young broiler chicks and 
metabolic pathways involving glycine include the synthesis of proteins, purines, 
porphyrin moiety of heme groups, glutathione, creatine, uric acid, glycocholic acid and 
hippuric acid. Two experiments reported in this study support the hypothesis that the 
dietary glycine concentration is an important determinant of C. perfringens growth in the 
intestinal tract of broiler chickens and thus can predispose birds to clostridial enteritis. It 
was also suggested that C. perfringens growth is not significantly influenced by dietary 
proline or crude protein levels tested in this study. 
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Figure 6.2. Mean Lactobacilli (A) and C. perfringens (B) populations in ileum and 
cecum of broiler chickens on day 28 of experiment 1. Bars represent mean ± SEM. 
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Figure 6.3. Mean Lactobacilli (A) and C. perfringens (B) populations in ileum and 
cecum of broiler chickens on day 28 of experiment 2. Bars represent mean ± SEM. 
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Figure 6.4. Mean necrotic enteritis lesion scores in 28-day-old broiler chickens given 
experimental diets (day 14 to 28) containing different levels of encapsulated glycine 
and proline in experiments 1 and 2. 
 
 
 
 
 
 
 
 
 
 
b b
ab
a
 159
 
0.E+00
1.E+04
2.E+04
3.E+04
4.E+04
5.E+04
6.E+04
7.E+04
LG MG HG UHG
Experimental diets
Co
un
ts
 p
er
 m
in
ut
e
Co
un
ts
 p
er
 m
in
ut
e
 
Figure 6.5. Whole blood chemiluminescence (WBCL) response of broiler chickens in 
experiment 2. Lucigenin-dependent, non-opsonized zymosan-stimulated WBCL 
response was measured on day 28 of age. Peak WBCL responses (cpm) are shown. 
Diet abbreviations are as follows: LG, low glycine diet i.e. 7.6 g/kg glycine and 190 g/kg 
CP; MG, medium glycine diet i.e. 21.0 g/kg glycine and 203 g/kg CP; HG, high glycine 
diet i.e. 34.3 g/kg glycine and 217 g/kg CP; UHG, ultra high glycine diet i.e. 47.7 g/kg 
glycine and 230 g/kg CP. 
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 Previous studies in our laboratory have demonstrated that diets high in glycine 
added as animal proteins such as fish meal or gelatin can result in increased populations 
of C. perfringens (Dahiya et al., 2005; Drew et al., 2004). However, the addition of 40 
g/kg of crystalline glycine to the diet had no effect on C. perfringens populations in 
broiler chickens (Wilkie et al., 2005). Several studies have reported that crystalline amino 
acids are absorbed very rapidly in the small intestine (Drew et al., 2003; Lingens and 
Molnar, 1996; Maenz and Engele-Schaan, 1996). This rapid absorption might prevent the 
added glycine from reaching the distal small intestine making it unavailable to enteric 
bacteria including C. perfringens.  
 In the pilot study, we demonstrated that lipid encapsulation increased glycine 
concentration in jejunum and ileum of birds and effect confirmed in the challenge 
experiments. This suggests that the crystalline glycine was rapidly absorbed in the upper 
gastrointestinal tract whereas fat encapsulated glycine was released slowly along the 
length of intestine and would therefore be more available to enteric bacteria. Lipid 
encapsulation of amino acids has previously been reported for use in aquaculture larval 
feeds to prevent leaching of amino acids after immersion in water (Onal and Langdon, 
2004; Lopez et al., 1994). However, to our knowledge, lipid encapsulated amino acids 
have not been evaluated in poultry.  
 Average daily feed intake during day 14-21 and day 21-28 was not significantly 
different among various dietary treatments in both experiments indicating that palatability 
was not an issue with the experimental diets. Average daily gain and feed conversion 
ratio were not significantly altered during the period 14-21 day in both experiments while 
dietary treatments had a significant effect on these performance parameters during 21-28 
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day. This might be due to the fact that although orally challenged from day 14-21, C. 
perfringens counts did not substantially increase in the intestine until the period 21-28 
day. Commercial outbreaks of NE are more common around 28 day of age and may be 
related to maturation of the intestinal microbiota establishing conditions more conducive 
to C. perfringens colonization.  As evidenced by intestinal lesion scores and high 
intestinal colonization of C. perfringens, most of the birds in the present study had a 
subclinical form of NE as documented by Lovland and Kaldhusdal (2001). Decreased 
growth rate and poor feed conversion efficiency have already been reported in broilers 
having high numbers of C. perfringens in the intestinal tract (Dahiya et al., 2005; 
Kaldhusdal and Hofshagen, 1992; Stutz, 1983). Another possible explanation of lower 
ADG and poor FE in birds receiving high glycine diets in both experiments is the poor 
digestibility of the encapsulated material.  
 In the present study, we observed an increase in the intestinal populations of C. 
perfringens and decrease in lactobacilli when a high concentration of encapsulated 
glycine was used. However, dietary crude protein or proline level did not significantly 
influence these bacteria in the current study. This observation suggests that birds fed diets 
containing high levels of glycine will be at greater risk for a clinical outbreak of NE, 
increased carcass condemnations during processing and an increased risk of infection in 
humans.  
Dietary components such as fish meal, wheat, barley and rye have been widely 
accepted as predisposing factors for NE (Kaldhusdal and Hofshagen, 1992; Kaldhusdal 
and Skjerve, 1996; Riddell and Kong, 1992). High protein diets, particularly those 
containing proteins of animal origin have been reported to increase the incidence of NE 
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and have been used successfully to induce the disease experimentally (Truscott and Al-
Sheikhly, 1977; Wilkie et al., 2005). A number of studies have demonstrated that source 
and level of protein in diets had a profound affect on the number of C. perfringens in 
intestinal contents in chickens (Dahiya et al., 2005; Drew et al., 2004; Wilkie et al., 
2005), pigs (Mansson and Smith, 1962) and dogs (Zentek et al., 1998). Kaldhusdal and 
Skjerve (1996) conducted a longitudinal study of NE and feeding practices in Norway 
over a 20-year period and documented an increased incidence of NE with the use of 
rendered animal products. Because animal-source proteins contain from 2 to 4 times as 
much glycine as a percentage of crude protein compared to plant based proteins, glycine 
content may be one factor in animal protein-based diets that could be responsible for over 
proliferation of C. perfringens in the intestinal tract of animals.  
 Previously Drew et al. (2004) documented a significant increase in C. perfringens 
populations in ileum and cecum of broiler chickens fed fish meal-based diets with 400 
g/kg CP. However, there was no difference in C. perfringens growth in birds that 
received soy protein concentrate-based diets containing 230, 315 or 400 g/kg crude 
protein. Amino acid analysis of the diets suggested that glycine was in relative excess in 
400 g/kg CP diet than 400 g/kg CP soy protein concentrate diet. Wilkie et al. (2005) 
compared the effect of various protein sources (animal vs. plants) on intestinal 
colonization of C. perfringens in broiler chickens and reported a significant correlation 
between dietary glycine concentration and the number of C. perfringens in both ileum 
and cecum. Correlations between all other dietary amino acids and C. perfringens 
populations were not significant. They also observed a significant correlation between the 
glycine content of ileal digesta and C. perfringens numbers in both ileum and cecum. 
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Earlier we observed a significant quadratic response for C. perfringens growth in cecum 
of 28-day-old broiler chickens with maximum response at 33.0, 38.9 and 35.1 g/kg 
dietary glycine concentration with r2 values of 0.95, 0.99 and 0.95 in three different 
experiments. Also number of lactobacilli in cecum declined significantly with increasing 
levels of glycine in these experiments (Dahiya et al., 2005). Although glycine levels and 
C. perfringens populations were strongly correlated in this study, but gelatin was used in 
the experimental diets which also contains high levels of proline and results of these 
experiments were confounded by this factor. 
 In the present study, the number of lactobacilli decreased with increasing dietary 
glycine concentration, and this effect was clearer in experiment 2 than experiment 1. 
There was almost one log decrease in lactobacilli counts (both in ileum and cecum) in 
birds fed either the lowest and highest levels of dietary glycine. Interestingly, the effect 
of various dietary treatments on intestinal lactobacilli populations was opposite to that on 
C. perfringens populations which is consistent with earlier findings in which protein-
bound glycine was fed (Dahiya et al., 2005; Wilkie et al., 2005). One possible 
explanation is that high dietary glycine concentration might cause a reduction in lactic 
acid producing bacteria (mainly Lactobacillus, Streptococci, and Staphylococci) which 
are predominant in the intestines of normal healthy chickens and generally considered to 
be protective against colonization of pathogenic micro-organisms.  Fukata et al. (1991) 
reported that pathogenic effect of C. perfringens could be reduced by feeding chicks a 
monoflora of Lactobacillus acidophilus or Streptococcus faecalis. The probiotic strains of 
lactobacilli which are able to colonize the human intestinal tract induce epithelial cells to 
secret mucins that diminish enteric pathogens binding to mucosal epithelial cells 
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(Johansson et al., 1993). An antagonistic effect of lactobacilli against Helicobacter pylori 
(Aiba et al., 1998), Salmonella spp. (Gill et al., 2001), E.coli (Mangell et al., 2002) and 
Listeria monocytogenes (de Waard et al., 2002) has been demonstrated in murine model. 
The antagonistic activity may be mediated either directly by the  production of inhibitory 
substances such as lactic acid, hydrogen peroxide and bacteriocins or by competing with 
the pathogen for binding sites on the epithelial cell surface. 
The exact mechanism(s) by which glycine promotes the intestinal growth of C. 
perfringens in broiler chickens is unclear. Titball et al. (1999) documented that growth of 
C. perfringens and production of α toxin is influenced by various amino acids. Glycine 
accelerated the C. perfringens growth (Ispolatovskaya, 1971) while α toxin production 
required the presence of glycine-containing peptides in defined media (Nakamura et al., 
1968; Stevens and Rood, 2000). Putrefactive clostridia and anaerobic Gram-positive 
cocci have been considered to be important amino acid fermenting bacteria (Mead, 1971). 
Earlier in an in vitro study of amino acid fermenting bacteria in human large intestine, it 
was reported that all clostridia were able to attack single amino acids, with pairs of amino 
acids not being essential, although Clostridium bifermentans and C. indolis were 
enhanced when provided with Stickland amino acid pairs (Smith and Macfarlane, 1998). 
It is well documented phenomenon that some strict anaerobic bacteria have a unique 
energy conserving mechanism and they catalyze with glycine as substrate using an 
internal Stickland reaction in which glycine serves as electron donor during oxidation by 
a glycine cleavage system or as electron acceptor being reduced by glycine reductase. 
The glycine reductase system is present in several clostridia (C. sticklandii, C. difficile, C. 
litorale and Eubacterium acidaminophilum) and catalyzes the reductive deamination of 
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glycine to acetylphosphate and ammonia with the generation of adenosine 5’-triphosphate 
from adenosine 5’-diphosphate and orthophophate (Costilow, 1977; Andreesen, 1994).  
However, C. perfringens is not a protein fermentor and this suggests that the effect of 
higher levels of dietary glycine on intestinal C. perfringens populations might be indirect. 
As C. perfringens is a strong mucolytic bacterium, it enjoys a growth advantage over 
several other bacteria in the intestinal tract (Deplancke et al., 2002). High glycine diets 
may somehow enhance mucus production and secretion through up regulation of mucin 
gene, thus providing intestinal mucus constantly. Another possibility is that the 
protein/amino acids are serving as energy and/or nitrogen source for other microflora in 
the intestinal tract that in turn modify the intestinal micro-environment in a way which 
promotes clostridial overgrowth or stimulates toxin production in the intestinal lumen. 
This may occur by providing positive selection pressure on those gastrointestinal 
microbes which can directly ferment amino acids for carbon and nitrogen, in doing so 
make available to C. perfringens nutritional resources that would be otherwise 
unavailable in highly competitive environment of intestinal tract. Alternatively, the high 
glycine diets might affect the host in such a manner that the gastrointestinal milieu is 
made more favorable for C. perfringens proliferation i.e. induction of an inflammatory 
response, which in turn leads to leakage of serum proteins into the gut lumen. This 
leakage of serum protein may ultimately provide the environmental stimulus required for 
an expansion of C. perfringens population, and perhaps even the up regulation of 
virulence factors (Shane et al., 1985). Clearly, further research is required to elucidate the 
exact mechanism by which glycine increases C. perfringens populations in the intestinal 
tract of broiler chickens 
 166
 In the current study, despite inoculation of very high doses (6.38 x 105 to 7.29 x 
106 CFU/mL) it was not possible to induce NE-specific mortality. Previous controlled 
studies of chickens challenged with C. perfringens have also failed to induce mortality or 
other signs of NE, even though high C. perfringens colonization was reported in the 
intestinal tract of the birds (Cowen et al., 1987; Drew et al., 2004; Wilkie et al., 2005). In 
several of the previously described models of clinical NE, birds were co-infected with 
Eimeria spp. along with C. perfringens (Al-Sheikhly and Al-Saieg, 1980; Shane et al., 
1985; Triscott and Al-Sheikhly, 1977), but the model described in the present study is 
designed for sub clinical form of the disease because lesions are more sensitive disease 
indicator than mortality, and sub clinical NE is more frequent than clinical disease in 
broiler chickens as described by Kaldhusdal et al. (1999).  Since C. perfringens is the 
etiological agent of NE it seems reasonable to assume that increased numbers of this 
organism in the gut are associated with an increased predisposition to clinical NE.  
 In agreement with our previous findings, with an increase in dietary glycine 
concentration there was a corresponding increase in NE lesion scores although the 
differences were only significant in experiment 2, between birds fed UHG and LG or MG 
diets. The demonstration of a relationship between NE lesion scores, performance data 
and C. perfringens numbers is an important feature of both experiments. There was no 
bird with full blown field type lesion of NE (i.e. with score of 4) in any of the 
experiments, although there were two birds with score of three in experiment 2. Lesion 
scores were very similar in birds fed either control or G0P4 diets indicating that dietary 
crude protein or proline concentrations had no effect on C. perfringens growth and NE 
lesions in these birds. In the present study, even clinically healthy birds were highly 
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colonized with C. perfringens which confirms the sub clinical nature of the disease 
because high numbers of C. perfringens with macroscopically visible, focal necrotic 
lesions in the small intestine is a strong indicator of an occurrence of NE (Kaldhusdal and 
Hofshagen, 1992). Previously, C. perfringens has also been isolated from the bile ducts 
and livers of affected birds and is associated with fibrosing hepatitis, which results in 
liver abnormalities and condemnation of processed birds. It would be interesting to 
enumerate C. perfringens in liver tissue and examine the liver for any lesions in 
subsequent studies. 
 The WBCL response was significantly elevated in HG and UHG groups 
compared to LG treatment. There was a nice relationship between the WBCL response, 
intestinal C. perfringens populations and NE lesions in the current study. Elevated 
WBCL responses are generally correlated with increased PMN numbers in blood in 
different species including chickens (Nagahata et al., 1991; Tono-Oka et al., 1983). 
Leukocytosis and heterophilia are often associated with infectious agents such as bacteria 
in birds, and the magnitude of heterophilia usually indicates the magnitude or severity of 
the initiating inflammatory process. Although the role of heterophils in fighting against 
bacterial infection usually involves infiltration of heterophils at the site of invasion, 
heterophil infiltration in the lesions was not observed in our experiments. This may be 
due to the fact that α toxin prevents the influx of PMNs at the site of infection (Bryant et 
al., 1993; Stevens et al., 1997). To our knowledge, this is the first report using the WBCL 
assay as a measure of innate immune reponses in domestic chickens exposed to various 
experimental treatments. Specifically, we used this assay to gain information about 
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phagocyte function in the blood of chickens on different experimental diets and 
challenged with C. perfringens.  
In contrast to some earlier findings, the microscopic lesions in intestine were not 
conclusive of NE in the present study (Long et al., 1974; Shane et al., 1985). Presence of 
slight edema and hemorrhages in lamina propria were observed in few birds. However, 
desquamated epithelial cells and polymorphonuclear cells (PMN) were not detected in 
any of the sections. Previously, an absence of PMN cells at the site of C. perfringens 
infection had been demonstrated, and it was postulated that higher in situ concentration of 
C. perfringens toxins, especially α toxin, may inhibit PMN influx (Stevens et al., 1997). 
So in spite of high numbers of C. perfringens in the intestinal tract of these birds, the 
clinical disease could not be produced. It is possible that some other triggering factors 
might be required to produce a full blown disease through secretion of α toxin. An 
experimental study investigating the effect of purified α toxin on intestinal epithelium is 
needed in order to provide evidence of a casual relationship between α toxin and NE 
changes. 
 In conclusion, dietary glycine concentration plays an important role in altering C. 
perfringens and lactobacilli populations in the intestinal tract of broiler chickens, whereas 
proline concentration or crude protein level as such has no significant effect on this 
important group of bacteria. Although there were very high numbers of C. perfringens in 
the intestinal tract of these birds, still the disease typical of field cases could not be 
produced, which again demonstrates a complex multi-factorial epizootiology of NE. 
Nevertheless high numbers of C. perfringens in the intestine are a strong indicator of an 
occurrence of clostridial enteritis. Poor feed conversion efficiency and reduced body 
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weight gain in birds with high C. perfringens colonization signifies the economic 
importance of this disease for the poultry producers. Balancing feed composition is 
probably the most cost-effective prevention and control measure of NE. Knowledge of 
specific dietary components, such as amino acid profile of different feed proteins and 
their propensity to cause disease, may aid in the formulation of broiler diets that reduce 
the risk of clostridial enteritis in post-antibiotic era.  The subclinical model of NE in 
broilers as presented here is suitable to evaluate the effects of feed additives and diet 
composition upon the occurrence of NE in broilers. 
6.6. Conclusions 
In conclusion, dietary glycine concentration plays an important role in altering C. 
perfringens and lactobacilli populations in the intestinal tract of broiler chickens, whereas 
proline concentration or crude protein level as such has no significant effect on this 
important group of bacteria. Although there were very high numbers of C. perfringens in 
the intestinal tract of these birds, still the disease typical of field cases could not be 
produced, which again demonstrates a complex multi-factorial epizootiology of NE. 
Nevertheless high numbers of C. perfringens in the intestine are a strong indicator of an 
occurrence of clostridial enteritis. Poor feed conversion efficiency and reduced body 
weight gain in birds with high C. perfringens colonization signifies the economic 
importance of this disease for the poultry producers. Balancing feed composition is 
probably the most cost-effective prevention and control measure of NE. Knowledge of 
specific dietary components, such as amino acid profile of different feed proteins and 
their propensity to cause disease, may aid in the formulation of broiler diets that reduce 
the risk of clostridial enteritis in post-antibiotic era.  The subclinical model of NE in 
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broilers as presented here is suitable to evaluate the effects of feed additives and diet 
composition upon the occurrence of NE in broilers. 
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7.0. OVERALL CONCLUSIONS 
 NE is a disease of poultry that has a high economic and animal welfare cost and 
has become increasingly prevalent in the world especially in the European Union due to 
removal of AGPs and coccidiostats from diet formulations. Currently, a large research 
effort is going on through out the world to develop cost-effective alternatives to AGPs in 
poultry feed. However, no single satisfactory non-antibiotic measure against C. 
perfringens has been identified so far. Strategies to control NE in the absence of AGPs, 
without resorting to the use of prophylactic or therapeutic treatment, have mainly 
centered upon dietary and management practices. 
 In order to explore new methods of controlling NE it is essential to be able to 
experimentally induce the disease in a controlled and reproducible manner that will allow 
testing of various therapeutic agents, feed additives, vaccines or other approaches. Nearly 
without exception, all current NE models employ a polymicrobial challenge using 
coccidia along with C. perfringens, the main etiological agent. However, to date, there is 
no generally accepted robust disease model for NE in poultry. In our model, the birds 
were not only challenged with a high dose of C. perfringens on day-of-hatch, but they 
were also orally gavaged for an additional seven days from day 14 through 20. This 
challenge model was based on work done by both others and ourselves and resulted in a 
reliable model for intestinal C. perfringens colonization. However, this model did not 
produce the disease typical of field cases although there were varying degrees of 
intestinal lesions of NE in most experiments. Additionally the microscopic lesions in the 
intestinal tissues were not conclusive of NE which illustrates a weakness of our challenge 
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model. Hence more comprehensive research is needed in this direction to develop a 
reliable and reproducible model of NE in poultry. 
 Chemical composition of the diet related to cereal grain selection, protein source 
and amino acid profile might influence disease propensity. Thus, a consideration of 
dietary chemical composition might be helpful in formulation of poultry diets to reduce 
the incidence of NE. The chicken gastrointestinal tract may contain more than 650 
bacterial species and they derive most of their energy for reproduction and growth from 
dietary compounds which are either not absorbed by the host or absorbed so slowly that 
bacteria can successfully compete for them. As different bacterial species have different 
substrate preferences and growth requirements, the chemical composition of the digesta 
largely determines the composition of microbial community in the chicken GIT. As a 
result, the microbial community structure is very much dependent upon the diet as the 
ultimate source of substrates for metabolism. This suggests that one of the most effective 
method to manage the enteric pathogens in the absence of AGPs is through appropriate 
ingredient selection and diet formulation that will influence the competitiveness of 
harmful and beneficial bacteria by changing the gut dynamics.  
 The amino acid composition and digestibility of dietary proteins has a profound 
impact on the incidence and severity of NE through altering the C. perfringens growth 
and/or α toxin synthesis and release. C. perfringens lacks the ability to produce at least 13 
amino acids out of 20 essential amino acids, and its growth is therefore enhanced in an 
environment rich with amino acids. Putrefactive clostridia and anaerobic gram-positive 
cocci have been considered to be important amino acid fermenting bacteria. Diets that 
contain relatively high concentrations of protein, as well as those with imbalanced 
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profiles of amino acids, have reduced digestibility in the upper GIT. Larger 
concentrations of these compounds are found in the lower GIT which act as substrates for 
the microflora, thus encouraging the proliferation of enteric pathogens including C. 
perfringens. It is worth noting that the amino acids are not always associated with C. 
perfringens growth. In one of our studies, we observed a significantly reduced population 
of C. perfringens in the intestinal tract of broiler chickens when fed high concentrations 
of dietary methionine.  The antibacterial effect against C. perfringens was not different 
among two commonly used methionine sources (DL-Met and MHA-FA). So there is a 
possibility of controlling NE in broiler chickens using low crude protein diets 
supplemented with relatively high concentrations of methionine. A further assessment of 
the putative associations between these methionine sources and NE is of considerable 
interest. Further studies to examine the impact of these two methionine sources on a 
wider group of bacteria in the GIT using PCR-based techniques would be an interesting 
addition to the present study.  
 The present studies demonstrated that the presence of glycine in the intestinal 
environment provides a stimulus for C. perfringens growth, thus increasing the risk of 
NE. It is still unclear whether glycine has a direct effect on C. perfringens or it affects 
indirectly through altering various other bacterial species in the GIT of birds. Some strict 
anaerobic bacteria have a unique energy conserving mechanism and they catalyze with 
glycine as substrate using an internal Stickland reaction. The glycine reductase system is 
present in several clostridia such as C. sticklandii, C. difficile, C. litorale and 
Eubacterium acidaminophilum. As C. perfringens is not a protein fermentor, the effect of 
higher levels of dietary glycine on intestinal C. perfringens populations might thus be 
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indirect. C. perfringens is a strong mucolytic bacterium, so it enjoys a growth advantage 
over several other bacteria in the intestinal tract. High glycine diets may somehow 
enhance mucus production and secretion through up regulation of mucin gene, thus 
providing intestinal mucus constantly. So further studies are needed to determine the 
exact mechanism(s) how glycine affects this important group of bacteria.  
 We also demonstrated a reduced lactobacilli population in birds fed high dietary 
glycine. Again it is hard to speculate whether it is lactobacilli populations that decrease 
first, resulting in C. perfringens overgrowth or vice versa. A better understanding of the 
dynamics of bacterial populations shifts due to dietary glycine concentrations are 
essential to developing a better understanding of the etiology of NE. However, it is 
possible to conclude that it is important to keep the glycine concentration to a minimum 
required level while formulating broiler diets to reduce the risk of NE, especially in adult 
birds.  
 In the present studies, we enumerated only some specific groups of intestinal 
bacteria using culture based methods. However, given the complexity of the intestinal 
microbiota, it would be extremely useful to use culture-independent approaches such as 
PCR with denaturing gradient gel electrophoresis that would allow the study populations 
shifts in a large number of intestinal bacterial species which may be involved in the 
development of clinical NE.  
A number of unresolved questions remain in determining the role of diet in 
predisposing broiler chickens to NE. What are the associated changes in intestinal 
morphology, gene expression and nutrient uptake that are associated with these dietary 
factors? Since C. perfringens metabolizes nutrients in the gut that were not absorbed by 
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the bird, what is the effect of reducing nutrient availability to the bacteria by increasing 
nutrient digestibility or lowering levels of dietary crude protein in broiler diets? How 
does the protein content of the diet interact with other dietary ingredients such as small 
grains? The answers to these questions may provide poultry producers with new tools for 
the reduction of NE in broiler chickens with the use of antibiotics. 
 New research should focus on reducing the risk of NE through control of C. 
perfringens in the immediate environment, removal of coccidiosis as a risk factor, and 
elimination of predisposing dietary factors. An improved understanding of the host, the 
microbes, molecular and cellular mechanisms of bacteria-host interactions, activation of 
innate and adaptive immune response in poultry and toxin-induced signal transduction 
across the intestinal epithelium is of prime importance. Further work is required to 
identify the initiating events of pathogenesis of NE. It is necessary to characterize various 
molecular and biochemical events that signal the cellular cascade that eventually results 
in clinical disease.   
 We are entering a new era of poultry nutrition where antibiotics and coccidiostats 
are becoming increasingly unavailable to the poultry industry. Thus new methods to 
control enteric pathogens must be developed. An improved understanding of the 
relationship between feed chemistry and enteric bacteria will help us in formulating 
broiler diets that might reduce the risk of various enteric pathogens including C. 
perfringens. 
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9.0. APPENDICES 
9.1. Appendix A 
 
Figure 9.1. Macroscopic appearance of C. perfringens colonies on Blood Agar Base 
containing 50 mL/L sheep blood and 0.01% neomycin sulfate, and incubated 
anaerobically for 24 h at 37°C.  The α- and β-hemolytic zones are clearly visible. 
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9.2. Appendix A 
 This in vitro experiment was conducted to find out the growth medium which 
supports the α toxin  production best so that we can use the same medium for growing C. 
perfringens for challenging the birds orally because the α toxin  is the main virulence 
factor responsible for NE in chickens. We studied three commonly used media for C. 
perfringens growth at two different concentrations (full strength, 100% and half strength, 
50%). 1. Brain heart infusion broth (BHI), 2. Cooked meat medium (CMM), and 3. 
Brewer’s thioglycolate broth (TGB) 
 Six, 250 mL culture flasks, each containing 100 mL of respective media (BHI, 
CMM and TGB) were used in this in vitro experiment. Culture flasks were pre-reduced 
overnight in anaerobic glovebox and the experiment was conducted anaerobically in the 
glovebox at 37˚C. 500 µL actively growing culture of C. perfringens type A was 
inoculated in each flask. At times 0, 2, 4, 6, 8, 12, 24, and 48 h, 500 µL culture were 
removed from each flask and centrifuged. The supernatant was stored quickly at -80°C. 
The α toxin (PC-PLC) activity was estimated using Amplex Red Phosphatidylcholine-
Specific Phospholipase C Assay Kit (Molecular Probes; Cedarlane Lab. Ltd.) according 
to the manufacture’s instructions.  
 We observed a much higher α toxin production in cooked meat media compared to 
brain heart infusion broth and thioglycolate broth (Figure 9.2A). Also there was not a 
significant difference in α toxin production between full strength (100%) and half 
strength (50%) cooked meat media and the production was maximum at h 8 in 50% 
CMM.  
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Figure 9.2A. Relative Phospholipase C production by C. perfringens in different 
media (CMM, cooked meat medium; BHI, brain heart infusion agar; TGB, 
thioglycolate broth) at different intervals of time. 
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9.2. Appendix B 
 This experiment was conducted to determine the relationship between C. 
perfringens populations and α toxin production in vitro.  
 Six, 250 mL culture flasks, each containing 100 mL of cooked meat media in 
three different concentrations i.e. 100, 50 and 10%, were used in this in vitro experiment 
i.e. there were two flasks for each concentration. Culture flasks were pre-reduced 
overnight in anaerobic glovebox and the experiment was conducted anaerobically in the 
glovebox at 37˚C. 500 µL of actively growing culture of C. perfringens type A were 
inoculated in three flasks (one from each concentration). At times 0, 2, 4, 6, 8, 12, 24, and 
48 h, 1mL culture was removed aseptically from each flask and divided in two aliquots. 
One aliquot (50µL) was diluted to10-2 and 10-4 dilutions and plated on BANeomycine plates 
in duplicates and plates were incubated at 37°C anaerobically. Second aliquot was 
centrifuged; supernatant was collected and stored immediately at -80°C for α toxin 
estimation using Amplex Red Phosphatidylcholine-Specific Phospholipase C Assay Kit 
(Molecular Probes, Cedarlane Lab. Ltd.). 
 We observed that there was a peak of α toxin at h 6 and 8 in 100 and 50% cooked 
meat media, respectively. Also there was an exponential growth of C. perfringens up to 6 
h in full strength media and it enters into the stationary phase. The exponential growth 
was achieved in first 2 and 4 h, respectively in 10 and 50% cooked meat media (Figure 
9.2B).  
Conclusions 
 From the above two in vitro experiments, we concluded that it is the cooked meat 
media which supports α toxin production best. There was a direct correlation between C. 
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perfringens count and α toxin production in vitro, which may not be true in vivo. We also 
concluded that C. perfringens count and α toxin production was at its peak between 6 to 8 
h in cooked meat media. So, we decided to use 6-8 h cooked meat media broth culture of 
C. perfringens for oral gavaging in our subsequent experiments so that we can challenge 
the birds with high number of actively growing C. perfringens and also a high amount of 
α toxin.  
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Figure 9.2B. C. perfringens growth and phospholipase C production in various 
concentrations of cooked meat medium at different time intervals. 
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9.3. Appendix A 
Supplemental image for chapter 5.  
A B
 
Figure 9.3A. Photographs showing mucosal surface of terminal ileum of 28-day-old 
broiler chickens challenged with Clostridium perfringens type A from 14-20 days of 
age. Mucosa is seen necrosed and covered with brownish pseudo-membrane (A and 
B).    
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Figure 9.3B. Photomicrographs of intestinal mucosa in normal healthy birds (A) 
and birds that developed lesions following the oral challenge with C. perfringens 
type A (B).  Original magnification: 50X. Severe congestion and/or hemorrhages 
were commonly present through out the lamina propria in challenged birds. Images 
are of formalin-fixed, H & E-stained tissue using an Axiostar plus Zeiss microscope 
(Carl Zeiss Vision GmbH, Germany) fitted with Axiocam MRc camera.   
 
